data_1pse_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1pse _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.512 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.7 t -90.57 162.15 15.13 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.249 -1.148 . . . . 0.0 109.416 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.83 115.58 23.56 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.502 -0.749 . . . . 0.0 109.151 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.4 m -116.85 124.54 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.499 -0.751 . . . . 0.0 110.016 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.4 ttpt -79.55 113.48 17.73 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.431 HG22 ' CZ ' ' A' ' 60' ' ' PHE . 35.3 mm -61.13 131.25 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.591 -0.693 . . . . 0.0 109.707 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -115.99 27.01 9.55 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.516 -0.74 . . . . 0.0 109.681 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.414 ' O ' ' CD1' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -85.64 119.77 26.34 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.421 -0.8 . . . . 0.0 109.283 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.87 -73.88 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.427 -0.795 . . . . 0.0 110.25 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -76.57 85.89 3.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.53 -0.731 . . . . 0.0 109.377 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.2 t -152.03 139.92 20.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.537 -0.727 . . . . 0.0 109.663 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.458 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 25.1 t80 -63.97 -15.42 59.2 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.686 -0.634 . . . . 0.0 110.366 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.502 ' CZ3' ' CD1' ' A' ' 40' ' ' PHE . 14.3 m0 -125.22 32.19 5.43 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.096 -1.002 . . . . 0.0 110.258 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.414 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 17.0 t80 -69.32 133.6 48.05 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.474 -0.766 . . . . 0.0 109.098 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.56 -12.73 66.04 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -95.04 -171.01 2.32 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.182 -1.187 . . . . 0.0 109.595 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.0 t -132.39 129.73 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.418 ' HA3' HG13 ' A' ' 38' ' ' VAL . . . -112.36 157.45 14.94 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 52.7 m -89.02 112.01 22.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.601 -0.941 . . . . 0.0 109.345 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 37.5 t -50.24 130.86 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.401 -0.812 . . . . 0.0 110.621 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -102.28 -48.35 4.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.663 -0.648 . . . . 0.0 109.529 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -174.37 156.16 2.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.594 -0.691 . . . . 0.0 109.601 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.436 ' N ' ' CD1' ' A' ' 27' ' ' ILE . 1.8 mp . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 . . . . . 0 N--CA 1.494 1.772 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -81.58 -15.34 9.82 Favored 'Trans proline' 0 C--N 1.325 -0.708 0 C-N-CA 122.007 1.805 . . . . 0.0 111.899 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.9 t -89.39 111.14 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.062 -1.024 . . . . 0.0 110.227 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.1 tp -91.21 117.66 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.322 -0.861 . . . . 0.0 108.725 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.425 ' HB ' ' CE1' ' A' ' 40' ' ' PHE . 44.3 t -94.0 162.98 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.5 -0.75 . . . . 0.0 109.476 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.406 ' N ' HG13 ' A' ' 38' ' ' VAL . 12.0 ttt180 -105.21 152.69 22.54 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.502 ' CD1' ' CZ3' ' A' ' 17' ' ' TRP . 87.3 m-85 -148.86 124.7 10.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.632 -0.667 . . . . 0.0 109.588 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -61.97 -26.18 68.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.497 -0.752 . . . . 0.0 109.214 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.76 160.28 9.66 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.553 -0.717 . . . . 0.0 109.601 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.3 t . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.828 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 . . . . . 0 N--CA 1.509 2.5 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.3 p -127.79 129.75 47.54 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.029 -1.044 . . . . 0.0 109.062 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.421 ' HB2' ' CE1' ' A' ' 40' ' ' PHE . 3.4 m-20 -105.75 174.73 5.76 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.572 -0.705 . . . . 0.0 109.425 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.404 ' O ' ' CD1' ' A' ' 60' ' ' PHE . 3.5 m-80 -112.0 140.09 46.96 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.431 ' CZ ' HG22 ' A' ' 10' ' ' ILE . 58.1 m-85 -154.82 147.69 24.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.6 -0.687 . . . . 0.0 109.505 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.5 173.2 12.2 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -63.4 -50.57 69.33 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.521 -0.737 . . . . 0.0 109.452 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.425 ' CD2' ' HG2' ' A' ' 64' ' ' GLU . 30.8 p-80 -69.09 -17.11 63.82 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.594 -0.691 . . . . 0.0 110.289 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.425 ' HG2' ' CD2' ' A' ' 63' ' ' HIS . 3.4 mm-40 -79.42 -20.89 46.44 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.251 -0.906 . . . . 0.0 110.054 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.3 mt -100.71 146.95 26.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.379 -0.826 . . . . 0.0 109.537 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -117.88 81.48 1.67 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.617 -0.677 . . . . 0.0 109.221 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.0 t -57.88 115.31 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.446 -0.784 . . . . 0.0 109.784 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.0 m . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.621 -0.675 . . . . 0.0 109.566 -179.923 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.567 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.2 t -90.55 162.99 14.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.228 -1.16 . . . . 0.0 109.421 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.5 mmtp -79.88 116.51 20.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.513 -0.742 . . . . 0.0 109.239 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.4 ' CG1' ' CG2' ' A' ' 24' ' ' VAL . 30.4 m -118.32 126.85 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.492 -0.755 . . . . 0.0 109.892 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -79.26 125.56 29.64 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.436 HG22 ' CZ ' ' A' ' 60' ' ' PHE . 26.6 mm -73.86 131.74 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.695 -0.628 . . . . 0.0 109.548 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -121.94 27.42 8.1 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.489 -0.757 . . . . 0.0 109.934 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.415 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -89.33 113.06 24.29 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.432 -0.792 . . . . 0.0 109.383 179.83 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.77 -55.4 26.72 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.475 -0.765 . . . . 0.0 110.239 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -84.9 77.19 10.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.544 -0.722 . . . . 0.0 109.382 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.98 137.93 20.24 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.554 -0.717 . . . . 0.0 109.699 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.455 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 16.8 t80 -64.05 -15.31 59.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.782 -0.574 . . . . 0.0 110.245 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.501 ' CE3' ' CD1' ' A' ' 40' ' ' PHE . 10.8 m0 -124.06 33.82 5.2 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.147 -0.971 . . . . 0.0 110.113 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.411 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 47.7 t80 -68.81 133.37 48.21 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.52 -0.738 . . . . 0.0 109.014 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.13 -18.89 55.9 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.42 158.03 15.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -1.142 . . . . 0.0 109.568 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 70.0 t -97.08 162.12 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -143.72 172.64 24.92 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.2 m -102.72 115.36 30.43 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.562 -0.963 . . . . 0.0 109.42 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.4 ' CG2' ' CG1' ' A' ' 8' ' ' VAL . 46.9 t -52.82 113.65 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.277 -0.889 . . . . 0.0 110.005 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -82.03 -48.38 11.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.659 -0.651 . . . . 0.0 109.777 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.1 m -167.78 156.69 9.57 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.499 -0.751 . . . . 0.0 110.026 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.1 mm . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.753 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.418 ' HB3' ' N ' ' A' ' 60' ' ' PHE . 22.1 m-85 . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -81.87 4.24 7.19 Favored 'Trans proline' 0 C--N 1.323 -0.776 0 C-N-CA 122.037 1.825 . . . . 0.0 112.021 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.2 t -112.86 112.79 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.977 -1.077 . . . . 0.0 110.505 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -101.41 116.53 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.136 -0.977 . . . . 0.0 108.904 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.419 ' HB ' ' CE1' ' A' ' 40' ' ' PHE . 20.4 t -92.9 164.33 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.499 -0.751 . . . . 0.0 109.008 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 -110.14 149.35 30.2 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.545 -0.722 . . . . 0.0 109.386 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.501 ' CD1' ' CE3' ' A' ' 17' ' ' TRP . 59.6 m-85 -142.57 138.54 30.89 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.595 -0.69 . . . . 0.0 109.543 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -62.88 -28.0 69.74 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.582 -0.699 . . . . 0.0 109.573 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.5 162.28 5.09 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.474 -0.766 . . . . 0.0 109.688 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.3 t . . . . . 0 N--CA 1.493 1.705 0 O-C-N 121.588 -0.695 . . . . 0.0 109.488 179.963 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.4 m120 . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 120.423 0.154 . . . . 0.0 110.692 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 59.4 p -154.78 129.65 9.4 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.156 -0.965 . . . . 0.0 109.383 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.434 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 13.1 t-20 -109.01 153.92 22.93 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.499 -0.751 . . . . 0.0 109.477 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.429 ' O ' ' CD1' ' A' ' 60' ' ' PHE . 6.2 m-80 -97.63 130.87 44.61 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.555 -0.716 . . . . 0.0 109.531 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.436 ' CZ ' HG22 ' A' ' 10' ' ' ILE . 32.9 m-85 -146.71 151.02 36.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.648 -0.657 . . . . 0.0 109.273 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.418 ' HB2' ' CE1' ' A' ' 63' ' ' HIS . . . -83.99 174.4 10.36 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -64.66 -42.96 95.05 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.51 -0.744 . . . . 0.0 109.511 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.418 ' CE1' ' HB2' ' A' ' 61' ' ' ALA . 8.7 p-80 -71.74 -23.25 61.58 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.628 -0.67 . . . . 0.0 110.21 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.403 ' HG3' ' CD2' ' A' ' 63' ' ' HIS . 12.4 mt-10 -79.74 -0.49 34.49 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.333 -0.855 . . . . 0.0 110.666 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.2 mt -120.8 146.13 46.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.072 -1.018 . . . . 0.0 109.453 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -116.33 91.36 3.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.593 -0.692 . . . . 0.0 109.452 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 43.0 t -60.15 95.02 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.474 -0.766 . . . . 0.0 109.596 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 N--CA 1.493 1.705 0 O-C-N 121.647 -0.658 . . . . 0.0 109.704 -179.908 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.524 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 31.0 t -90.73 162.0 15.09 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.34 -1.094 . . . . 0.0 109.513 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 56.1 mttt -80.57 111.31 16.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.511 -0.743 . . . . 0.0 109.169 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.6 m -112.75 127.77 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.485 -0.76 . . . . 0.0 109.88 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -79.15 127.67 32.32 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.424 HG22 ' CZ ' ' A' ' 60' ' ' PHE . 27.8 mm -76.45 132.3 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.642 -0.661 . . . . 0.0 109.326 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -124.51 28.92 6.45 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.509 -0.744 . . . . 0.0 109.875 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.411 ' O ' ' CD1' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -89.55 115.72 27.17 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.502 -0.749 . . . . 0.0 109.503 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.7 mmtm -53.03 -62.02 1.92 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.472 -0.768 . . . . 0.0 110.273 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -80.59 82.19 6.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.605 -0.684 . . . . 0.0 109.292 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.2 t -154.43 137.19 15.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.558 -0.714 . . . . 0.0 109.616 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.457 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 15.7 t80 -63.08 -16.32 59.55 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.665 -0.647 . . . . 0.0 110.183 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.495 ' CE3' ' CD2' ' A' ' 40' ' ' PHE . 9.0 m0 -123.91 35.73 4.77 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.188 -0.945 . . . . 0.0 110.0 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.411 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 26.6 t80 -70.17 118.65 13.26 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.63 -20.46 29.64 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.09 158.07 15.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -1.127 . . . . 0.0 109.563 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 66.6 t -95.75 162.54 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.401 ' HA3' HG13 ' A' ' 38' ' ' VAL . . . -143.45 173.18 24.53 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.5 m -105.61 113.43 26.99 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.407 -1.055 . . . . 0.0 109.488 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 37.7 t -51.28 117.49 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.286 -0.884 . . . . 0.0 110.409 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -89.8 -45.53 9.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.679 -0.638 . . . . 0.0 109.824 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -173.36 165.68 4.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.509 -0.744 . . . . 0.0 109.907 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.8 mm . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.833 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.412 ' HB3' ' N ' ' A' ' 60' ' ' PHE . 16.8 m-85 . . . . . 0 N--CA 1.496 1.863 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -84.27 -21.61 3.64 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.266 1.977 . . . . 0.0 111.961 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.6 t -79.84 111.19 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.225 -0.922 . . . . 0.0 110.728 -178.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -96.25 117.93 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.332 -0.855 . . . . 0.0 108.758 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.418 ' HB ' ' CZ ' ' A' ' 40' ' ' PHE . 21.7 t -96.17 163.77 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.462 -0.774 . . . . 0.0 108.977 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.7 mtt180 -105.06 149.08 26.12 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.449 -0.782 . . . . 0.0 109.338 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.495 ' CD2' ' CE3' ' A' ' 17' ' ' TRP . 82.0 m-85 -143.47 135.94 27.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.609 -0.682 . . . . 0.0 109.566 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -62.96 -28.93 70.42 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.576 -0.703 . . . . 0.0 109.392 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.27 162.18 6.3 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.605 -0.685 . . . . 0.0 109.614 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.2 t . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.558 -0.714 . . . . 0.0 109.482 179.964 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.2 m120 . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 120.385 0.136 . . . . 0.0 110.717 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 72.4 p -154.72 130.39 9.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.151 -0.968 . . . . 0.0 109.206 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.425 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 1.0 OUTLIER -118.39 125.82 50.79 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.444 -0.785 . . . . 0.0 109.67 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.42 ' O ' ' CG ' ' A' ' 60' ' ' PHE . 6.7 m-20 -64.01 149.84 46.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.555 -0.716 . . . . 0.0 109.19 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.425 ' CE2' ' HB3' ' A' ' 58' ' ' ASN . 14.5 m-85 -160.57 147.91 15.85 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.42 ' HB2' ' CE1' ' A' ' 63' ' ' HIS . . . -82.82 167.19 18.34 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -62.98 -46.52 87.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.476 -0.765 . . . . 0.0 109.444 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.42 ' CE1' ' HB2' ' A' ' 61' ' ' ALA . 10.2 p-80 -68.7 -20.56 64.42 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.581 -0.7 . . . . 0.0 110.191 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.405 ' HG3' ' CD2' ' A' ' 63' ' ' HIS . 35.7 mt-10 -79.36 -19.7 49.59 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.265 -0.897 . . . . 0.0 110.196 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.2 mt -100.92 154.06 18.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.296 -0.877 . . . . 0.0 109.532 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.67 88.75 2.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.547 -0.721 . . . . 0.0 109.393 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.0 t -57.75 105.81 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.465 -0.772 . . . . 0.0 109.851 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.709 -0.62 . . . . 0.0 109.557 -179.967 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.548 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.0 t -90.42 160.54 16.0 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.169 -1.195 . . . . 0.0 109.48 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.3 mttt -88.59 118.33 28.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.51 -0.744 . . . . 0.0 109.219 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.1 m -118.86 126.16 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.581 -0.699 . . . . 0.0 109.937 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt -79.49 116.66 19.85 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.422 HD13 ' CD2' ' A' ' 60' ' ' PHE . 24.3 mm -62.78 131.94 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.651 -0.656 . . . . 0.0 109.539 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -114.91 3.36 14.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.498 -0.751 . . . . 0.0 110.598 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.406 ' O ' ' CD1' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -62.53 120.54 11.32 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.075 -1.016 . . . . 0.0 109.363 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -56.45 -76.48 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.473 -0.767 . . . . 0.0 110.174 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -70.71 89.33 0.74 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.543 -0.723 . . . . 0.0 109.326 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.37 141.88 19.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.573 -0.705 . . . . 0.0 109.801 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.454 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 20.2 t80 -66.75 -13.41 61.36 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.691 -0.631 . . . . 0.0 110.187 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.501 ' CE3' ' CD1' ' A' ' 40' ' ' PHE . 13.8 m0 -126.04 25.73 6.69 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.112 -0.992 . . . . 0.0 110.336 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.406 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 18.9 t80 -67.0 137.11 56.26 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.449 -0.782 . . . . 0.0 109.065 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.36 -9.33 77.64 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -106.24 -169.85 1.64 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.195 -1.179 . . . . 0.0 109.52 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 62.2 t -128.06 162.54 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -145.58 175.1 25.3 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.6 m -106.92 115.14 29.68 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.537 -0.979 . . . . 0.0 109.349 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.0 t -50.3 115.18 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.344 -0.847 . . . . 0.0 110.635 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -85.35 -47.23 10.22 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.668 -0.645 . . . . 0.0 109.733 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -172.05 160.15 5.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.516 -0.74 . . . . 0.0 109.871 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.1 mm . . . . . 0 N--CA 1.492 1.664 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.736 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 . . . . . 0 N--CA 1.496 1.853 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -81.64 -14.22 10.33 Favored 'Trans proline' 0 C--N 1.324 -0.76 0 C-N-CA 122.126 1.884 . . . . 0.0 111.991 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.3 t -94.33 110.72 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.004 -1.06 . . . . 0.0 110.558 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -96.15 116.63 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.226 -0.922 . . . . 0.0 108.969 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.425 ' HB ' ' CZ ' ' A' ' 40' ' ' PHE . 21.6 t -92.4 164.6 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.481 -0.762 . . . . 0.0 109.131 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.3 mtt85 -106.87 146.52 30.87 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.518 -0.739 . . . . 0.0 109.382 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.501 ' CD1' ' CE3' ' A' ' 17' ' ' TRP . 69.0 m-85 -140.26 135.22 32.08 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.583 -0.698 . . . . 0.0 109.589 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -62.7 -27.24 69.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.535 -0.728 . . . . 0.0 109.443 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.26 168.27 1.51 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.509 -0.744 . . . . 0.0 109.686 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.3 t . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.593 -0.692 . . . . 0.0 109.453 -179.974 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 120.423 0.154 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 81.2 p -154.56 129.94 9.77 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.281 -0.887 . . . . 0.0 109.424 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.423 ' HB2' ' CE1' ' A' ' 40' ' ' PHE . 1.6 m-20 -123.99 120.55 32.79 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.528 -0.733 . . . . 0.0 109.509 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.427 ' O ' ' CG ' ' A' ' 60' ' ' PHE . 0.7 OUTLIER -62.55 152.72 34.02 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.553 -0.717 . . . . 0.0 109.365 179.755 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.427 ' CG ' ' O ' ' A' ' 59' ' ' ASN . 17.1 m-85 -161.4 141.85 10.9 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.428 ' CB ' ' CE1' ' A' ' 63' ' ' HIS . . . -73.13 160.12 32.48 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -60.29 -41.84 94.24 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.478 -0.764 . . . . 0.0 109.682 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.428 ' CE1' ' CB ' ' A' ' 61' ' ' ALA . 7.6 p-80 -70.63 -21.97 62.57 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.545 -0.722 . . . . 0.0 110.088 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -79.7 -12.88 59.78 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.397 -0.814 . . . . 0.0 110.393 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.3 mt -103.31 140.17 37.78 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.147 -0.971 . . . . 0.0 109.53 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.7 86.71 2.49 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.609 -0.682 . . . . 0.0 109.345 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 44.0 t -58.38 117.19 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.453 -0.779 . . . . 0.0 109.732 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.0 m . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.69 -0.632 . . . . 0.0 109.55 -179.985 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.519 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.0 t -90.47 -178.07 5.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.325 -1.103 . . . . 0.0 109.465 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.5 mttt -109.26 112.82 25.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.518 -0.739 . . . . 0.0 109.042 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.2 m -117.09 128.39 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.497 -0.752 . . . . 0.0 110.231 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -79.57 127.16 31.81 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.437 HG22 ' CZ ' ' A' ' 60' ' ' PHE . 26.1 mm -75.02 132.69 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.719 -0.613 . . . . 0.0 109.418 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -124.35 27.73 6.92 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.468 -0.77 . . . . 0.0 110.149 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.403 ' O ' ' CD1' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -86.97 124.64 33.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.464 -0.773 . . . . 0.0 109.092 179.596 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.6 mtpt -57.6 -70.3 0.14 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.437 -0.789 . . . . 0.0 110.015 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -76.93 85.67 3.48 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.545 -0.722 . . . . 0.0 109.438 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.9 t -151.78 138.92 19.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.526 -0.734 . . . . 0.0 109.627 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.433 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 20.8 t80 -63.79 -15.15 58.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.694 -0.628 . . . . 0.0 110.319 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.497 ' CE3' ' CD2' ' A' ' 40' ' ' PHE . 12.8 m0 -126.48 32.33 5.2 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.18 -0.95 . . . . 0.0 110.386 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.403 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 19.5 t80 -71.04 114.46 9.12 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 118.21 -11.4 12.99 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 120.152 -1.023 . . . . 0.0 110.759 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.26 171.2 7.76 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.084 -1.245 . . . . 0.0 109.512 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.5 t -103.25 162.43 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.422 ' HA3' HG13 ' A' ' 38' ' ' VAL . . . -141.27 157.14 25.98 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 51.0 m -90.74 112.24 23.93 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.56 -0.965 . . . . 0.0 109.368 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.2 t -50.56 131.9 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.357 -0.839 . . . . 0.0 110.522 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.05 -48.53 3.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.728 -0.607 . . . . 0.0 109.713 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.43 -178.02 0.9 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.592 -0.693 . . . . 0.0 109.666 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 34.1 mm . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.944 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.408 ' HB3' ' N ' ' A' ' 60' ' ' PHE . 16.4 m-85 . . . . . 0 N--CA 1.494 1.746 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -83.26 -20.07 5.2 Favored 'Trans proline' 0 C--N 1.324 -0.722 0 C-N-CA 122.047 1.831 . . . . 0.0 111.735 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.1 t -79.98 110.92 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.248 -0.908 . . . . 0.0 110.497 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.4 ' CD1' ' ND2' ' A' ' 59' ' ' ASN . 0.6 OUTLIER -96.26 117.23 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.053 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.426 ' HB ' ' CE2' ' A' ' 40' ' ' PHE . 34.5 t -93.35 163.69 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.533 -0.73 . . . . 0.0 109.218 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 31.3 ttt180 -105.1 149.36 25.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.637 -0.664 . . . . 0.0 109.368 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.497 ' CD2' ' CE3' ' A' ' 17' ' ' TRP . 82.2 m-85 -145.73 129.27 17.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.584 -0.698 . . . . 0.0 109.582 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -62.56 -28.77 70.1 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.517 -0.74 . . . . 0.0 109.3 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.9 tptm -60.71 161.52 7.77 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.638 -0.664 . . . . 0.0 109.469 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.1 t . . . . . 0 N--CA 1.494 1.733 0 O-C-N 121.56 -0.713 . . . . 0.0 109.446 179.955 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.4 m120 . . . . . 0 N--CA 1.498 1.925 0 CA-C-O 120.362 0.125 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.8 p -155.32 129.76 9.04 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.187 -0.946 . . . . 0.0 109.134 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.442 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 11.3 t-20 -119.39 124.89 47.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.545 -0.722 . . . . 0.0 109.782 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.425 ' O ' ' CD1' ' A' ' 60' ' ' PHE . 8.2 m120 -63.86 148.86 48.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.581 -0.7 . . . . 0.0 109.31 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.442 ' CE2' ' HB3' ' A' ' 58' ' ' ASN . 14.7 m-85 -159.79 146.01 15.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.6 -0.688 . . . . 0.0 109.41 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.09 168.42 19.17 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -62.66 -46.8 86.53 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.46 -0.775 . . . . 0.0 109.58 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -70.81 -17.22 62.76 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.52 -0.737 . . . . 0.0 110.279 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -79.72 -15.04 58.27 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.251 -0.906 . . . . 0.0 110.37 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.0 mt -105.07 154.37 20.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.32 -0.863 . . . . 0.0 109.421 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -127.87 84.28 2.23 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 45.1 t -56.04 113.05 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.432 -0.792 . . . . 0.0 109.897 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.0 m . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.605 -0.684 . . . . 0.0 109.562 179.956 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.547 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 28.4 t -90.5 159.98 16.23 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.319 -1.107 . . . . 0.0 109.566 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.0 mttp -84.6 98.74 10.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.561 -0.712 . . . . 0.0 109.177 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.6 m -99.59 125.41 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.569 -0.707 . . . . 0.0 110.211 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.5 tttp -79.23 113.2 17.17 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.44 HG22 ' CZ ' ' A' ' 60' ' ' PHE . 37.1 mm -61.67 130.48 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.627 -0.671 . . . . 0.0 109.747 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -119.01 27.88 8.61 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.81 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.409 ' O ' ' CD1' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -87.04 120.44 28.31 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.452 -0.78 . . . . 0.0 109.261 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.18 -67.2 0.34 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.409 -0.807 . . . . 0.0 109.947 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -80.37 82.68 6.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.479 -0.763 . . . . 0.0 109.416 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -147.99 139.51 23.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.587 -0.696 . . . . 0.0 109.541 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.457 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 20.0 t80 -64.4 -17.41 63.74 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.678 -0.638 . . . . 0.0 110.181 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.5 ' CE3' ' CD1' ' A' ' 40' ' ' PHE . 11.2 m0 -124.25 32.8 5.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.211 -0.931 . . . . 0.0 109.956 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.409 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 13.8 t80 -68.6 134.63 50.25 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.542 -0.724 . . . . 0.0 109.124 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.65 -17.2 58.29 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -100.17 160.12 14.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.238 -1.154 . . . . 0.0 109.647 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.0 t -95.79 162.73 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -144.61 154.4 25.78 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 51.6 m -86.92 112.29 21.64 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.553 -0.969 . . . . 0.0 109.223 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.3 t -50.59 128.29 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.383 -0.823 . . . . 0.0 110.652 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.24 -49.93 4.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.557 -0.715 . . . . 0.0 109.226 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -176.73 171.21 2.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.588 -0.695 . . . . 0.0 109.624 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.437 ' N ' ' CD1' ' A' ' 27' ' ' ILE . 1.8 mp . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 . . . . . 0 N--CA 1.496 1.84 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -81.76 -13.49 10.56 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.008 1.806 . . . . 0.0 111.925 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.1 t -90.04 163.65 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.137 -0.977 . . . . 0.0 109.988 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 tp -139.22 116.37 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.428 ' HB ' ' CE1' ' A' ' 40' ' ' PHE . 30.9 t -93.22 163.68 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.506 -0.746 . . . . 0.0 109.477 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 28.5 ttt180 -106.42 149.37 27.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.58 -0.7 . . . . 0.0 109.233 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.5 ' CD1' ' CE3' ' A' ' 17' ' ' TRP . 85.1 m-85 -143.88 158.63 43.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.604 -0.685 . . . . 0.0 109.757 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -100.47 31.75 3.33 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -118.71 158.75 24.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.689 -0.632 . . . . 0.0 109.353 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.3 t . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.588 -0.695 . . . . 0.0 109.272 179.886 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.8 m120 . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.3 p -154.3 130.42 10.33 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.361 -0.837 . . . . 0.0 108.887 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.437 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 4.6 m-20 -115.63 136.94 52.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.543 -0.723 . . . . 0.0 109.685 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -74.89 133.79 41.75 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.571 -0.706 . . . . 0.0 109.475 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.44 ' CZ ' HG22 ' A' ' 10' ' ' ILE . 28.7 m-85 -145.71 152.13 39.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.58 -0.7 . . . . 0.0 109.555 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.77 167.75 17.85 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -64.06 -46.82 82.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.468 -0.77 . . . . 0.0 109.241 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -71.75 -18.15 62.15 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.611 -0.681 . . . . 0.0 110.399 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -79.4 -11.49 59.92 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.278 -0.889 . . . . 0.0 110.274 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.9 mt -107.43 144.34 34.5 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.231 -0.918 . . . . 0.0 109.243 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -119.49 83.95 2.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.617 -0.677 . . . . 0.0 109.337 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.0 t -51.65 97.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.323 -0.861 . . . . 0.0 110.064 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.8 m . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.595 -0.69 . . . . 0.0 109.588 -179.803 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.532 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.8 t -90.53 -177.48 5.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.317 -1.108 . . . . 0.0 109.414 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.9 mttp -109.8 118.8 37.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.526 -0.734 . . . . 0.0 109.24 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.4 m -122.96 123.66 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.557 -0.714 . . . . 0.0 109.959 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.4 ttpt -79.62 115.15 19.07 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.41 HG22 ' CZ ' ' A' ' 60' ' ' PHE . 22.2 mm -61.49 132.26 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.611 -0.68 . . . . 0.0 109.629 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -113.6 1.52 14.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.552 -0.718 . . . . 0.0 110.602 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.411 ' O ' ' CD1' ' A' ' 18' ' ' TYR . 1.8 tmt_? -62.23 119.67 9.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.088 -1.007 . . . . 0.0 109.398 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -56.02 -75.33 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.46 -0.775 . . . . 0.0 110.185 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -69.89 89.78 0.6 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.523 -0.735 . . . . 0.0 109.276 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.3 141.13 14.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.602 -0.686 . . . . 0.0 109.833 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.458 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 20.2 t80 -66.72 -13.06 60.89 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.73 -0.606 . . . . 0.0 110.247 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.458 ' NE1' ' CD2' ' A' ' 16' ' ' TYR . 11.5 m0 -125.04 26.77 6.89 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.066 -1.021 . . . . 0.0 110.334 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.411 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 19.4 t80 -68.07 137.56 55.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.4 -0.812 . . . . 0.0 109.163 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.55 -10.47 69.48 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.786 -0.925 . . . . 0.0 110.786 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.16 -169.58 1.72 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.108 -1.231 . . . . 0.0 109.483 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.1 t -127.85 162.68 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.416 ' HA3' HG13 ' A' ' 38' ' ' VAL . . . -145.75 156.48 26.99 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 49.3 m -89.73 112.78 24.17 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.558 -0.966 . . . . 0.0 109.225 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.0 t -47.77 125.21 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.527 -0.733 . . . . 0.0 110.927 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.1 -46.49 5.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.669 -0.644 . . . . 0.0 109.615 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.64 170.66 2.4 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.529 -0.732 . . . . 0.0 109.631 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.447 ' N ' ' CD1' ' A' ' 27' ' ' ILE . 1.8 mp . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.4 ' HB3' ' N ' ' A' ' 60' ' ' PHE . 15.0 m-85 . . . . . 0 N--CA 1.496 1.868 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -82.65 -17.05 7.52 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.048 1.832 . . . . 0.0 111.916 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.8 t -86.56 113.03 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.139 -0.976 . . . . 0.0 110.659 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.2 tp -96.39 116.81 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.357 -0.839 . . . . 0.0 108.955 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.428 ' HB ' ' CE2' ' A' ' 40' ' ' PHE . 39.2 t -91.3 164.33 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.454 -0.779 . . . . 0.0 109.115 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -102.01 140.76 35.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.561 -0.712 . . . . 0.0 109.386 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.428 ' CE2' ' HB ' ' A' ' 38' ' ' VAL . 91.0 m-85 -137.92 126.88 24.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.559 -0.713 . . . . 0.0 109.647 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -62.47 -27.37 69.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.595 -0.69 . . . . 0.0 109.269 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.73 173.9 0.52 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.584 -0.697 . . . . 0.0 109.573 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 36.8 t . . . . . 0 N--CA 1.493 1.701 0 O-C-N 121.553 -0.717 . . . . 0.0 109.244 179.838 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 120.623 0.249 . . . . 0.0 110.389 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 72.1 p -155.06 130.08 9.47 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.181 -0.949 . . . . 0.0 108.984 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.428 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . 0.8 OUTLIER -120.02 148.63 43.33 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.561 -0.712 . . . . 0.0 109.439 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.411 ' O ' ' CD1' ' A' ' 60' ' ' PHE . 11.2 m120 -82.9 143.13 30.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.52 -0.737 . . . . 0.0 109.315 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.415 ' CE2' ' HB3' ' A' ' 58' ' ' ASN . 21.4 m-85 -156.63 141.95 17.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.537 -0.727 . . . . 0.0 109.537 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.62 169.06 18.95 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -63.38 -46.23 87.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.513 -0.742 . . . . 0.0 109.454 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 12.7 p-80 -68.93 -18.94 64.17 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.597 -0.689 . . . . 0.0 110.213 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -79.6 -19.65 48.79 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.366 -0.834 . . . . 0.0 110.2 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 19.5 mt -99.37 143.13 29.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.242 -0.911 . . . . 0.0 109.666 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.02 89.21 3.02 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.3 t -58.24 115.29 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.495 -0.753 . . . . 0.0 110.018 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.0 m . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.617 -0.677 . . . . 0.0 109.51 179.947 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.42 0 N-CA-C 110.189 -1.165 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.4 t -90.87 -177.36 4.93 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.228 -1.16 . . . . 0.0 109.755 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.7 mtmt -108.59 124.53 50.63 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.0 m -118.68 127.16 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.532 -0.73 . . . . 0.0 110.165 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.8 tttp -79.48 114.02 18.08 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.424 HG22 ' CZ ' ' A' ' 60' ' ' PHE . 29.3 mm -59.99 129.62 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.646 -0.659 . . . . 0.0 110.008 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -119.62 26.05 9.63 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.659 -0.651 . . . . 0.0 109.567 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.41 ' O ' ' CD1' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -84.88 120.95 27.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.404 -0.81 . . . . 0.0 109.466 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.6 mtpt -59.24 -56.18 25.37 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.497 -0.752 . . . . 0.0 110.004 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -90.31 78.72 6.44 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.483 -0.761 . . . . 0.0 109.921 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.1 p -147.81 141.76 25.88 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.42 -0.8 . . . . 0.0 109.598 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.458 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 21.8 t80 -61.59 -15.6 40.52 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.7 -0.625 . . . . 0.0 110.869 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.495 ' CZ3' ' CD1' ' A' ' 40' ' ' PHE . 11.9 m0 -125.35 35.14 4.8 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.09 -1.006 . . . . 0.0 110.738 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.41 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 20.9 t80 -68.36 130.72 43.72 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.448 -0.783 . . . . 0.0 109.067 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.64 -11.68 62.91 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 120.249 -0.977 . . . . 0.0 110.823 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -109.07 173.94 6.09 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.159 -1.2 . . . . 0.0 109.655 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 87.4 t -111.2 162.53 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.4 ' HA3' HG13 ' A' ' 38' ' ' VAL . . . -143.07 155.17 25.84 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.7 m -86.13 111.43 20.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.514 -0.992 . . . . 0.0 109.219 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 t -53.16 140.29 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 121.306 -0.871 . . . . 0.0 109.987 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -109.37 -49.94 3.05 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.544 -0.722 . . . . 0.0 109.706 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -170.96 164.82 7.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.622 -0.674 . . . . 0.0 109.584 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 38.1 mm . . . . . 0 N--CA 1.494 1.726 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.902 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.412 ' HB3' ' N ' ' A' ' 60' ' ' PHE . 17.6 m-85 . . . . . 0 N--CA 1.494 1.758 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -82.52 -9.53 11.21 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.08 1.854 . . . . 0.0 111.95 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.3 t -93.79 113.46 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 120.962 -1.086 . . . . 0.0 110.261 -178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.6 tp -98.05 116.0 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.17 -0.956 . . . . 0.0 108.78 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.429 ' HB ' ' CE1' ' A' ' 40' ' ' PHE . 40.7 t -92.08 164.58 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.573 -0.704 . . . . 0.0 109.365 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.5 ttt180 -109.22 149.52 29.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.565 -0.71 . . . . 0.0 109.467 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.495 ' CD1' ' CZ3' ' A' ' 17' ' ' TRP . 61.7 m-85 -146.55 154.71 41.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.581 -0.7 . . . . 0.0 109.486 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -100.82 34.0 2.61 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -125.18 55.81 1.37 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 36.8 t . . . . . 0 N--CA 1.494 1.743 0 O-C-N 121.299 -0.876 . . . . 0.0 109.761 -179.822 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 120.479 0.181 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -167.78 132.22 1.8 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.24 -0.913 . . . . 0.0 108.825 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.45 ' ND2' ' CZ3' ' A' ' 17' ' ' TRP . 0.3 OUTLIER -108.39 167.9 9.7 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.522 -0.736 . . . . 0.0 109.357 -179.755 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.413 ' O ' ' CD1' ' A' ' 60' ' ' PHE . 5.6 m120 -104.85 141.44 36.51 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.575 -0.703 . . . . 0.0 109.173 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.424 ' CZ ' HG22 ' A' ' 10' ' ' ILE . 42.2 m-85 -155.36 146.61 22.75 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.491 -0.756 . . . . 0.0 109.447 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.0 171.0 14.29 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -62.81 -48.73 77.83 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.543 -0.723 . . . . 0.0 109.571 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 16.2 p-80 -68.0 -20.93 65.06 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.557 -0.714 . . . . 0.0 110.225 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -79.57 -20.49 46.87 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.315 -0.866 . . . . 0.0 110.175 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.9 mt -98.98 146.23 26.24 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.264 -0.897 . . . . 0.0 109.669 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -120.63 86.79 2.63 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.8 t -50.97 114.35 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.372 -0.83 . . . . 0.0 110.363 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.4 m . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.556 -0.715 . . . . 0.0 109.562 -179.793 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.552 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.2 t -90.4 162.06 15.28 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.375 -1.073 . . . . 0.0 109.377 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.6 mtpp -79.77 116.93 20.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.552 -0.718 . . . . 0.0 109.286 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.402 ' CG1' ' CG2' ' A' ' 24' ' ' VAL . 33.2 m -120.04 122.49 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.533 -0.729 . . . . 0.0 109.776 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.1 ttpt -79.38 113.72 17.74 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.416 HD13 ' CD2' ' A' ' 60' ' ' PHE . 27.1 mm -61.78 132.23 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.66 -0.65 . . . . 0.0 109.516 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -114.9 5.0 14.98 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.504 -0.747 . . . . 0.0 110.694 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.412 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . 0.2 OUTLIER -62.43 124.44 20.95 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.948 -1.095 . . . . 0.0 109.422 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -59.55 -73.95 0.08 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.483 -0.76 . . . . 0.0 109.818 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -76.32 86.19 3.1 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.575 -0.703 . . . . 0.0 109.359 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.98 143.15 28.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.553 -0.717 . . . . 0.0 109.613 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.45 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 20.0 t80 -66.2 -13.62 60.58 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.682 -0.636 . . . . 0.0 110.191 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.505 ' CE3' ' CD2' ' A' ' 40' ' ' PHE . 13.2 m0 -127.34 25.76 6.09 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.084 -1.01 . . . . 0.0 110.333 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -67.82 127.93 34.62 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.381 -0.824 . . . . 0.0 108.834 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.17 -5.4 49.47 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.639 -0.985 . . . . 0.0 110.639 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -117.72 175.05 5.83 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.111 -1.229 . . . . 0.0 109.359 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.6 t -108.63 162.5 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.4 ' HA3' HG13 ' A' ' 38' ' ' VAL . . . -143.44 154.94 25.82 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 48.5 m -87.92 111.95 22.0 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.444 -1.033 . . . . 0.0 109.241 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.402 ' CG2' ' CG1' ' A' ' 8' ' ' VAL . 47.9 t -51.32 125.41 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.446 -0.784 . . . . 0.0 110.379 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -95.11 -49.98 5.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.716 -0.615 . . . . 0.0 109.441 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -176.48 175.55 1.74 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.5 -0.75 . . . . 0.0 109.661 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.44 ' N ' ' CD1' ' A' ' 27' ' ' ILE . 1.8 mp . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.405 ' HB3' ' N ' ' A' ' 60' ' ' PHE . 17.5 m-85 . . . . . 0 N--CA 1.494 1.731 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -81.91 -15.97 9.07 Favored 'Trans proline' 0 C--N 1.324 -0.714 0 C-N-CA 122.048 1.832 . . . . 0.0 111.969 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.7 t -87.22 164.47 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.066 -1.021 . . . . 0.0 109.898 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.2 tp -140.62 114.85 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.419 ' HB ' ' CZ ' ' A' ' 40' ' ' PHE . 39.5 t -91.45 164.49 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.429 -0.795 . . . . 0.0 109.283 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 12.5 ttt85 -105.48 145.14 31.27 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.637 -0.664 . . . . 0.0 109.349 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.505 ' CD2' ' CE3' ' A' ' 17' ' ' TRP . 80.7 m-85 -141.77 136.87 31.14 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.656 -0.653 . . . . 0.0 109.759 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 30.8 m-20 -67.66 -28.19 67.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.551 -0.718 . . . . 0.0 109.094 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.26 165.87 2.46 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.537 -0.727 . . . . 0.0 109.62 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.5 t . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.507 -0.746 . . . . 0.0 109.453 -179.909 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.0 m120 . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 120.544 0.212 . . . . 0.0 110.497 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 72.6 p -154.76 129.75 9.48 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.155 -0.966 . . . . 0.0 109.202 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.428 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -117.24 151.22 37.38 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.55 -0.719 . . . . 0.0 109.287 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -87.46 134.54 33.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.487 -0.758 . . . . 0.0 109.376 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.428 ' CE2' ' HB3' ' A' ' 58' ' ' ASN . 22.3 m-85 -148.61 150.78 33.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.632 -0.668 . . . . 0.0 109.35 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.9 168.33 17.16 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -64.17 -45.95 86.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.497 -0.752 . . . . 0.0 109.28 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -70.87 -19.75 62.59 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.615 -0.678 . . . . 0.0 110.288 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -79.29 -14.24 59.14 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.292 -0.88 . . . . 0.0 110.215 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.1 mt -103.73 144.38 31.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 109.31 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -111.25 87.23 2.49 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.599 -0.688 . . . . 0.0 109.588 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.1 t -58.95 100.88 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.505 -0.747 . . . . 0.0 109.784 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.7 m . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.625 -0.672 . . . . 0.0 109.598 -179.89 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.491 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.3 t -90.44 160.88 15.81 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.358 -1.084 . . . . 0.0 109.364 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.4 mtpp -79.88 118.32 21.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.503 -0.748 . . . . 0.0 109.289 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.0 m -120.3 123.48 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.601 -0.687 . . . . 0.0 109.773 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -79.36 115.13 18.82 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.425 HG22 ' CZ ' ' A' ' 60' ' ' PHE . 27.3 mm -62.56 132.14 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.657 -0.652 . . . . 0.0 109.462 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -116.5 5.28 13.36 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.489 -0.757 . . . . 0.0 110.786 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.413 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -63.35 124.31 20.94 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.984 -1.072 . . . . 0.0 109.36 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -59.06 -69.31 0.2 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.479 -0.763 . . . . 0.0 109.968 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -81.14 81.87 7.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.602 -0.686 . . . . 0.0 109.337 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.64 143.35 37.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.495 -0.753 . . . . 0.0 109.579 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.449 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 25.4 t80 -64.28 -15.64 60.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.667 -0.646 . . . . 0.0 110.101 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.497 ' CE3' ' CD1' ' A' ' 40' ' ' PHE . 16.2 m0 -129.58 30.71 4.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.254 -0.904 . . . . 0.0 110.242 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.403 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 16.3 t80 -69.17 121.3 16.49 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.45 -8.67 26.41 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 120.205 -0.998 . . . . 0.0 110.63 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -116.36 171.6 7.73 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.065 -1.256 . . . . 0.0 109.512 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.7 t -104.58 162.63 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.407 ' HA3' HG13 ' A' ' 38' ' ' VAL . . . -143.56 153.69 25.04 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 51.8 m -87.91 112.35 22.43 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.566 -0.961 . . . . 0.0 109.239 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.1 t -52.35 127.03 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.458 -0.776 . . . . 0.0 110.186 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -96.48 -49.61 5.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.633 -0.667 . . . . 0.0 109.682 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -173.89 167.8 4.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.638 -0.664 . . . . 0.0 109.748 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.4 mm . . . . . 0 N--CA 1.493 1.703 0 O-C-N 121.609 -0.682 . . . . 0.0 109.255 179.919 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 . . . . . 0 N--CA 1.494 1.763 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -82.54 -17.12 7.62 Favored 'Trans proline' 0 C--N 1.325 -0.663 0 C-N-CA 122.131 1.887 . . . . 0.0 111.653 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.0 t -79.6 113.05 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.203 -0.936 . . . . 0.0 110.169 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 tp -95.45 115.24 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.428 ' HB ' ' CE1' ' A' ' 40' ' ' PHE . 35.3 t -90.8 163.67 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.518 -0.739 . . . . 0.0 109.258 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.3 ttt180 -106.47 147.95 28.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.595 -0.69 . . . . 0.0 109.221 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.497 ' CD1' ' CE3' ' A' ' 17' ' ' TRP . 79.6 m-85 -144.05 157.62 44.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.553 -0.717 . . . . 0.0 109.502 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -100.07 32.19 3.04 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.33 136.64 52.2 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 36.2 t . . . . . 0 N--CA 1.493 1.687 0 O-C-N 121.481 -0.762 . . . . 0.0 109.479 -179.925 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 20.8 m-20 . . . . . 0 N--CA 1.496 1.833 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 65.1 p -154.61 132.35 11.45 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.247 -0.908 . . . . 0.0 108.894 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.451 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 3.7 t-20 -124.36 133.24 53.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.538 -0.726 . . . . 0.0 109.872 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.422 ' O ' ' CD1' ' A' ' 60' ' ' PHE . 28.6 m-80 -68.74 145.68 53.6 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.597 -0.689 . . . . 0.0 109.453 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.451 ' CE2' ' HB3' ' A' ' 58' ' ' ASN . 14.9 m-85 -158.04 145.91 18.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.634 -0.666 . . . . 0.0 109.343 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.73 169.1 16.56 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -62.71 -48.29 79.9 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.442 -0.786 . . . . 0.0 109.601 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -69.32 -18.1 63.78 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.534 -0.729 . . . . 0.0 110.452 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -79.6 -19.14 50.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.178 -0.951 . . . . 0.0 110.256 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.4 mt -102.34 146.38 28.13 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.272 -0.892 . . . . 0.0 109.496 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -116.49 88.11 2.83 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.652 -0.655 . . . . 0.0 109.265 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.3 t -57.92 110.9 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.498 -0.751 . . . . 0.0 109.861 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.4 m . . . . . 0 N--CA 1.494 1.726 0 O-C-N 121.645 -0.659 . . . . 0.0 109.485 -179.919 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.458 HD12 HG22 ' A' ' 2' ' ' ILE . 59.7 mt 60.13 78.17 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.532 -0.73 . . . . 0.0 109.698 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -87.38 177.84 7.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.551 -0.718 . . . . 0.0 109.473 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 15.1 ttt180 -90.13 126.37 35.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.574 -0.703 . . . . 0.0 109.659 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.68 17.12 78.08 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.7 t -90.57 162.15 15.13 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.249 -1.148 . . . . 0.0 109.416 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.83 115.58 23.56 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.502 -0.749 . . . . 0.0 109.151 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.4 m -116.85 124.54 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.499 -0.751 . . . . 0.0 110.016 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.4 ttpt -79.55 113.48 17.73 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.431 HG22 ' CZ ' ' A' ' 60' ' ' PHE . 35.3 mm -61.13 131.25 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.591 -0.693 . . . . 0.0 109.707 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -115.99 27.01 9.55 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.516 -0.74 . . . . 0.0 109.681 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.414 ' O ' ' CD1' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -85.64 119.77 26.34 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.421 -0.8 . . . . 0.0 109.283 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.87 -73.88 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.427 -0.795 . . . . 0.0 110.25 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -76.57 85.89 3.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.53 -0.731 . . . . 0.0 109.377 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.2 t -152.03 139.92 20.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.537 -0.727 . . . . 0.0 109.663 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.458 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 25.1 t80 -63.97 -15.42 59.2 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.686 -0.634 . . . . 0.0 110.366 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.502 ' CZ3' ' CD1' ' A' ' 40' ' ' PHE . 14.3 m0 -125.22 32.19 5.43 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.096 -1.002 . . . . 0.0 110.258 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.414 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 17.0 t80 -69.32 133.6 48.05 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.474 -0.766 . . . . 0.0 109.098 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.56 -12.73 66.04 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -95.04 -171.01 2.32 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.182 -1.187 . . . . 0.0 109.595 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.0 t -132.39 129.73 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.418 ' HA3' HG13 ' A' ' 38' ' ' VAL . . . -112.36 157.45 14.94 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 52.7 m -89.02 112.01 22.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.601 -0.941 . . . . 0.0 109.345 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 37.5 t -50.24 130.86 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.401 -0.812 . . . . 0.0 110.621 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -102.28 -48.35 4.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.663 -0.648 . . . . 0.0 109.529 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -174.37 156.16 2.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.594 -0.691 . . . . 0.0 109.601 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.436 ' N ' ' CD1' ' A' ' 27' ' ' ILE . 1.8 mp -101.39 161.62 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -116.94 119.34 35.02 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.585 -0.697 . . . . 0.0 109.504 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.43 52.31 2.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.572 -0.705 . . . . 0.0 109.315 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.7 t -100.78 -50.67 3.78 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.447 -0.783 . . . . 0.0 109.529 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.62 -2.52 6.08 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 34.3 pt -60.97 -173.06 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.044 -1.268 . . . . 0.0 109.642 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.428 HG12 ' CE1' ' A' ' 34' ' ' TYR . 16.6 tt -90.04 -25.94 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.508 -0.745 . . . . 0.0 109.903 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.428 ' CE1' HG12 ' A' ' 33' ' ' ILE . 21.0 m-85 -129.29 72.21 81.99 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.41 -0.806 . . . . 0.0 109.412 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -81.58 -15.34 9.82 Favored 'Trans proline' 0 C--N 1.325 -0.708 0 C-N-CA 122.007 1.805 . . . . 0.0 111.899 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.9 t -89.39 111.14 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.062 -1.024 . . . . 0.0 110.227 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.1 tp -91.21 117.66 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.322 -0.861 . . . . 0.0 108.725 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.425 ' HB ' ' CE1' ' A' ' 40' ' ' PHE . 44.3 t -94.0 162.98 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.5 -0.75 . . . . 0.0 109.476 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.406 ' N ' HG13 ' A' ' 38' ' ' VAL . 12.0 ttt180 -105.21 152.69 22.54 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.502 ' CD1' ' CZ3' ' A' ' 17' ' ' TRP . 87.3 m-85 -148.86 124.7 10.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.632 -0.667 . . . . 0.0 109.588 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -61.97 -26.18 68.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.497 -0.752 . . . . 0.0 109.214 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.76 160.28 9.66 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.553 -0.717 . . . . 0.0 109.601 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.438 ' CG1' ' CE2' ' A' ' 45' ' ' TYR . 35.3 t -140.94 162.91 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -123.57 136.25 54.43 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.488 -0.757 . . . . 0.0 109.651 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.438 ' CE2' ' CG1' ' A' ' 43' ' ' VAL . 23.0 m-85 -155.88 28.57 0.37 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.607 -0.683 . . . . 0.0 109.529 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -116.5 97.06 5.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.537 -0.727 . . . . 0.0 109.675 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.71 78.03 0.19 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.401 ' CD2' ' O ' ' A' ' 52' ' ' ALA . 39.6 p90 -120.0 32.55 5.99 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.56 -0.964 . . . . 0.0 109.519 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 60.15 -167.39 0.18 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.535 -0.728 . . . . 0.0 109.688 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -106.74 59.65 0.38 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.1 t -154.16 103.0 2.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.565 -0.962 . . . . 0.0 109.393 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.401 ' O ' ' CD2' ' A' ' 48' ' ' PHE . . . 59.89 -175.09 0.11 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.515 -0.741 . . . . 0.0 109.682 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -155.78 139.31 6.52 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.9 139.16 0.05 OUTLIER Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.422 ' O ' ' CB ' ' A' ' 56' ' ' ASN . 4.1 mm? -89.35 -61.11 1.77 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.584 -0.95 . . . . 0.0 109.288 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.422 ' CB ' ' O ' ' A' ' 55' ' ' LEU . 9.3 m-20 84.01 -39.75 0.07 Allowed 'General case' 0 N--CA 1.509 2.5 0 O-C-N 122.127 -0.358 . . . . 0.0 110.438 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.3 p -127.79 129.75 47.54 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.029 -1.044 . . . . 0.0 109.062 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.421 ' HB2' ' CE1' ' A' ' 40' ' ' PHE . 3.4 m-20 -105.75 174.73 5.76 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.572 -0.705 . . . . 0.0 109.425 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.404 ' O ' ' CD1' ' A' ' 60' ' ' PHE . 3.5 m-80 -112.0 140.09 46.96 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.431 ' CZ ' HG22 ' A' ' 10' ' ' ILE . 58.1 m-85 -154.82 147.69 24.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.6 -0.687 . . . . 0.0 109.505 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.5 173.2 12.2 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -63.4 -50.57 69.33 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.521 -0.737 . . . . 0.0 109.452 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.425 ' CD2' ' HG2' ' A' ' 64' ' ' GLU . 30.8 p-80 -69.09 -17.11 63.82 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.594 -0.691 . . . . 0.0 110.289 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.425 ' HG2' ' CD2' ' A' ' 63' ' ' HIS . 3.4 mm-40 -79.42 -20.89 46.44 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.251 -0.906 . . . . 0.0 110.054 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.3 mt -100.71 146.95 26.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.379 -0.826 . . . . 0.0 109.537 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -117.88 81.48 1.67 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.617 -0.677 . . . . 0.0 109.221 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.0 t -57.88 115.31 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.446 -0.784 . . . . 0.0 109.784 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.0 m -111.76 -30.42 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.621 -0.675 . . . . 0.0 109.566 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.396 0 CA-C-O 118.029 -1.429 . . . . 0.0 109.568 179.994 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 36.8 mm -108.9 131.4 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.528 -0.732 . . . . 0.0 109.44 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -80.99 161.1 24.4 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.578 -0.701 . . . . 0.0 109.538 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 14.3 ttp180 -90.06 130.04 36.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.582 -0.698 . . . . 0.0 109.481 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 59.77 19.63 50.07 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.2 t -90.55 162.99 14.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.228 -1.16 . . . . 0.0 109.421 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.5 mmtp -79.88 116.51 20.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.513 -0.742 . . . . 0.0 109.239 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.4 ' CG1' ' CG2' ' A' ' 24' ' ' VAL . 30.4 m -118.32 126.85 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.492 -0.755 . . . . 0.0 109.892 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -79.26 125.56 29.64 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.436 HG22 ' CZ ' ' A' ' 60' ' ' PHE . 26.6 mm -73.86 131.74 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.695 -0.628 . . . . 0.0 109.548 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -121.94 27.42 8.1 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.489 -0.757 . . . . 0.0 109.934 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.415 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -89.33 113.06 24.29 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.432 -0.792 . . . . 0.0 109.383 179.83 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.77 -55.4 26.72 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.475 -0.765 . . . . 0.0 110.239 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -84.9 77.19 10.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.544 -0.722 . . . . 0.0 109.382 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.98 137.93 20.24 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.554 -0.717 . . . . 0.0 109.699 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.455 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 16.8 t80 -64.05 -15.31 59.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.782 -0.574 . . . . 0.0 110.245 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.501 ' CE3' ' CD1' ' A' ' 40' ' ' PHE . 10.8 m0 -124.06 33.82 5.2 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.147 -0.971 . . . . 0.0 110.113 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.411 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 47.7 t80 -68.81 133.37 48.21 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.52 -0.738 . . . . 0.0 109.014 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.13 -18.89 55.9 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.42 158.03 15.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -1.142 . . . . 0.0 109.568 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 70.0 t -97.08 162.12 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -143.72 172.64 24.92 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.2 m -102.72 115.36 30.43 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.562 -0.963 . . . . 0.0 109.42 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.4 ' CG2' ' CG1' ' A' ' 8' ' ' VAL . 46.9 t -52.82 113.65 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.277 -0.889 . . . . 0.0 110.005 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -82.03 -48.38 11.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.659 -0.651 . . . . 0.0 109.777 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.1 m -167.78 156.69 9.57 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.499 -0.751 . . . . 0.0 110.026 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.1 mm -114.35 165.03 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -102.3 -169.14 1.63 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.486 -0.759 . . . . 0.0 109.35 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -96.78 28.65 3.35 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.659 -0.651 . . . . 0.0 109.829 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 18.4 t 59.44 83.22 0.13 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.465 -0.772 . . . . 0.0 109.736 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -154.32 -45.35 0.02 OUTLIER Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 19.0 pt -84.99 -173.62 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.632 -0.922 . . . . 0.0 109.568 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 75.1 mt -72.9 -56.73 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.681 -0.637 . . . . 0.0 109.52 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.418 ' HB3' ' N ' ' A' ' 60' ' ' PHE . 22.1 m-85 -115.89 89.47 24.36 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.706 -0.621 . . . . 0.0 109.521 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -81.87 4.24 7.19 Favored 'Trans proline' 0 C--N 1.323 -0.776 0 C-N-CA 122.037 1.825 . . . . 0.0 112.021 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.2 t -112.86 112.79 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.977 -1.077 . . . . 0.0 110.505 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -101.41 116.53 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.136 -0.977 . . . . 0.0 108.904 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.419 ' HB ' ' CE1' ' A' ' 40' ' ' PHE . 20.4 t -92.9 164.33 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.499 -0.751 . . . . 0.0 109.008 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 -110.14 149.35 30.2 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.545 -0.722 . . . . 0.0 109.386 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.501 ' CD1' ' CE3' ' A' ' 17' ' ' TRP . 59.6 m-85 -142.57 138.54 30.89 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.595 -0.69 . . . . 0.0 109.543 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -62.88 -28.0 69.74 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.582 -0.699 . . . . 0.0 109.573 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.5 162.28 5.09 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.474 -0.766 . . . . 0.0 109.688 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.3 t -145.13 132.28 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.588 -0.695 . . . . 0.0 109.488 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -108.11 115.18 29.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.534 -0.729 . . . . 0.0 109.488 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -109.68 105.74 15.12 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.593 -0.692 . . . . 0.0 109.503 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -97.29 -34.68 10.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.539 -0.725 . . . . 0.0 109.461 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -167.77 111.32 0.43 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 21.3 p90 -134.61 138.82 44.86 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.574 -0.956 . . . . 0.0 109.514 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.2 t -98.66 35.44 1.83 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.534 -0.729 . . . . 0.0 109.496 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 166.12 -103.8 0.21 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 30.6 t -132.71 -69.21 0.58 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.568 -0.96 . . . . 0.0 109.48 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 60.16 -168.42 0.16 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.489 -0.757 . . . . 0.0 109.655 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.2 -37.53 2.29 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.65 -152.21 21.78 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.1 mp -78.71 -77.44 0.17 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.61 -0.935 . . . . 0.0 109.408 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.4 m120 63.26 13.5 7.01 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.472 -0.768 . . . . 0.0 110.692 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 59.4 p -154.78 129.65 9.4 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.156 -0.965 . . . . 0.0 109.383 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.434 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 13.1 t-20 -109.01 153.92 22.93 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.499 -0.751 . . . . 0.0 109.477 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.429 ' O ' ' CD1' ' A' ' 60' ' ' PHE . 6.2 m-80 -97.63 130.87 44.61 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.555 -0.716 . . . . 0.0 109.531 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.436 ' CZ ' HG22 ' A' ' 10' ' ' ILE . 32.9 m-85 -146.71 151.02 36.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.648 -0.657 . . . . 0.0 109.273 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.418 ' HB2' ' CE1' ' A' ' 63' ' ' HIS . . . -83.99 174.4 10.36 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -64.66 -42.96 95.05 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.51 -0.744 . . . . 0.0 109.511 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.418 ' CE1' ' HB2' ' A' ' 61' ' ' ALA . 8.7 p-80 -71.74 -23.25 61.58 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.628 -0.67 . . . . 0.0 110.21 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.403 ' HG3' ' CD2' ' A' ' 63' ' ' HIS . 12.4 mt-10 -79.74 -0.49 34.49 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.333 -0.855 . . . . 0.0 110.666 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.2 mt -120.8 146.13 46.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.072 -1.018 . . . . 0.0 109.453 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -116.33 91.36 3.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.593 -0.692 . . . . 0.0 109.452 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 43.0 t -60.15 95.02 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.474 -0.766 . . . . 0.0 109.596 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.6 m -82.02 -28.86 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.647 -0.658 . . . . 0.0 109.704 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.384 0 CA-C-O 117.998 -1.446 . . . . 0.0 109.575 179.998 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.423 HD13 HG22 ' A' ' 2' ' ' ILE . 41.6 mm -102.33 128.65 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.573 -0.704 . . . . 0.0 109.492 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -85.28 161.41 19.54 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.604 -0.685 . . . . 0.0 109.502 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.8 ttt85 -90.1 130.54 36.25 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.548 -0.72 . . . . 0.0 109.633 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 59.12 19.71 46.75 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 31.0 t -90.73 162.0 15.09 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.34 -1.094 . . . . 0.0 109.513 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 56.1 mttt -80.57 111.31 16.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.511 -0.743 . . . . 0.0 109.169 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.6 m -112.75 127.77 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.485 -0.76 . . . . 0.0 109.88 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -79.15 127.67 32.32 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.424 HG22 ' CZ ' ' A' ' 60' ' ' PHE . 27.8 mm -76.45 132.3 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.642 -0.661 . . . . 0.0 109.326 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -124.51 28.92 6.45 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.509 -0.744 . . . . 0.0 109.875 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.411 ' O ' ' CD1' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -89.55 115.72 27.17 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.502 -0.749 . . . . 0.0 109.503 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.7 mmtm -53.03 -62.02 1.92 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.472 -0.768 . . . . 0.0 110.273 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -80.59 82.19 6.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.605 -0.684 . . . . 0.0 109.292 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.2 t -154.43 137.19 15.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.558 -0.714 . . . . 0.0 109.616 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.457 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 15.7 t80 -63.08 -16.32 59.55 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.665 -0.647 . . . . 0.0 110.183 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.495 ' CE3' ' CD2' ' A' ' 40' ' ' PHE . 9.0 m0 -123.91 35.73 4.77 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.188 -0.945 . . . . 0.0 110.0 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.411 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 26.6 t80 -70.17 118.65 13.26 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.63 -20.46 29.64 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.09 158.07 15.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -1.127 . . . . 0.0 109.563 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 66.6 t -95.75 162.54 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.401 ' HA3' HG13 ' A' ' 38' ' ' VAL . . . -143.45 173.18 24.53 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.5 m -105.61 113.43 26.99 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.407 -1.055 . . . . 0.0 109.488 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 37.7 t -51.28 117.49 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.286 -0.884 . . . . 0.0 110.409 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -89.8 -45.53 9.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.679 -0.638 . . . . 0.0 109.824 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -173.36 165.68 4.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.509 -0.744 . . . . 0.0 109.907 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.8 mm -115.11 144.05 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -93.55 89.15 6.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.56 -0.713 . . . . 0.0 109.476 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.4 mmtm -63.28 98.76 0.16 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.67 -0.644 . . . . 0.0 109.426 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -161.33 -44.05 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.608 -0.683 . . . . 0.0 109.488 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.1 6.69 10.76 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 41.0 pt -61.16 -171.73 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.236 -1.155 . . . . 0.0 109.775 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.418 HG23 ' CZ ' ' A' ' 34' ' ' TYR . 62.3 mt -82.57 -50.76 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.532 -0.73 . . . . 0.0 110.18 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.418 ' CZ ' HG23 ' A' ' 33' ' ' ILE . 16.8 m-85 -123.97 78.86 58.22 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.498 -0.751 . . . . 0.0 109.752 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -84.27 -21.61 3.64 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.266 1.977 . . . . 0.0 111.961 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.6 t -79.84 111.19 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.225 -0.922 . . . . 0.0 110.728 -178.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -96.25 117.93 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.332 -0.855 . . . . 0.0 108.758 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.418 ' HB ' ' CZ ' ' A' ' 40' ' ' PHE . 21.7 t -96.17 163.77 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.462 -0.774 . . . . 0.0 108.977 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.7 mtt180 -105.06 149.08 26.12 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.449 -0.782 . . . . 0.0 109.338 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.495 ' CD2' ' CE3' ' A' ' 17' ' ' TRP . 82.0 m-85 -143.47 135.94 27.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.609 -0.682 . . . . 0.0 109.566 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -62.96 -28.93 70.42 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.576 -0.703 . . . . 0.0 109.392 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.27 162.18 6.3 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.605 -0.685 . . . . 0.0 109.614 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.2 t -146.87 120.53 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.558 -0.714 . . . . 0.0 109.482 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -103.0 108.15 19.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.609 -0.682 . . . . 0.0 109.469 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -94.74 88.36 5.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.54 -0.725 . . . . 0.0 109.454 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -134.12 114.18 12.86 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.584 -0.698 . . . . 0.0 109.451 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.93 48.84 1.7 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -119.63 136.85 54.22 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.624 -0.927 . . . . 0.0 109.452 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.2 m -160.76 31.02 0.15 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.552 -0.718 . . . . 0.0 109.477 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 143.95 -78.67 0.26 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.7 t -104.94 90.3 3.42 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.619 -0.93 . . . . 0.0 109.46 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -118.89 -73.39 0.65 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.575 -0.703 . . . . 0.0 109.483 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.77 -33.48 6.05 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.01 -166.66 21.34 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.8 mp -115.83 -77.04 0.57 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.556 -0.967 . . . . 0.0 109.402 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.2 m120 63.68 13.01 7.03 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.517 -0.74 . . . . 0.0 110.717 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 72.4 p -154.72 130.39 9.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.151 -0.968 . . . . 0.0 109.206 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.425 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 1.0 OUTLIER -118.39 125.82 50.79 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.444 -0.785 . . . . 0.0 109.67 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.42 ' O ' ' CG ' ' A' ' 60' ' ' PHE . 6.7 m-20 -64.01 149.84 46.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.555 -0.716 . . . . 0.0 109.19 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.425 ' CE2' ' HB3' ' A' ' 58' ' ' ASN . 14.5 m-85 -160.57 147.91 15.85 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.42 ' HB2' ' CE1' ' A' ' 63' ' ' HIS . . . -82.82 167.19 18.34 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -62.98 -46.52 87.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.476 -0.765 . . . . 0.0 109.444 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.42 ' CE1' ' HB2' ' A' ' 61' ' ' ALA . 10.2 p-80 -68.7 -20.56 64.42 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.581 -0.7 . . . . 0.0 110.191 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.405 ' HG3' ' CD2' ' A' ' 63' ' ' HIS . 35.7 mt-10 -79.36 -19.7 49.59 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.265 -0.897 . . . . 0.0 110.196 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.2 mt -100.92 154.06 18.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.296 -0.877 . . . . 0.0 109.532 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.67 88.75 2.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.547 -0.721 . . . . 0.0 109.393 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.0 t -57.75 105.81 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.465 -0.772 . . . . 0.0 109.851 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.3 m -114.4 30.29 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.709 -0.62 . . . . 0.0 109.557 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.484 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.898 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.5 mp -76.12 105.06 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.569 -0.707 . . . . 0.0 109.491 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -89.34 177.65 6.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.689 -0.632 . . . . 0.0 109.439 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 19.2 mtm180 -90.02 125.37 35.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.558 -0.714 . . . . 0.0 109.609 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.92 10.7 80.49 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.0 t -90.42 160.54 16.0 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.169 -1.195 . . . . 0.0 109.48 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.3 mttt -88.59 118.33 28.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.51 -0.744 . . . . 0.0 109.219 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.1 m -118.86 126.16 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.581 -0.699 . . . . 0.0 109.937 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt -79.49 116.66 19.85 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.422 HD13 ' CD2' ' A' ' 60' ' ' PHE . 24.3 mm -62.78 131.94 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.651 -0.656 . . . . 0.0 109.539 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -114.91 3.36 14.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.498 -0.751 . . . . 0.0 110.598 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.406 ' O ' ' CD1' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -62.53 120.54 11.32 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.075 -1.016 . . . . 0.0 109.363 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -56.45 -76.48 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.473 -0.767 . . . . 0.0 110.174 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -70.71 89.33 0.74 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.543 -0.723 . . . . 0.0 109.326 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.37 141.88 19.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.573 -0.705 . . . . 0.0 109.801 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.454 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 20.2 t80 -66.75 -13.41 61.36 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.691 -0.631 . . . . 0.0 110.187 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.501 ' CE3' ' CD1' ' A' ' 40' ' ' PHE . 13.8 m0 -126.04 25.73 6.69 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.112 -0.992 . . . . 0.0 110.336 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.406 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 18.9 t80 -67.0 137.11 56.26 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.449 -0.782 . . . . 0.0 109.065 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.36 -9.33 77.64 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -106.24 -169.85 1.64 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.195 -1.179 . . . . 0.0 109.52 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 62.2 t -128.06 162.54 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -145.58 175.1 25.3 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.6 m -106.92 115.14 29.68 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.537 -0.979 . . . . 0.0 109.349 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.0 t -50.3 115.18 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.344 -0.847 . . . . 0.0 110.635 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -85.35 -47.23 10.22 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.668 -0.645 . . . . 0.0 109.733 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -172.05 160.15 5.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.516 -0.74 . . . . 0.0 109.871 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.1 mm -109.6 154.84 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -109.5 89.75 3.1 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.523 -0.736 . . . . 0.0 109.403 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.6 tptm -63.12 92.4 0.05 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.551 -0.718 . . . . 0.0 109.488 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.6 m -152.98 -45.62 0.1 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.614 -0.679 . . . . 0.0 109.417 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.86 4.39 10.44 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 40.1 pt -61.21 -171.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.158 -1.201 . . . . 0.0 109.717 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.452 ' CG2' ' CE2' ' A' ' 34' ' ' TYR . 87.7 mt -88.39 -35.35 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.488 -0.757 . . . . 0.0 110.241 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.452 ' CE2' ' CG2' ' A' ' 33' ' ' ILE . 18.7 m-85 -130.84 70.44 82.55 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.359 -0.838 . . . . 0.0 109.805 -178.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -81.64 -14.22 10.33 Favored 'Trans proline' 0 C--N 1.324 -0.76 0 C-N-CA 122.126 1.884 . . . . 0.0 111.991 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.3 t -94.33 110.72 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.004 -1.06 . . . . 0.0 110.558 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -96.15 116.63 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.226 -0.922 . . . . 0.0 108.969 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.425 ' HB ' ' CZ ' ' A' ' 40' ' ' PHE . 21.6 t -92.4 164.6 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.481 -0.762 . . . . 0.0 109.131 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.3 mtt85 -106.87 146.52 30.87 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.518 -0.739 . . . . 0.0 109.382 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.501 ' CD1' ' CE3' ' A' ' 17' ' ' TRP . 69.0 m-85 -140.26 135.22 32.08 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.583 -0.698 . . . . 0.0 109.589 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -62.7 -27.24 69.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.535 -0.728 . . . . 0.0 109.443 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.26 168.27 1.51 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.509 -0.744 . . . . 0.0 109.686 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.3 t -150.26 118.52 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.593 -0.692 . . . . 0.0 109.453 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -86.57 87.9 7.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.532 -0.73 . . . . 0.0 109.521 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.407 ' O ' ' CE1' ' A' ' 48' ' ' PHE . 6.8 m-85 -77.35 -27.56 52.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.529 -0.732 . . . . 0.0 109.678 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 39.1 t30 60.71 -90.15 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.616 -0.678 . . . . 0.0 109.669 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.51 40.74 0.04 OUTLIER Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.407 ' CE1' ' O ' ' A' ' 45' ' ' TYR . 39.3 p90 -119.01 35.45 4.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.506 -0.996 . . . . 0.0 109.448 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.38 163.94 0.06 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.58 -0.7 . . . . 0.0 109.679 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -78.17 -94.44 0.26 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.9 -89.09 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.631 -0.923 . . . . 0.0 109.705 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.12 167.1 20.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.064 -1.022 . . . . 0.0 109.443 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.05 140.55 30.1 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -63.16 -167.81 0.9 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.9 mp -80.4 -75.99 0.24 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.593 -0.945 . . . . 0.0 109.365 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 61.62 15.78 7.14 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.476 -0.765 . . . . 0.0 110.589 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 81.2 p -154.56 129.94 9.77 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.281 -0.887 . . . . 0.0 109.424 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.423 ' HB2' ' CE1' ' A' ' 40' ' ' PHE . 1.6 m-20 -123.99 120.55 32.79 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.528 -0.733 . . . . 0.0 109.509 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.427 ' O ' ' CG ' ' A' ' 60' ' ' PHE . 0.7 OUTLIER -62.55 152.72 34.02 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.553 -0.717 . . . . 0.0 109.365 179.755 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.427 ' CG ' ' O ' ' A' ' 59' ' ' ASN . 17.1 m-85 -161.4 141.85 10.9 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.428 ' CB ' ' CE1' ' A' ' 63' ' ' HIS . . . -73.13 160.12 32.48 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -60.29 -41.84 94.24 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.478 -0.764 . . . . 0.0 109.682 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.428 ' CE1' ' CB ' ' A' ' 61' ' ' ALA . 7.6 p-80 -70.63 -21.97 62.57 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.545 -0.722 . . . . 0.0 110.088 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -79.7 -12.88 59.78 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.397 -0.814 . . . . 0.0 110.393 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.3 mt -103.31 140.17 37.78 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.147 -0.971 . . . . 0.0 109.53 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.7 86.71 2.49 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.609 -0.682 . . . . 0.0 109.345 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 44.0 t -58.38 117.19 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.453 -0.779 . . . . 0.0 109.732 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.0 m -111.49 -30.36 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.69 -0.632 . . . . 0.0 109.55 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.43 0 CA-C-O 117.993 -1.449 . . . . 0.0 109.562 -179.996 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.7 mp -86.38 119.14 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.492 -0.755 . . . . 0.0 109.464 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -89.67 178.67 6.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.623 -0.673 . . . . 0.0 109.528 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 27.7 ttm105 -90.17 140.67 29.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.606 -0.684 . . . . 0.0 109.651 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 59.95 20.38 53.21 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.0 t -90.47 -178.07 5.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.325 -1.103 . . . . 0.0 109.465 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.5 mttt -109.26 112.82 25.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.518 -0.739 . . . . 0.0 109.042 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.2 m -117.09 128.39 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.497 -0.752 . . . . 0.0 110.231 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -79.57 127.16 31.81 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.437 HG22 ' CZ ' ' A' ' 60' ' ' PHE . 26.1 mm -75.02 132.69 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.719 -0.613 . . . . 0.0 109.418 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -124.35 27.73 6.92 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.468 -0.77 . . . . 0.0 110.149 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.403 ' O ' ' CD1' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -86.97 124.64 33.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.464 -0.773 . . . . 0.0 109.092 179.596 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.6 mtpt -57.6 -70.3 0.14 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.437 -0.789 . . . . 0.0 110.015 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -76.93 85.67 3.48 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.545 -0.722 . . . . 0.0 109.438 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.9 t -151.78 138.92 19.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.526 -0.734 . . . . 0.0 109.627 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.433 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 20.8 t80 -63.79 -15.15 58.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.694 -0.628 . . . . 0.0 110.319 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.497 ' CE3' ' CD2' ' A' ' 40' ' ' PHE . 12.8 m0 -126.48 32.33 5.2 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.18 -0.95 . . . . 0.0 110.386 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.403 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 19.5 t80 -71.04 114.46 9.12 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 118.21 -11.4 12.99 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 120.152 -1.023 . . . . 0.0 110.759 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.26 171.2 7.76 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.084 -1.245 . . . . 0.0 109.512 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.5 t -103.25 162.43 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.422 ' HA3' HG13 ' A' ' 38' ' ' VAL . . . -141.27 157.14 25.98 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 51.0 m -90.74 112.24 23.93 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.56 -0.965 . . . . 0.0 109.368 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.2 t -50.56 131.9 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.357 -0.839 . . . . 0.0 110.522 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.05 -48.53 3.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.728 -0.607 . . . . 0.0 109.713 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.43 -178.02 0.9 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.592 -0.693 . . . . 0.0 109.666 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 34.1 mm -121.56 163.7 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -96.45 44.99 1.06 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.525 -0.734 . . . . 0.0 109.356 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp 57.25 21.13 6.33 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.723 -0.611 . . . . 0.0 110.424 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 m 57.83 81.89 0.14 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.232 -0.918 . . . . 0.0 109.867 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -141.63 -75.81 0.04 OUTLIER Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 25.2 pt -61.92 167.55 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.573 -0.957 . . . . 0.0 109.678 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.416 HG21 ' CD2' ' A' ' 34' ' ' TYR . 6.7 tp -62.41 -27.84 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.648 -0.657 . . . . 0.0 109.554 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.416 ' CD2' HG21 ' A' ' 33' ' ' ILE . 16.4 m-85 -127.16 75.87 76.58 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.478 -0.764 . . . . 0.0 109.026 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -83.26 -20.07 5.2 Favored 'Trans proline' 0 C--N 1.324 -0.722 0 C-N-CA 122.047 1.831 . . . . 0.0 111.735 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.1 t -79.98 110.92 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.248 -0.908 . . . . 0.0 110.497 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.4 ' CD1' ' ND2' ' A' ' 59' ' ' ASN . 0.6 OUTLIER -96.26 117.23 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.053 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.426 ' HB ' ' CE2' ' A' ' 40' ' ' PHE . 34.5 t -93.35 163.69 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.533 -0.73 . . . . 0.0 109.218 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 31.3 ttt180 -105.1 149.36 25.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.637 -0.664 . . . . 0.0 109.368 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.497 ' CD2' ' CE3' ' A' ' 17' ' ' TRP . 82.2 m-85 -145.73 129.27 17.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.584 -0.698 . . . . 0.0 109.582 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -62.56 -28.77 70.1 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.517 -0.74 . . . . 0.0 109.3 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.9 tptm -60.71 161.52 7.77 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.638 -0.664 . . . . 0.0 109.469 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.417 HG13 ' CZ ' ' A' ' 45' ' ' TYR . 31.1 t -130.42 122.97 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.56 -0.713 . . . . 0.0 109.446 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.401 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 33.5 t30 -97.05 174.33 6.81 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.562 -0.711 . . . . 0.0 109.432 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.417 ' CZ ' HG13 ' A' ' 43' ' ' VAL . 54.9 m-85 -155.54 112.75 3.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.61 -0.681 . . . . 0.0 109.493 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -101.56 33.34 2.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.626 -0.672 . . . . 0.0 109.475 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.17 69.42 0.83 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -77.6 149.32 34.81 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.656 -0.908 . . . . 0.0 109.449 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.9 t -131.27 31.33 4.39 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.6 -0.687 . . . . 0.0 109.493 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.95 -168.18 13.3 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.1 m 59.91 175.3 0.09 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.513 -0.992 . . . . 0.0 109.742 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -106.96 97.81 7.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.555 -0.715 . . . . 0.0 109.424 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -121.3 -91.38 1.16 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.4 -175.61 25.08 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.7 mp -116.31 -76.4 0.57 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.552 -0.97 . . . . 0.0 109.409 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.4 m120 64.76 12.0 7.31 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.487 -0.758 . . . . 0.0 110.761 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.8 p -155.32 129.76 9.04 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.187 -0.946 . . . . 0.0 109.134 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.442 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 11.3 t-20 -119.39 124.89 47.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.545 -0.722 . . . . 0.0 109.782 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.425 ' O ' ' CD1' ' A' ' 60' ' ' PHE . 8.2 m120 -63.86 148.86 48.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.581 -0.7 . . . . 0.0 109.31 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.442 ' CE2' ' HB3' ' A' ' 58' ' ' ASN . 14.7 m-85 -159.79 146.01 15.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.6 -0.688 . . . . 0.0 109.41 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.09 168.42 19.17 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -62.66 -46.8 86.53 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.46 -0.775 . . . . 0.0 109.58 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -70.81 -17.22 62.76 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.52 -0.737 . . . . 0.0 110.279 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -79.72 -15.04 58.27 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.251 -0.906 . . . . 0.0 110.37 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.0 mt -105.07 154.37 20.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.32 -0.863 . . . . 0.0 109.421 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -127.87 84.28 2.23 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 45.1 t -56.04 113.05 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.432 -0.792 . . . . 0.0 109.897 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.0 m -120.95 30.17 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.605 -0.684 . . . . 0.0 109.562 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.408 0 CA-C-O 117.968 -1.462 . . . . 0.0 109.589 -179.985 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.439 HD11 HG22 ' A' ' 2' ' ' ILE . 41.6 mm -114.23 129.59 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.592 -0.692 . . . . 0.0 109.478 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -87.87 163.84 16.19 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.648 -0.658 . . . . 0.0 109.375 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.0 ttt-85 -90.03 133.27 34.92 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.556 -0.715 . . . . 0.0 109.469 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.69 21.29 57.89 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 28.4 t -90.5 159.98 16.23 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.319 -1.107 . . . . 0.0 109.566 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.0 mttp -84.6 98.74 10.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.561 -0.712 . . . . 0.0 109.177 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.6 m -99.59 125.41 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.569 -0.707 . . . . 0.0 110.211 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.5 tttp -79.23 113.2 17.17 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.44 HG22 ' CZ ' ' A' ' 60' ' ' PHE . 37.1 mm -61.67 130.48 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.627 -0.671 . . . . 0.0 109.747 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -119.01 27.88 8.61 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.81 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.409 ' O ' ' CD1' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -87.04 120.44 28.31 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.452 -0.78 . . . . 0.0 109.261 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.18 -67.2 0.34 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.409 -0.807 . . . . 0.0 109.947 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -80.37 82.68 6.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.479 -0.763 . . . . 0.0 109.416 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -147.99 139.51 23.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.587 -0.696 . . . . 0.0 109.541 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.457 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 20.0 t80 -64.4 -17.41 63.74 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.678 -0.638 . . . . 0.0 110.181 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.5 ' CE3' ' CD1' ' A' ' 40' ' ' PHE . 11.2 m0 -124.25 32.8 5.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.211 -0.931 . . . . 0.0 109.956 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.409 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 13.8 t80 -68.6 134.63 50.25 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.542 -0.724 . . . . 0.0 109.124 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.65 -17.2 58.29 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -100.17 160.12 14.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.238 -1.154 . . . . 0.0 109.647 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.0 t -95.79 162.73 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -144.61 154.4 25.78 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 51.6 m -86.92 112.29 21.64 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.553 -0.969 . . . . 0.0 109.223 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.3 t -50.59 128.29 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.383 -0.823 . . . . 0.0 110.652 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.24 -49.93 4.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.557 -0.715 . . . . 0.0 109.226 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -176.73 171.21 2.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.588 -0.695 . . . . 0.0 109.624 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.437 ' N ' ' CD1' ' A' ' 27' ' ' ILE . 1.8 mp -112.12 163.48 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -136.95 78.52 1.7 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.558 -0.714 . . . . 0.0 109.517 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.3 mmmt -63.09 92.38 0.05 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.529 -0.732 . . . . 0.0 109.4 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.1 m -124.5 -53.31 1.69 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.589 -0.695 . . . . 0.0 109.638 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 152.81 -23.01 0.81 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 36.8 pt -57.47 173.36 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.31 -1.112 . . . . 0.0 110.008 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.424 HG21 ' CD2' ' A' ' 34' ' ' TYR . 1.3 tp -76.32 -34.01 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.585 -0.697 . . . . 0.0 109.676 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.424 ' CD2' HG21 ' A' ' 33' ' ' ILE . 17.4 m-85 -120.03 81.18 27.45 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.49 -0.756 . . . . 0.0 109.454 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -81.76 -13.49 10.56 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.008 1.806 . . . . 0.0 111.925 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.1 t -90.04 163.65 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.137 -0.977 . . . . 0.0 109.988 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 tp -139.22 116.37 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.428 ' HB ' ' CE1' ' A' ' 40' ' ' PHE . 30.9 t -93.22 163.68 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.506 -0.746 . . . . 0.0 109.477 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 28.5 ttt180 -106.42 149.37 27.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.58 -0.7 . . . . 0.0 109.233 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.5 ' CD1' ' CE3' ' A' ' 17' ' ' TRP . 85.1 m-85 -143.88 158.63 43.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.604 -0.685 . . . . 0.0 109.757 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -100.47 31.75 3.33 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -118.71 158.75 24.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.689 -0.632 . . . . 0.0 109.353 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.429 ' CG1' ' CZ ' ' A' ' 45' ' ' TYR . 38.3 t -142.03 116.68 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.588 -0.695 . . . . 0.0 109.272 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -79.79 106.29 11.71 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.489 -0.757 . . . . 0.0 109.701 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.429 ' CZ ' ' CG1' ' A' ' 43' ' ' VAL . 82.1 m-85 -95.23 43.55 1.09 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.693 -0.629 . . . . 0.0 109.503 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -137.58 -54.85 0.68 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.435 -0.791 . . . . 0.0 109.481 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.25 81.54 1.73 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -131.68 133.7 45.15 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.678 -0.895 . . . . 0.0 109.469 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.6 p -130.68 112.72 13.36 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.552 -0.718 . . . . 0.0 109.533 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 129.8 -126.44 5.08 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -112.78 -33.1 6.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.564 -0.962 . . . . 0.0 109.499 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -114.59 159.97 19.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.569 -0.707 . . . . 0.0 109.542 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -145.72 -154.69 6.23 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.89 117.7 0.03 OUTLIER Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.445 ' N ' ' CD2' ' A' ' 55' ' ' LEU . 2.6 mm? -106.77 130.8 54.42 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.486 -1.008 . . . . 0.0 109.125 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -117.48 20.5 13.53 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.613 -0.679 . . . . 0.0 109.612 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.3 p -154.3 130.42 10.33 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.361 -0.837 . . . . 0.0 108.887 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.437 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 4.6 m-20 -115.63 136.94 52.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.543 -0.723 . . . . 0.0 109.685 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -74.89 133.79 41.75 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.571 -0.706 . . . . 0.0 109.475 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.44 ' CZ ' HG22 ' A' ' 10' ' ' ILE . 28.7 m-85 -145.71 152.13 39.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.58 -0.7 . . . . 0.0 109.555 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.77 167.75 17.85 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -64.06 -46.82 82.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.468 -0.77 . . . . 0.0 109.241 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -71.75 -18.15 62.15 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.611 -0.681 . . . . 0.0 110.399 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -79.4 -11.49 59.92 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.278 -0.889 . . . . 0.0 110.274 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.9 mt -107.43 144.34 34.5 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.231 -0.918 . . . . 0.0 109.243 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -119.49 83.95 2.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.617 -0.677 . . . . 0.0 109.337 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.0 t -51.65 97.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.323 -0.861 . . . . 0.0 110.064 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.8 m -97.45 36.14 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.595 -0.69 . . . . 0.0 109.588 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.488 0 CA-C-O 118.024 -1.431 . . . . 0.0 109.59 179.962 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 37.5 mt -70.4 89.64 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.572 -0.705 . . . . 0.0 109.372 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -81.16 -179.16 7.23 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.628 -0.67 . . . . 0.0 109.369 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -89.97 141.88 28.24 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.599 -0.688 . . . . 0.0 109.505 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.69 21.29 57.89 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.8 t -90.53 -177.48 5.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.317 -1.108 . . . . 0.0 109.414 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.9 mttp -109.8 118.8 37.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.526 -0.734 . . . . 0.0 109.24 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.4 m -122.96 123.66 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.557 -0.714 . . . . 0.0 109.959 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.4 ttpt -79.62 115.15 19.07 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.41 HG22 ' CZ ' ' A' ' 60' ' ' PHE . 22.2 mm -61.49 132.26 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.611 -0.68 . . . . 0.0 109.629 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -113.6 1.52 14.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.552 -0.718 . . . . 0.0 110.602 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.411 ' O ' ' CD1' ' A' ' 18' ' ' TYR . 1.8 tmt_? -62.23 119.67 9.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.088 -1.007 . . . . 0.0 109.398 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -56.02 -75.33 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.46 -0.775 . . . . 0.0 110.185 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -69.89 89.78 0.6 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.523 -0.735 . . . . 0.0 109.276 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.3 141.13 14.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.602 -0.686 . . . . 0.0 109.833 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.458 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 20.2 t80 -66.72 -13.06 60.89 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.73 -0.606 . . . . 0.0 110.247 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.458 ' NE1' ' CD2' ' A' ' 16' ' ' TYR . 11.5 m0 -125.04 26.77 6.89 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.066 -1.021 . . . . 0.0 110.334 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.411 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 19.4 t80 -68.07 137.56 55.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.4 -0.812 . . . . 0.0 109.163 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.55 -10.47 69.48 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.786 -0.925 . . . . 0.0 110.786 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.16 -169.58 1.72 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.108 -1.231 . . . . 0.0 109.483 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.1 t -127.85 162.68 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.416 ' HA3' HG13 ' A' ' 38' ' ' VAL . . . -145.75 156.48 26.99 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 49.3 m -89.73 112.78 24.17 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.558 -0.966 . . . . 0.0 109.225 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.0 t -47.77 125.21 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.527 -0.733 . . . . 0.0 110.927 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.1 -46.49 5.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.669 -0.644 . . . . 0.0 109.615 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.64 170.66 2.4 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.529 -0.732 . . . . 0.0 109.631 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.447 ' N ' ' CD1' ' A' ' 27' ' ' ILE . 1.8 mp -111.95 162.58 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -125.98 74.47 1.43 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.507 -0.746 . . . . 0.0 109.512 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.1 tptt -63.46 92.36 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.484 -0.76 . . . . 0.0 109.449 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.6 t -137.0 -45.24 0.57 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.564 -0.71 . . . . 0.0 109.658 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.24 -20.36 1.91 Allowed Glycine 0 N--CA 1.495 2.571 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 33.8 pt -56.75 174.63 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.296 -1.12 . . . . 0.0 110.112 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.424 HG21 ' CD2' ' A' ' 34' ' ' TYR . 7.7 tp -90.12 -17.57 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.556 -0.715 . . . . 0.0 110.318 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.424 ' CD2' HG21 ' A' ' 33' ' ' ILE . 15.0 m-85 -130.46 69.31 82.11 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.148 -0.97 . . . . 0.0 109.692 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -82.65 -17.05 7.52 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.048 1.832 . . . . 0.0 111.916 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.8 t -86.56 113.03 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.139 -0.976 . . . . 0.0 110.659 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.2 tp -96.39 116.81 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.357 -0.839 . . . . 0.0 108.955 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.428 ' HB ' ' CE2' ' A' ' 40' ' ' PHE . 39.2 t -91.3 164.33 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.454 -0.779 . . . . 0.0 109.115 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -102.01 140.76 35.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.561 -0.712 . . . . 0.0 109.386 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.428 ' CE2' ' HB ' ' A' ' 38' ' ' VAL . 91.0 m-85 -137.92 126.88 24.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.559 -0.713 . . . . 0.0 109.647 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -62.47 -27.37 69.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.595 -0.69 . . . . 0.0 109.269 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.73 173.9 0.52 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.584 -0.697 . . . . 0.0 109.573 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 36.8 t -150.77 114.37 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.553 -0.717 . . . . 0.0 109.244 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -94.15 144.13 25.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.52 -0.737 . . . . 0.0 109.405 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.419 ' CZ ' ' HA3' ' A' ' 54' ' ' GLY . 14.5 m-85 -139.72 165.05 28.3 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.574 -0.704 . . . . 0.0 109.572 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -149.1 82.83 1.44 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.619 -0.676 . . . . 0.0 109.318 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.86 29.27 74.7 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.96 -172.09 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.565 -0.961 . . . . 0.0 110.247 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.1 t -164.53 31.54 0.07 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.591 -0.693 . . . . 0.0 109.407 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 153.86 -161.09 29.75 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 61.0 107.67 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.535 -0.979 . . . . 0.0 109.712 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.22 -60.46 3.54 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.538 -0.726 . . . . 0.0 109.59 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.9 143.64 32.56 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.419 ' HA3' ' CZ ' ' A' ' 45' ' ' TYR . . . -141.05 116.86 1.17 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 60.41 -89.98 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.698 -0.884 . . . . 0.0 109.898 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 61.98 15.56 7.36 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.935 -1.103 . . . . 0.0 110.389 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 72.1 p -155.06 130.08 9.47 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.181 -0.949 . . . . 0.0 108.984 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.428 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . 0.8 OUTLIER -120.02 148.63 43.33 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.561 -0.712 . . . . 0.0 109.439 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.411 ' O ' ' CD1' ' A' ' 60' ' ' PHE . 11.2 m120 -82.9 143.13 30.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.52 -0.737 . . . . 0.0 109.315 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.415 ' CE2' ' HB3' ' A' ' 58' ' ' ASN . 21.4 m-85 -156.63 141.95 17.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.537 -0.727 . . . . 0.0 109.537 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.62 169.06 18.95 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -63.38 -46.23 87.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.513 -0.742 . . . . 0.0 109.454 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 12.7 p-80 -68.93 -18.94 64.17 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.597 -0.689 . . . . 0.0 110.213 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -79.6 -19.65 48.79 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.366 -0.834 . . . . 0.0 110.2 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 19.5 mt -99.37 143.13 29.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.242 -0.911 . . . . 0.0 109.666 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.02 89.21 3.02 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.3 t -58.24 115.29 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.495 -0.753 . . . . 0.0 110.018 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.0 m -119.6 29.22 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.617 -0.677 . . . . 0.0 109.51 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.402 0 CA-C-O 118.013 -1.437 . . . . 0.0 109.525 -179.936 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 54.3 mt 60.42 50.38 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.5 -0.75 . . . . 0.0 109.547 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -79.95 170.94 15.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.498 -0.751 . . . . 0.0 109.282 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.14 151.82 21.41 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.552 -0.718 . . . . 0.0 109.692 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.65 -16.81 59.24 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.189 -1.165 . . . . 0.0 110.189 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.4 t -90.87 -177.36 4.93 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.228 -1.16 . . . . 0.0 109.755 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.7 mtmt -108.59 124.53 50.63 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.0 m -118.68 127.16 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.532 -0.73 . . . . 0.0 110.165 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.8 tttp -79.48 114.02 18.08 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.424 HG22 ' CZ ' ' A' ' 60' ' ' PHE . 29.3 mm -59.99 129.62 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.646 -0.659 . . . . 0.0 110.008 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -119.62 26.05 9.63 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.659 -0.651 . . . . 0.0 109.567 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.41 ' O ' ' CD1' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -84.88 120.95 27.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.404 -0.81 . . . . 0.0 109.466 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.6 mtpt -59.24 -56.18 25.37 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.497 -0.752 . . . . 0.0 110.004 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -90.31 78.72 6.44 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.483 -0.761 . . . . 0.0 109.921 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.1 p -147.81 141.76 25.88 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.42 -0.8 . . . . 0.0 109.598 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.458 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 21.8 t80 -61.59 -15.6 40.52 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.7 -0.625 . . . . 0.0 110.869 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.495 ' CZ3' ' CD1' ' A' ' 40' ' ' PHE . 11.9 m0 -125.35 35.14 4.8 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.09 -1.006 . . . . 0.0 110.738 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.41 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 20.9 t80 -68.36 130.72 43.72 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.448 -0.783 . . . . 0.0 109.067 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.64 -11.68 62.91 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 120.249 -0.977 . . . . 0.0 110.823 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -109.07 173.94 6.09 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.159 -1.2 . . . . 0.0 109.655 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 87.4 t -111.2 162.53 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.4 ' HA3' HG13 ' A' ' 38' ' ' VAL . . . -143.07 155.17 25.84 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.7 m -86.13 111.43 20.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.514 -0.992 . . . . 0.0 109.219 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 t -53.16 140.29 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 121.306 -0.871 . . . . 0.0 109.987 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -109.37 -49.94 3.05 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.544 -0.722 . . . . 0.0 109.706 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -170.96 164.82 7.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.622 -0.674 . . . . 0.0 109.584 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 38.1 mm -112.14 163.29 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -101.47 -171.93 2.07 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.637 -0.665 . . . . 0.0 109.323 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -99.64 37.41 1.6 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.448 -0.782 . . . . 0.0 109.536 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.1 t 60.15 32.11 20.79 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.478 -0.764 . . . . 0.0 109.676 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.38 -30.76 48.69 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 16.3 pt -124.21 -174.82 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.563 -0.963 . . . . 0.0 109.511 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.419 HG21 ' CD2' ' A' ' 34' ' ' TYR . 16.1 tt -78.37 -27.78 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.537 -0.727 . . . . 0.0 109.488 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.419 ' CD2' HG21 ' A' ' 33' ' ' ILE . 17.6 m-85 -121.65 80.1 39.53 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.473 -0.767 . . . . 0.0 109.373 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -82.52 -9.53 11.21 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.08 1.854 . . . . 0.0 111.95 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.3 t -93.79 113.46 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 120.962 -1.086 . . . . 0.0 110.261 -178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.6 tp -98.05 116.0 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.17 -0.956 . . . . 0.0 108.78 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.429 ' HB ' ' CE1' ' A' ' 40' ' ' PHE . 40.7 t -92.08 164.58 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.573 -0.704 . . . . 0.0 109.365 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.5 ttt180 -109.22 149.52 29.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.565 -0.71 . . . . 0.0 109.467 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.495 ' CD1' ' CZ3' ' A' ' 17' ' ' TRP . 61.7 m-85 -146.55 154.71 41.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.581 -0.7 . . . . 0.0 109.486 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -100.82 34.0 2.61 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -125.18 55.81 1.37 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 36.8 t -59.12 114.1 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.299 -0.876 . . . . 0.0 109.761 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -80.3 153.11 28.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.62 -0.675 . . . . 0.0 109.513 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -138.77 78.38 1.67 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.542 -0.724 . . . . 0.0 109.451 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -96.74 -63.68 1.12 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.509 -0.744 . . . . 0.0 109.526 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.421 ' O ' ' CG ' ' A' ' 48' ' ' PHE . . . -163.82 -82.24 0.04 OUTLIER Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.421 ' CG ' ' O ' ' A' ' 47' ' ' GLY . 42.8 p90 40.82 31.09 0.11 Allowed 'General case' 0 N--CA 1.509 2.524 0 O-C-N 122.136 -0.626 . . . . 0.0 111.568 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.6 t -63.03 125.19 23.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.487 -0.758 . . . . 0.0 109.51 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.95 30.68 3.87 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 t -176.11 97.99 0.06 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.552 -0.97 . . . . 0.0 109.532 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 60.14 179.26 0.09 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.456 -0.777 . . . . 0.0 109.612 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.56 -30.26 3.86 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -159.6 166.22 34.79 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.4 mp -87.9 -74.24 0.46 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.614 -0.933 . . . . 0.0 109.441 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 64.53 13.38 8.16 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.543 -0.723 . . . . 0.0 110.547 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -167.78 132.22 1.8 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.24 -0.913 . . . . 0.0 108.825 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.45 ' ND2' ' CZ3' ' A' ' 17' ' ' TRP . 0.3 OUTLIER -108.39 167.9 9.7 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.522 -0.736 . . . . 0.0 109.357 -179.755 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.413 ' O ' ' CD1' ' A' ' 60' ' ' PHE . 5.6 m120 -104.85 141.44 36.51 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.575 -0.703 . . . . 0.0 109.173 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.424 ' CZ ' HG22 ' A' ' 10' ' ' ILE . 42.2 m-85 -155.36 146.61 22.75 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.491 -0.756 . . . . 0.0 109.447 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.0 171.0 14.29 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -62.81 -48.73 77.83 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.543 -0.723 . . . . 0.0 109.571 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 16.2 p-80 -68.0 -20.93 65.06 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.557 -0.714 . . . . 0.0 110.225 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -79.57 -20.49 46.87 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.315 -0.866 . . . . 0.0 110.175 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.9 mt -98.98 146.23 26.24 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.264 -0.897 . . . . 0.0 109.669 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -120.63 86.79 2.63 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.8 t -50.97 114.35 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.372 -0.83 . . . . 0.0 110.363 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.4 m -106.9 -29.58 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.556 -0.715 . . . . 0.0 109.562 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.461 0 CA-C-O 117.958 -1.468 . . . . 0.0 109.531 -179.992 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.433 HG21 HD11 ' A' ' 2' ' ' ILE . 41.0 mm -106.06 133.51 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.575 -0.703 . . . . 0.0 109.538 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -80.05 161.54 25.32 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.488 -0.758 . . . . 0.0 109.421 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -90.05 128.94 36.4 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.581 -0.699 . . . . 0.0 109.569 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.57 20.91 56.91 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.2 t -90.4 162.06 15.28 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.375 -1.073 . . . . 0.0 109.377 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.6 mtpp -79.77 116.93 20.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.552 -0.718 . . . . 0.0 109.286 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.402 ' CG1' ' CG2' ' A' ' 24' ' ' VAL . 33.2 m -120.04 122.49 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.533 -0.729 . . . . 0.0 109.776 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.1 ttpt -79.38 113.72 17.74 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.416 HD13 ' CD2' ' A' ' 60' ' ' PHE . 27.1 mm -61.78 132.23 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.66 -0.65 . . . . 0.0 109.516 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -114.9 5.0 14.98 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.504 -0.747 . . . . 0.0 110.694 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.412 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . 0.2 OUTLIER -62.43 124.44 20.95 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.948 -1.095 . . . . 0.0 109.422 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -59.55 -73.95 0.08 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.483 -0.76 . . . . 0.0 109.818 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -76.32 86.19 3.1 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.575 -0.703 . . . . 0.0 109.359 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.98 143.15 28.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.553 -0.717 . . . . 0.0 109.613 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.45 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 20.0 t80 -66.2 -13.62 60.58 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.682 -0.636 . . . . 0.0 110.191 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.505 ' CE3' ' CD2' ' A' ' 40' ' ' PHE . 13.2 m0 -127.34 25.76 6.09 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.084 -1.01 . . . . 0.0 110.333 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -67.82 127.93 34.62 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.381 -0.824 . . . . 0.0 108.834 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.17 -5.4 49.47 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.639 -0.985 . . . . 0.0 110.639 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -117.72 175.05 5.83 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.111 -1.229 . . . . 0.0 109.359 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.6 t -108.63 162.5 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.4 ' HA3' HG13 ' A' ' 38' ' ' VAL . . . -143.44 154.94 25.82 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 48.5 m -87.92 111.95 22.0 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.444 -1.033 . . . . 0.0 109.241 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.402 ' CG2' ' CG1' ' A' ' 8' ' ' VAL . 47.9 t -51.32 125.41 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.446 -0.784 . . . . 0.0 110.379 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -95.11 -49.98 5.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.716 -0.615 . . . . 0.0 109.441 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -176.48 175.55 1.74 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.5 -0.75 . . . . 0.0 109.661 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.44 ' N ' ' CD1' ' A' ' 27' ' ' ILE . 1.8 mp -113.65 164.36 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.406 ' N ' ' CG2' ' A' ' 27' ' ' ILE . 9.5 t0 -135.62 96.17 3.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.477 -0.764 . . . . 0.0 109.546 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.5 mmtm -71.64 89.2 0.99 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.642 -0.661 . . . . 0.0 109.282 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.5 m -123.25 -58.37 1.63 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.593 -0.692 . . . . 0.0 109.603 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.67 -21.67 1.03 Allowed Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.099 -1.201 . . . . 0.0 110.099 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 29.8 pt -57.65 163.66 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.212 -1.17 . . . . 0.0 110.019 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.419 HG22 ' CE2' ' A' ' 34' ' ' TYR . 5.0 tt -69.22 -26.27 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.595 -0.691 . . . . 0.0 109.759 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.419 ' CE2' HG22 ' A' ' 33' ' ' ILE . 17.5 m-85 -121.65 78.82 38.74 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.402 -0.811 . . . . 0.0 109.312 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -81.91 -15.97 9.07 Favored 'Trans proline' 0 C--N 1.324 -0.714 0 C-N-CA 122.048 1.832 . . . . 0.0 111.969 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.7 t -87.22 164.47 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.066 -1.021 . . . . 0.0 109.898 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.2 tp -140.62 114.85 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.419 ' HB ' ' CZ ' ' A' ' 40' ' ' PHE . 39.5 t -91.45 164.49 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.429 -0.795 . . . . 0.0 109.283 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 12.5 ttt85 -105.48 145.14 31.27 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.637 -0.664 . . . . 0.0 109.349 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.505 ' CD2' ' CE3' ' A' ' 17' ' ' TRP . 80.7 m-85 -141.77 136.87 31.14 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.656 -0.653 . . . . 0.0 109.759 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 30.8 m-20 -67.66 -28.19 67.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.551 -0.718 . . . . 0.0 109.094 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.26 165.87 2.46 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.537 -0.727 . . . . 0.0 109.62 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.435 ' CG1' ' CZ ' ' A' ' 45' ' ' TYR . 31.5 t -149.16 120.32 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.507 -0.746 . . . . 0.0 109.453 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -93.1 92.8 7.96 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.599 -0.688 . . . . 0.0 109.482 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.435 ' CZ ' ' CG1' ' A' ' 43' ' ' VAL . 66.9 m-85 -80.95 -58.73 2.95 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.58 -0.7 . . . . 0.0 109.446 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 60.03 32.6 21.13 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.545 -0.722 . . . . 0.0 109.674 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.434 ' O ' ' CG ' ' A' ' 48' ' ' PHE . . . 122.65 176.29 14.91 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.434 ' CG ' ' O ' ' A' ' 47' ' ' GLY . 42.6 p90 40.82 31.12 0.11 Allowed 'General case' 0 N--CA 1.509 2.513 0 O-C-N 122.052 -0.675 . . . . 0.0 111.6 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.8 t -63.49 96.98 0.13 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.562 -0.711 . . . . 0.0 109.425 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -151.34 36.42 0.87 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 59.97 -167.5 0.17 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.505 -0.997 . . . . 0.0 109.745 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 63.23 -89.0 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.597 -0.689 . . . . 0.0 109.727 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.93 142.03 44.43 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 173.69 165.5 30.52 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.8 mp -97.9 -76.96 0.51 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.615 -0.932 . . . . 0.0 109.381 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.0 m120 61.6 15.98 7.3 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.505 -0.747 . . . . 0.0 110.497 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 72.6 p -154.76 129.75 9.48 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.155 -0.966 . . . . 0.0 109.202 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.428 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -117.24 151.22 37.38 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.55 -0.719 . . . . 0.0 109.287 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -87.46 134.54 33.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.487 -0.758 . . . . 0.0 109.376 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.428 ' CE2' ' HB3' ' A' ' 58' ' ' ASN . 22.3 m-85 -148.61 150.78 33.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.632 -0.668 . . . . 0.0 109.35 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.9 168.33 17.16 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -64.17 -45.95 86.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.497 -0.752 . . . . 0.0 109.28 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -70.87 -19.75 62.59 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.615 -0.678 . . . . 0.0 110.288 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -79.29 -14.24 59.14 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.292 -0.88 . . . . 0.0 110.215 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.1 mt -103.73 144.38 31.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 109.31 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -111.25 87.23 2.49 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.599 -0.688 . . . . 0.0 109.588 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.1 t -58.95 100.88 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.505 -0.747 . . . . 0.0 109.784 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.7 m -103.6 -29.06 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.625 -0.672 . . . . 0.0 109.598 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.377 0 CA-C-O 117.986 -1.452 . . . . 0.0 109.564 -179.994 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 39.2 mm -101.43 136.11 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.571 -0.706 . . . . 0.0 109.404 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -79.93 162.22 25.08 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.577 -0.702 . . . . 0.0 109.529 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -90.07 129.27 36.39 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.644 -0.66 . . . . 0.0 109.523 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.71 18.97 54.22 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.3 t -90.44 160.88 15.81 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.358 -1.084 . . . . 0.0 109.364 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.4 mtpp -79.88 118.32 21.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.503 -0.748 . . . . 0.0 109.289 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.0 m -120.3 123.48 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.601 -0.687 . . . . 0.0 109.773 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -79.36 115.13 18.82 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.425 HG22 ' CZ ' ' A' ' 60' ' ' PHE . 27.3 mm -62.56 132.14 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.657 -0.652 . . . . 0.0 109.462 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -116.5 5.28 13.36 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.489 -0.757 . . . . 0.0 110.786 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.413 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -63.35 124.31 20.94 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.984 -1.072 . . . . 0.0 109.36 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -59.06 -69.31 0.2 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.479 -0.763 . . . . 0.0 109.968 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -81.14 81.87 7.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.602 -0.686 . . . . 0.0 109.337 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.64 143.35 37.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.495 -0.753 . . . . 0.0 109.579 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.449 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 25.4 t80 -64.28 -15.64 60.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.667 -0.646 . . . . 0.0 110.101 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.497 ' CE3' ' CD1' ' A' ' 40' ' ' PHE . 16.2 m0 -129.58 30.71 4.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.254 -0.904 . . . . 0.0 110.242 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.403 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 16.3 t80 -69.17 121.3 16.49 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.45 -8.67 26.41 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 120.205 -0.998 . . . . 0.0 110.63 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -116.36 171.6 7.73 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.065 -1.256 . . . . 0.0 109.512 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.7 t -104.58 162.63 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.407 ' HA3' HG13 ' A' ' 38' ' ' VAL . . . -143.56 153.69 25.04 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 51.8 m -87.91 112.35 22.43 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.566 -0.961 . . . . 0.0 109.239 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.1 t -52.35 127.03 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.458 -0.776 . . . . 0.0 110.186 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -96.48 -49.61 5.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.633 -0.667 . . . . 0.0 109.682 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -173.89 167.8 4.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.638 -0.664 . . . . 0.0 109.748 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.4 mm -113.73 164.3 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.609 -0.682 . . . . 0.0 109.255 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.15 44.65 1.0 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.58 -0.7 . . . . 0.0 109.283 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? 57.17 21.36 6.45 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.665 -0.647 . . . . 0.0 110.399 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 31.1 t 57.02 81.74 0.13 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.213 -0.929 . . . . 0.0 109.872 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -135.09 -70.88 0.07 OUTLIER Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 17.8 pt -69.64 178.04 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.547 -0.972 . . . . 0.0 109.907 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.465 ' CG2' ' CE1' ' A' ' 34' ' ' TYR . 61.6 mt -68.65 -32.78 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.65 -0.656 . . . . 0.0 109.474 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.465 ' CE1' ' CG2' ' A' ' 33' ' ' ILE . 4.7 m-85 -131.97 70.4 80.68 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.547 -0.721 . . . . 0.0 109.101 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -82.54 -17.12 7.62 Favored 'Trans proline' 0 C--N 1.325 -0.663 0 C-N-CA 122.131 1.887 . . . . 0.0 111.653 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.0 t -79.6 113.05 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.203 -0.936 . . . . 0.0 110.169 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 tp -95.45 115.24 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.428 ' HB ' ' CE1' ' A' ' 40' ' ' PHE . 35.3 t -90.8 163.67 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.518 -0.739 . . . . 0.0 109.258 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.3 ttt180 -106.47 147.95 28.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.595 -0.69 . . . . 0.0 109.221 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.497 ' CD1' ' CE3' ' A' ' 17' ' ' TRP . 79.6 m-85 -144.05 157.62 44.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.553 -0.717 . . . . 0.0 109.502 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -100.07 32.19 3.04 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.33 136.64 52.2 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.434 ' CG1' ' CZ ' ' A' ' 45' ' ' TYR . 36.2 t -108.91 141.88 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.481 -0.762 . . . . 0.0 109.479 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -119.68 96.54 5.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.528 -0.732 . . . . 0.0 109.458 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.434 ' CZ ' ' CG1' ' A' ' 43' ' ' VAL . 82.1 m-85 -83.72 88.19 7.07 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.569 -0.707 . . . . 0.0 109.495 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -97.92 122.02 40.53 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.619 -0.676 . . . . 0.0 109.489 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.25 73.98 0.57 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -121.62 134.87 55.0 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.541 -0.976 . . . . 0.0 109.507 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.5 m -161.13 31.09 0.14 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.607 -0.683 . . . . 0.0 109.517 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 124.19 49.09 0.21 Allowed Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.8 m -154.26 151.77 29.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.555 -0.968 . . . . 0.0 109.482 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -111.28 177.21 4.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.606 -0.684 . . . . 0.0 109.565 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.82 91.46 2.17 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.49 -162.83 38.69 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.402 ' CD1' ' N ' ' A' ' 55' ' ' LEU . 7.5 mp -115.73 -76.3 0.58 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.605 -0.938 . . . . 0.0 109.513 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 20.8 m-20 61.58 16.81 8.0 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.489 -0.757 . . . . 0.0 110.32 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 65.1 p -154.61 132.35 11.45 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.247 -0.908 . . . . 0.0 108.894 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.451 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 3.7 t-20 -124.36 133.24 53.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.538 -0.726 . . . . 0.0 109.872 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.422 ' O ' ' CD1' ' A' ' 60' ' ' PHE . 28.6 m-80 -68.74 145.68 53.6 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.597 -0.689 . . . . 0.0 109.453 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.451 ' CE2' ' HB3' ' A' ' 58' ' ' ASN . 14.9 m-85 -158.04 145.91 18.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.634 -0.666 . . . . 0.0 109.343 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.73 169.1 16.56 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -62.71 -48.29 79.9 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.442 -0.786 . . . . 0.0 109.601 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -69.32 -18.1 63.78 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.534 -0.729 . . . . 0.0 110.452 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -79.6 -19.14 50.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.178 -0.951 . . . . 0.0 110.256 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.4 mt -102.34 146.38 28.13 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.272 -0.892 . . . . 0.0 109.496 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -116.49 88.11 2.83 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.652 -0.655 . . . . 0.0 109.265 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.3 t -57.92 110.9 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.498 -0.751 . . . . 0.0 109.861 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.4 m -109.67 -29.87 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.645 -0.659 . . . . 0.0 109.485 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.434 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.98 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.512 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.7 t -90.57 162.15 15.13 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.249 -1.148 . . . . 0.0 109.416 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.83 115.58 23.56 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.502 -0.749 . . . . 0.0 109.151 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.82 HG12 HG22 ' A' ' 67' ' ' VAL . 28.4 m -116.85 124.54 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.499 -0.751 . . . . 0.0 110.016 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.464 ' CE ' HD21 ' A' ' 11' ' ' LEU . 9.4 ttpt -79.55 113.48 17.73 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.527 HG22 ' H ' ' A' ' 12' ' ' ARG . 35.3 mm -61.13 131.25 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.591 -0.693 . . . . 0.0 109.707 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.464 HD21 ' CE ' ' A' ' 9' ' ' LYS . 3.5 mm? -115.99 27.01 9.55 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.516 -0.74 . . . . 0.0 109.681 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.527 ' H ' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -85.64 119.77 26.34 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.421 -0.8 . . . . 0.0 109.283 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.87 -73.88 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.427 -0.795 . . . . 0.0 110.25 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -76.57 85.89 3.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.53 -0.731 . . . . 0.0 109.377 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.2 t -152.03 139.92 20.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.537 -0.727 . . . . 0.0 109.663 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.458 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 25.1 t80 -63.97 -15.42 59.2 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.686 -0.634 . . . . 0.0 110.366 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.502 ' CZ3' ' CD1' ' A' ' 40' ' ' PHE . 14.3 m0 -125.22 32.19 5.43 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.096 -1.002 . . . . 0.0 110.258 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.414 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 17.0 t80 -69.32 133.6 48.05 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.474 -0.766 . . . . 0.0 109.098 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.56 -12.73 66.04 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -95.04 -171.01 2.32 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.182 -1.187 . . . . 0.0 109.595 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.0 t -132.39 129.73 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -112.36 157.45 14.94 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 52.7 m -89.02 112.01 22.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.601 -0.941 . . . . 0.0 109.345 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 37.5 t -50.24 130.86 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.401 -0.812 . . . . 0.0 110.621 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -102.28 -48.35 4.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.663 -0.648 . . . . 0.0 109.529 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.486 ' C ' HD12 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -174.37 156.16 2.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.594 -0.691 . . . . 0.0 109.601 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.616 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.8 mp . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.403 ' HB3' ' N ' ' A' ' 60' ' ' PHE . 21.0 m-85 . . . . . 0 N--CA 1.494 1.772 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -81.58 -15.34 9.82 Favored 'Trans proline' 0 C--N 1.325 -0.708 0 C-N-CA 122.007 1.805 . . . . 0.0 111.899 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.568 HG22 HG13 ' A' ' 27' ' ' ILE . 19.9 t -89.39 111.14 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.062 -1.024 . . . . 0.0 110.227 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.1 tp -91.21 117.66 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.322 -0.861 . . . . 0.0 108.725 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.491 HG12 ' N ' ' A' ' 39' ' ' ARG . 44.3 t -94.0 162.98 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.5 -0.75 . . . . 0.0 109.476 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.491 ' N ' HG12 ' A' ' 38' ' ' VAL . 12.0 ttt180 -105.21 152.69 22.54 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.502 ' CD1' ' CZ3' ' A' ' 17' ' ' TRP . 87.3 m-85 -148.86 124.7 10.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.632 -0.667 . . . . 0.0 109.588 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -61.97 -26.18 68.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.497 -0.752 . . . . 0.0 109.214 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.76 160.28 9.66 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.553 -0.717 . . . . 0.0 109.601 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.3 t . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.828 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 . . . . . 0 N--CA 1.509 2.5 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.3 p -127.79 129.75 47.54 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.029 -1.044 . . . . 0.0 109.062 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.445 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 3.4 m-20 -105.75 174.73 5.76 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.572 -0.705 . . . . 0.0 109.425 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.404 ' O ' ' CD1' ' A' ' 60' ' ' PHE . 3.5 m-80 -112.0 140.09 46.96 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.457 ' HB2' HD21 ' A' ' 65' ' ' LEU . 58.1 m-85 -154.82 147.69 24.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.6 -0.687 . . . . 0.0 109.505 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.407 ' HB3' ' HG3' ' A' ' 64' ' ' GLU . . . -82.5 173.2 12.2 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -63.4 -50.57 69.33 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.521 -0.737 . . . . 0.0 109.452 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.44 ' CD2' ' HG2' ' A' ' 64' ' ' GLU . 30.8 p-80 -69.09 -17.11 63.82 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.594 -0.691 . . . . 0.0 110.289 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.44 ' HG2' ' CD2' ' A' ' 63' ' ' HIS . 3.4 mm-40 -79.42 -20.89 46.44 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.251 -0.906 . . . . 0.0 110.054 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.457 HD21 ' HB2' ' A' ' 60' ' ' PHE . 8.3 mt -100.71 146.95 26.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.379 -0.826 . . . . 0.0 109.537 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.454 ' HB2' HD23 ' A' ' 11' ' ' LEU . 10.2 tt0 -117.88 81.48 1.67 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.617 -0.677 . . . . 0.0 109.221 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.82 HG22 HG12 ' A' ' 8' ' ' VAL . 42.0 t -57.88 115.31 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.446 -0.784 . . . . 0.0 109.784 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.42 HG13 ' O ' ' A' ' 66' ' ' GLU . 30.0 m . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.621 -0.675 . . . . 0.0 109.566 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.567 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.2 t -90.55 162.99 14.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.228 -1.16 . . . . 0.0 109.421 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.5 mmtp -79.88 116.51 20.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.513 -0.742 . . . . 0.0 109.239 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 8' ' ' VAL . 30.4 m -118.32 126.85 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.492 -0.755 . . . . 0.0 109.892 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.659 ' CE ' HD21 ' A' ' 11' ' ' LEU . 20.3 ttpt -79.26 125.56 29.64 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.588 ' C ' HD22 ' A' ' 11' ' ' LEU . 26.6 mm -73.86 131.74 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.695 -0.628 . . . . 0.0 109.548 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.659 HD21 ' CE ' ' A' ' 9' ' ' LYS . 4.2 mm? -121.94 27.42 8.1 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.489 -0.757 . . . . 0.0 109.934 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.433 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -89.33 113.06 24.29 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.432 -0.792 . . . . 0.0 109.383 179.83 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.77 -55.4 26.72 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.475 -0.765 . . . . 0.0 110.239 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -84.9 77.19 10.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.544 -0.722 . . . . 0.0 109.382 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.98 137.93 20.24 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.554 -0.717 . . . . 0.0 109.699 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.455 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 16.8 t80 -64.05 -15.31 59.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.782 -0.574 . . . . 0.0 110.245 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.501 ' CE3' ' CD1' ' A' ' 40' ' ' PHE . 10.8 m0 -124.06 33.82 5.2 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.147 -0.971 . . . . 0.0 110.113 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.411 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 47.7 t80 -68.81 133.37 48.21 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.52 -0.738 . . . . 0.0 109.014 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.13 -18.89 55.9 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.42 158.03 15.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -1.142 . . . . 0.0 109.568 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 22' ' ' GLY . 70.0 t -97.08 162.12 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.47 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -143.72 172.64 24.92 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.2 m -102.72 115.36 30.43 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.562 -0.963 . . . . 0.0 109.42 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.4 ' CG2' ' CG1' ' A' ' 8' ' ' VAL . 46.9 t -52.82 113.65 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.277 -0.889 . . . . 0.0 110.005 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.608 ' HB2' ' CG ' ' A' ' 39' ' ' ARG . . . -82.03 -48.38 11.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.659 -0.651 . . . . 0.0 109.777 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.1 m -167.78 156.69 9.57 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.499 -0.751 . . . . 0.0 110.026 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.815 ' CD1' HG13 ' A' ' 36' ' ' VAL . 32.1 mm . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.452 ' HD1' ' HB2' ' A' ' 61' ' ' ALA . 22.1 m-85 . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -81.87 4.24 7.19 Favored 'Trans proline' 0 C--N 1.323 -0.776 0 C-N-CA 122.037 1.825 . . . . 0.0 112.021 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.815 HG13 ' CD1' ' A' ' 27' ' ' ILE . 22.2 t -112.86 112.79 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.977 -1.077 . . . . 0.0 110.505 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -101.41 116.53 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.136 -0.977 . . . . 0.0 108.904 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 39' ' ' ARG . 20.4 t -92.9 164.33 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.499 -0.751 . . . . 0.0 109.008 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.608 ' CG ' ' HB2' ' A' ' 25' ' ' ALA . 6.8 mtt180 -110.14 149.35 30.2 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.545 -0.722 . . . . 0.0 109.386 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.501 ' CD1' ' CE3' ' A' ' 17' ' ' TRP . 59.6 m-85 -142.57 138.54 30.89 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.595 -0.69 . . . . 0.0 109.543 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -62.88 -28.0 69.74 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.582 -0.699 . . . . 0.0 109.573 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.405 ' HB3' ' NE1' ' A' ' 17' ' ' TRP . 0.7 OUTLIER -59.5 162.28 5.09 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.474 -0.766 . . . . 0.0 109.688 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.3 t . . . . . 0 N--CA 1.493 1.705 0 O-C-N 121.588 -0.695 . . . . 0.0 109.488 179.963 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.406 ' C ' HG23 ' A' ' 57' ' ' THR . 7.4 m120 . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 120.423 0.154 . . . . 0.0 110.692 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.406 HG23 ' C ' ' A' ' 56' ' ' ASN . 59.4 p -154.78 129.65 9.4 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.156 -0.965 . . . . 0.0 109.383 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.439 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 13.1 t-20 -109.01 153.92 22.93 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.499 -0.751 . . . . 0.0 109.477 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.429 ' O ' ' CD1' ' A' ' 60' ' ' PHE . 1.8 m120 -97.63 130.87 44.61 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.555 -0.716 . . . . 0.0 109.531 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.439 ' CE2' ' HB3' ' A' ' 58' ' ' ASN . 32.9 m-85 -146.71 151.02 36.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.648 -0.657 . . . . 0.0 109.273 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.452 ' HB2' ' HD1' ' A' ' 34' ' ' TYR . . . -83.99 174.4 10.36 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -64.66 -42.96 95.05 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.51 -0.744 . . . . 0.0 109.511 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.531 ' CE1' ' HG3' ' A' ' 64' ' ' GLU . 22.4 p80 -71.74 -23.25 61.58 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.628 -0.67 . . . . 0.0 110.21 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.531 ' HG3' ' CE1' ' A' ' 63' ' ' HIS . 12.4 mt-10 -79.74 -0.49 34.49 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.333 -0.855 . . . . 0.0 110.666 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.468 ' CD1' HG11 ' A' ' 36' ' ' VAL . 13.2 mt -120.8 146.13 46.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.072 -1.018 . . . . 0.0 109.453 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -116.33 91.36 3.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.593 -0.692 . . . . 0.0 109.452 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 43.0 t -60.15 95.02 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.474 -0.766 . . . . 0.0 109.596 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 N--CA 1.493 1.705 0 O-C-N 121.647 -0.658 . . . . 0.0 109.704 -179.908 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.524 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 31.0 t -90.73 162.0 15.09 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.34 -1.094 . . . . 0.0 109.513 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 56.1 mttt -80.57 111.31 16.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.511 -0.743 . . . . 0.0 109.169 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 8' ' ' VAL . 25.6 m -112.75 127.77 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.485 -0.76 . . . . 0.0 109.88 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.72 ' CE ' HD21 ' A' ' 11' ' ' LEU . 28.2 ttpt -79.15 127.67 32.32 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.685 ' C ' HD22 ' A' ' 11' ' ' LEU . 27.8 mm -76.45 132.3 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.642 -0.661 . . . . 0.0 109.326 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.72 HD21 ' CE ' ' A' ' 9' ' ' LYS . 4.4 mm? -124.51 28.92 6.45 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.509 -0.744 . . . . 0.0 109.875 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.411 ' O ' ' CD1' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -89.55 115.72 27.17 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.502 -0.749 . . . . 0.0 109.503 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.7 mmtm -53.03 -62.02 1.92 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.472 -0.768 . . . . 0.0 110.273 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -80.59 82.19 6.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.605 -0.684 . . . . 0.0 109.292 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.2 t -154.43 137.19 15.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.558 -0.714 . . . . 0.0 109.616 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.457 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 15.7 t80 -63.08 -16.32 59.55 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.665 -0.647 . . . . 0.0 110.183 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.495 ' CE3' ' CD2' ' A' ' 40' ' ' PHE . 9.0 m0 -123.91 35.73 4.77 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.188 -0.945 . . . . 0.0 110.0 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.411 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 26.6 t80 -70.17 118.65 13.26 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.63 -20.46 29.64 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.09 158.07 15.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -1.127 . . . . 0.0 109.563 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.474 HG12 ' N ' ' A' ' 22' ' ' GLY . 66.6 t -95.75 162.54 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.474 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -143.45 173.18 24.53 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.5 m -105.61 113.43 26.99 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.407 -1.055 . . . . 0.0 109.488 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 37.7 t -51.28 117.49 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.286 -0.884 . . . . 0.0 110.409 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -89.8 -45.53 9.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.679 -0.638 . . . . 0.0 109.824 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -173.36 165.68 4.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.509 -0.744 . . . . 0.0 109.907 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.832 HD12 HG22 ' A' ' 36' ' ' VAL . 33.8 mm . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.463 ' HD1' ' HB2' ' A' ' 61' ' ' ALA . 16.8 m-85 . . . . . 0 N--CA 1.496 1.863 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -84.27 -21.61 3.64 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.266 1.977 . . . . 0.0 111.961 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.832 HG22 HD12 ' A' ' 27' ' ' ILE . 21.6 t -79.84 111.19 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.225 -0.922 . . . . 0.0 110.728 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.456 HD12 ' CG ' ' A' ' 59' ' ' ASN . 0.7 OUTLIER -96.25 117.93 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.332 -0.855 . . . . 0.0 108.758 178.897 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 39' ' ' ARG . 21.7 t -96.17 163.77 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.462 -0.774 . . . . 0.0 108.977 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.477 ' N ' HG12 ' A' ' 38' ' ' VAL . 6.7 mtt180 -105.06 149.08 26.12 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.449 -0.782 . . . . 0.0 109.338 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.495 ' CD2' ' CE3' ' A' ' 17' ' ' TRP . 82.0 m-85 -143.47 135.94 27.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.609 -0.682 . . . . 0.0 109.566 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -62.96 -28.93 70.42 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.576 -0.703 . . . . 0.0 109.392 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.27 162.18 6.3 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.605 -0.685 . . . . 0.0 109.614 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.2 t . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.558 -0.714 . . . . 0.0 109.482 179.964 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.407 ' C ' HG23 ' A' ' 57' ' ' THR . 7.2 m120 . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 120.385 0.136 . . . . 0.0 110.717 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.407 HG23 ' C ' ' A' ' 56' ' ' ASN . 72.4 p -154.72 130.39 9.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.151 -0.968 . . . . 0.0 109.206 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.448 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 1.0 OUTLIER -118.39 125.82 50.79 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.444 -0.785 . . . . 0.0 109.67 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.456 ' CG ' HD12 ' A' ' 37' ' ' ILE . 6.7 m-20 -64.01 149.84 46.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.555 -0.716 . . . . 0.0 109.19 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.448 ' CE2' ' HB3' ' A' ' 58' ' ' ASN . 14.5 m-85 -160.57 147.91 15.85 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.463 ' HB2' ' HD1' ' A' ' 34' ' ' TYR . . . -82.82 167.19 18.34 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -62.98 -46.52 87.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.476 -0.765 . . . . 0.0 109.444 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.43 ' CD2' ' HG3' ' A' ' 64' ' ' GLU . 10.2 p-80 -68.7 -20.56 64.42 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.581 -0.7 . . . . 0.0 110.191 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.43 ' HG3' ' CD2' ' A' ' 63' ' ' HIS . 35.7 mt-10 -79.36 -19.7 49.59 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.265 -0.897 . . . . 0.0 110.196 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.418 ' CD1' HG11 ' A' ' 36' ' ' VAL . 14.2 mt -100.92 154.06 18.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.296 -0.877 . . . . 0.0 109.532 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.474 ' O ' HG13 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -124.67 88.75 2.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.547 -0.721 . . . . 0.0 109.393 179.946 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.0 t -57.75 105.81 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.465 -0.772 . . . . 0.0 109.851 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 66' ' ' GLU . 30.3 m . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.709 -0.62 . . . . 0.0 109.557 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.548 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.0 t -90.42 160.54 16.0 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.169 -1.195 . . . . 0.0 109.48 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.3 mttt -88.59 118.33 28.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.51 -0.744 . . . . 0.0 109.219 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.731 HG12 HG22 ' A' ' 67' ' ' VAL . 33.1 m -118.86 126.16 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.581 -0.699 . . . . 0.0 109.937 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.456 ' CE ' HD21 ' A' ' 11' ' ' LEU . 8.8 ttpt -79.49 116.66 19.85 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.417 HD12 ' CD2' ' A' ' 60' ' ' PHE . 24.3 mm -62.78 131.94 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.651 -0.656 . . . . 0.0 109.539 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.456 HD21 ' CE ' ' A' ' 9' ' ' LYS . 3.6 mm? -114.91 3.36 14.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.498 -0.751 . . . . 0.0 110.598 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.423 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -62.53 120.54 11.32 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.075 -1.016 . . . . 0.0 109.363 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -56.45 -76.48 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.473 -0.767 . . . . 0.0 110.174 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -70.71 89.33 0.74 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.543 -0.723 . . . . 0.0 109.326 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.37 141.88 19.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.573 -0.705 . . . . 0.0 109.801 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.454 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 20.2 t80 -66.75 -13.41 61.36 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.691 -0.631 . . . . 0.0 110.187 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.501 ' CE3' ' CD1' ' A' ' 40' ' ' PHE . 13.8 m0 -126.04 25.73 6.69 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.112 -0.992 . . . . 0.0 110.336 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.406 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 18.9 t80 -67.0 137.11 56.26 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.449 -0.782 . . . . 0.0 109.065 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.36 -9.33 77.64 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -106.24 -169.85 1.64 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.195 -1.179 . . . . 0.0 109.52 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 22' ' ' GLY . 62.2 t -128.06 162.54 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.477 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -145.58 175.1 25.3 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.6 m -106.92 115.14 29.68 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.537 -0.979 . . . . 0.0 109.349 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.0 t -50.3 115.18 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.344 -0.847 . . . . 0.0 110.635 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.554 ' HB2' ' CG ' ' A' ' 39' ' ' ARG . . . -85.35 -47.23 10.22 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.668 -0.645 . . . . 0.0 109.733 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -172.05 160.15 5.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.516 -0.74 . . . . 0.0 109.871 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.817 HD12 HG22 ' A' ' 36' ' ' VAL . 33.1 mm . . . . . 0 N--CA 1.492 1.664 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.4 ' HB3' ' N ' ' A' ' 60' ' ' PHE . 18.7 m-85 . . . . . 0 N--CA 1.496 1.853 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -81.64 -14.22 10.33 Favored 'Trans proline' 0 C--N 1.324 -0.76 0 C-N-CA 122.126 1.884 . . . . 0.0 111.991 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.817 HG22 HD12 ' A' ' 27' ' ' ILE . 24.3 t -94.33 110.72 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.004 -1.06 . . . . 0.0 110.558 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.661 HD12 ' HA ' ' A' ' 59' ' ' ASN . 0.8 OUTLIER -96.15 116.63 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.226 -0.922 . . . . 0.0 108.969 179.093 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 39' ' ' ARG . 21.6 t -92.4 164.6 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.481 -0.762 . . . . 0.0 109.131 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.554 ' CG ' ' HB2' ' A' ' 25' ' ' ALA . 3.3 mtt85 -106.87 146.52 30.87 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.518 -0.739 . . . . 0.0 109.382 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.501 ' CD1' ' CE3' ' A' ' 17' ' ' TRP . 69.0 m-85 -140.26 135.22 32.08 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.583 -0.698 . . . . 0.0 109.589 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -62.7 -27.24 69.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.535 -0.728 . . . . 0.0 109.443 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.26 168.27 1.51 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.509 -0.744 . . . . 0.0 109.686 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.406 HG22 ' OD1' ' A' ' 56' ' ' ASN . 33.3 t . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.593 -0.692 . . . . 0.0 109.453 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.409 ' C ' HG23 ' A' ' 57' ' ' THR . 33.4 m-80 . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 120.423 0.154 . . . . 0.0 110.589 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.409 HG23 ' C ' ' A' ' 56' ' ' ASN . 81.2 p -154.56 129.94 9.77 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.281 -0.887 . . . . 0.0 109.424 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.437 ' HB2' ' CE1' ' A' ' 40' ' ' PHE . 1.6 m-20 -123.99 120.55 32.79 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.528 -0.733 . . . . 0.0 109.509 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.661 ' HA ' HD12 ' A' ' 37' ' ' ILE . 8.4 p30 -62.55 152.72 34.02 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.553 -0.717 . . . . 0.0 109.365 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 58' ' ' ASN . 17.1 m-85 -161.4 141.85 10.9 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.499 ' HB3' ' CE1' ' A' ' 63' ' ' HIS . . . -73.13 160.12 32.48 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -60.29 -41.84 94.24 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.478 -0.764 . . . . 0.0 109.682 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.499 ' CE1' ' HB3' ' A' ' 61' ' ' ALA . 20.8 p80 -70.63 -21.97 62.57 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.545 -0.722 . . . . 0.0 110.088 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -79.7 -12.88 59.78 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.397 -0.814 . . . . 0.0 110.393 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.3 mt -103.31 140.17 37.78 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.147 -0.971 . . . . 0.0 109.53 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.7 86.71 2.49 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.609 -0.682 . . . . 0.0 109.345 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.731 HG22 HG12 ' A' ' 8' ' ' VAL . 44.0 t -58.38 117.19 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.453 -0.779 . . . . 0.0 109.732 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.0 m . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.69 -0.632 . . . . 0.0 109.55 -179.985 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.519 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.0 t -90.47 -178.07 5.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.325 -1.103 . . . . 0.0 109.465 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.5 mttt -109.26 112.82 25.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.518 -0.739 . . . . 0.0 109.042 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.73 HG12 HG22 ' A' ' 67' ' ' VAL . 29.2 m -117.09 128.39 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.497 -0.752 . . . . 0.0 110.231 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.685 ' CE ' HD21 ' A' ' 11' ' ' LEU . 25.3 ttpt -79.57 127.16 31.81 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.656 ' C ' HD22 ' A' ' 11' ' ' LEU . 26.1 mm -75.02 132.69 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.719 -0.613 . . . . 0.0 109.418 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.685 HD21 ' CE ' ' A' ' 9' ' ' LYS . 4.3 mm? -124.35 27.73 6.92 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.468 -0.77 . . . . 0.0 110.149 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.406 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -86.97 124.64 33.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.464 -0.773 . . . . 0.0 109.092 179.596 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.6 mtpt -57.6 -70.3 0.14 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.437 -0.789 . . . . 0.0 110.015 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -76.93 85.67 3.48 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.545 -0.722 . . . . 0.0 109.438 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.9 t -151.78 138.92 19.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.526 -0.734 . . . . 0.0 109.627 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.433 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 20.8 t80 -63.79 -15.15 58.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.694 -0.628 . . . . 0.0 110.319 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.497 ' CE3' ' CD2' ' A' ' 40' ' ' PHE . 12.8 m0 -126.48 32.33 5.2 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.18 -0.95 . . . . 0.0 110.386 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.403 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 19.5 t80 -71.04 114.46 9.12 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 118.21 -11.4 12.99 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 120.152 -1.023 . . . . 0.0 110.759 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.26 171.2 7.76 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.084 -1.245 . . . . 0.0 109.512 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 22' ' ' GLY . 59.5 t -103.25 162.43 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.481 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -141.27 157.14 25.98 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 51.0 m -90.74 112.24 23.93 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.56 -0.965 . . . . 0.0 109.368 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.2 t -50.56 131.9 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.357 -0.839 . . . . 0.0 110.522 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.05 -48.53 3.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.728 -0.607 . . . . 0.0 109.713 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.43 -178.02 0.9 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.592 -0.693 . . . . 0.0 109.666 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.715 HD12 HG22 ' A' ' 36' ' ' VAL . 34.1 mm . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.46 ' HD1' ' HB2' ' A' ' 61' ' ' ALA . 16.4 m-85 . . . . . 0 N--CA 1.494 1.746 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -83.26 -20.07 5.2 Favored 'Trans proline' 0 C--N 1.324 -0.722 0 C-N-CA 122.047 1.831 . . . . 0.0 111.735 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.715 HG22 HD12 ' A' ' 27' ' ' ILE . 18.1 t -79.98 110.92 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.248 -0.908 . . . . 0.0 110.497 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.416 HD12 ' HA ' ' A' ' 59' ' ' ASN . 0.6 OUTLIER -96.26 117.23 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.053 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.487 HG12 ' N ' ' A' ' 39' ' ' ARG . 34.5 t -93.35 163.69 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.533 -0.73 . . . . 0.0 109.218 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.487 ' N ' HG12 ' A' ' 38' ' ' VAL . 31.3 ttt180 -105.1 149.36 25.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.637 -0.664 . . . . 0.0 109.368 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.497 ' CD2' ' CE3' ' A' ' 17' ' ' TRP . 82.2 m-85 -145.73 129.27 17.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.584 -0.698 . . . . 0.0 109.582 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -62.56 -28.77 70.1 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.517 -0.74 . . . . 0.0 109.3 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.41 ' HB3' ' NE1' ' A' ' 17' ' ' TRP . 4.9 tptm -60.71 161.52 7.77 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.638 -0.664 . . . . 0.0 109.469 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.1 t . . . . . 0 N--CA 1.494 1.733 0 O-C-N 121.56 -0.713 . . . . 0.0 109.446 179.955 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.4 m120 . . . . . 0 N--CA 1.498 1.925 0 CA-C-O 120.362 0.125 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.8 p -155.32 129.76 9.04 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.187 -0.946 . . . . 0.0 109.134 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.449 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 11.3 t-20 -119.39 124.89 47.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.545 -0.722 . . . . 0.0 109.782 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.425 ' O ' ' CD1' ' A' ' 60' ' ' PHE . 8.2 m120 -63.86 148.86 48.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.581 -0.7 . . . . 0.0 109.31 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.449 ' CE2' ' HB3' ' A' ' 58' ' ' ASN . 14.7 m-85 -159.79 146.01 15.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.6 -0.688 . . . . 0.0 109.41 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.46 ' HB2' ' HD1' ' A' ' 34' ' ' TYR . . . -80.09 168.42 19.17 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -62.66 -46.8 86.53 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.46 -0.775 . . . . 0.0 109.58 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -70.81 -17.22 62.76 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.52 -0.737 . . . . 0.0 110.279 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -79.72 -15.04 58.27 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.251 -0.906 . . . . 0.0 110.37 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.528 ' CD1' HG11 ' A' ' 36' ' ' VAL . 11.0 mt -105.07 154.37 20.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.32 -0.863 . . . . 0.0 109.421 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.505 ' O ' HG13 ' A' ' 68' ' ' VAL . 6.1 tp10 -127.87 84.28 2.23 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.73 HG22 HG12 ' A' ' 8' ' ' VAL . 45.1 t -56.04 113.05 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.432 -0.792 . . . . 0.0 109.897 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 66' ' ' GLU . 30.0 m . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.605 -0.684 . . . . 0.0 109.562 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.547 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.442 ' OG ' HG13 ' A' ' 67' ' ' VAL . 28.4 t -90.5 159.98 16.23 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.319 -1.107 . . . . 0.0 109.566 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.0 mttp -84.6 98.74 10.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.561 -0.712 . . . . 0.0 109.177 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.781 HG12 HG22 ' A' ' 67' ' ' VAL . 26.6 m -99.59 125.41 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.569 -0.707 . . . . 0.0 110.211 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.42 ' CE ' HD21 ' A' ' 11' ' ' LEU . 5.5 tttp -79.23 113.2 17.17 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.484 HG22 ' H ' ' A' ' 12' ' ' ARG . 37.1 mm -61.67 130.48 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.627 -0.671 . . . . 0.0 109.747 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.497 ' HA ' HD13 ' A' ' 11' ' ' LEU . 2.7 mm? -119.01 27.88 8.61 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.81 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.484 ' H ' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -87.04 120.44 28.31 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.452 -0.78 . . . . 0.0 109.261 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.18 -67.2 0.34 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.409 -0.807 . . . . 0.0 109.947 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -80.37 82.68 6.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.479 -0.763 . . . . 0.0 109.416 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -147.99 139.51 23.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.587 -0.696 . . . . 0.0 109.541 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.457 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 20.0 t80 -64.4 -17.41 63.74 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.678 -0.638 . . . . 0.0 110.181 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.5 ' CE3' ' CD1' ' A' ' 40' ' ' PHE . 11.2 m0 -124.25 32.8 5.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.211 -0.931 . . . . 0.0 109.956 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.409 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 13.8 t80 -68.6 134.63 50.25 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.542 -0.724 . . . . 0.0 109.124 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.65 -17.2 58.29 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -100.17 160.12 14.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.238 -1.154 . . . . 0.0 109.647 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 22' ' ' GLY . 60.0 t -95.79 162.73 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.484 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -144.61 154.4 25.78 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 51.6 m -86.92 112.29 21.64 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.553 -0.969 . . . . 0.0 109.223 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 6' ' ' SER . 25.3 t -50.59 128.29 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.383 -0.823 . . . . 0.0 110.652 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.24 -49.93 4.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.557 -0.715 . . . . 0.0 109.226 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.676 ' C ' HD12 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -176.73 171.21 2.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.588 -0.695 . . . . 0.0 109.624 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.676 HD12 ' C ' ' A' ' 26' ' ' SER . 1.8 mp . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.413 ' HB3' ' N ' ' A' ' 60' ' ' PHE . 17.4 m-85 . . . . . 0 N--CA 1.496 1.84 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -81.76 -13.49 10.56 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.008 1.806 . . . . 0.0 111.925 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 37' ' ' ILE . 14.1 t -90.04 163.65 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.137 -0.977 . . . . 0.0 109.988 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.653 HD12 ' HA ' ' A' ' 59' ' ' ASN . 1.3 tp -139.22 116.37 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 39' ' ' ARG . 30.9 t -93.22 163.68 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.506 -0.746 . . . . 0.0 109.477 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.486 ' N ' HG12 ' A' ' 38' ' ' VAL . 28.5 ttt180 -106.42 149.37 27.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.58 -0.7 . . . . 0.0 109.233 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.5 ' CD1' ' CE3' ' A' ' 17' ' ' TRP . 85.1 m-85 -143.88 158.63 43.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.604 -0.685 . . . . 0.0 109.757 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -100.47 31.75 3.33 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -118.71 158.75 24.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.689 -0.632 . . . . 0.0 109.353 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.3 t . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.588 -0.695 . . . . 0.0 109.272 179.886 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.436 ' ND2' ' N ' ' A' ' 56' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.402 HG23 ' C ' ' A' ' 56' ' ' ASN . 66.3 p -154.3 130.42 10.33 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.361 -0.837 . . . . 0.0 108.887 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.467 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 4.6 m-20 -115.63 136.94 52.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.543 -0.723 . . . . 0.0 109.685 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.653 ' HA ' HD12 ' A' ' 37' ' ' ILE . 6.6 m120 -74.89 133.79 41.75 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.571 -0.706 . . . . 0.0 109.475 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.467 ' CE2' ' HB3' ' A' ' 58' ' ' ASN . 28.7 m-85 -145.71 152.13 39.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.58 -0.7 . . . . 0.0 109.555 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.77 167.75 17.85 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -64.06 -46.82 82.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.468 -0.77 . . . . 0.0 109.241 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -71.75 -18.15 62.15 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.611 -0.681 . . . . 0.0 110.399 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -79.4 -11.49 59.92 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.278 -0.889 . . . . 0.0 110.274 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.9 mt -107.43 144.34 34.5 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.231 -0.918 . . . . 0.0 109.243 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.604 ' O ' HG13 ' A' ' 68' ' ' VAL . 5.5 tp10 -119.49 83.95 2.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.617 -0.677 . . . . 0.0 109.337 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.781 HG22 HG12 ' A' ' 8' ' ' VAL . 47.0 t -51.65 97.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.323 -0.861 . . . . 0.0 110.064 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.604 HG13 ' O ' ' A' ' 66' ' ' GLU . 30.8 m . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.595 -0.69 . . . . 0.0 109.588 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.532 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.8 t -90.53 -177.48 5.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.317 -1.108 . . . . 0.0 109.414 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.9 mttp -109.8 118.8 37.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.526 -0.734 . . . . 0.0 109.24 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 8' ' ' VAL . 34.4 m -122.96 123.66 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.557 -0.714 . . . . 0.0 109.959 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.415 ' HE2' HD21 ' A' ' 11' ' ' LEU . 9.4 ttpt -79.62 115.15 19.07 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.2 mm -61.49 132.26 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.611 -0.68 . . . . 0.0 109.629 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.464 ' HA ' HD13 ' A' ' 11' ' ' LEU . 3.6 mm? -113.6 1.52 14.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.552 -0.718 . . . . 0.0 110.602 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.411 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . 1.8 tmt_? -62.23 119.67 9.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.088 -1.007 . . . . 0.0 109.398 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -56.02 -75.33 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.46 -0.775 . . . . 0.0 110.185 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -69.89 89.78 0.6 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.523 -0.735 . . . . 0.0 109.276 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.3 141.13 14.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.602 -0.686 . . . . 0.0 109.833 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.458 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 20.2 t80 -66.72 -13.06 60.89 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.73 -0.606 . . . . 0.0 110.247 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.458 ' NE1' ' CD2' ' A' ' 16' ' ' TYR . 11.5 m0 -125.04 26.77 6.89 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.066 -1.021 . . . . 0.0 110.334 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.411 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 19.4 t80 -68.07 137.56 55.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.4 -0.812 . . . . 0.0 109.163 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.55 -10.47 69.48 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.786 -0.925 . . . . 0.0 110.786 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.16 -169.58 1.72 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.108 -1.231 . . . . 0.0 109.483 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 22' ' ' GLY . 60.1 t -127.85 162.68 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.476 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -145.75 156.48 26.99 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 49.3 m -89.73 112.78 24.17 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.558 -0.966 . . . . 0.0 109.225 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.0 t -47.77 125.21 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.527 -0.733 . . . . 0.0 110.927 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.1 -46.49 5.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.669 -0.644 . . . . 0.0 109.615 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.664 ' C ' HD12 ' A' ' 27' ' ' ILE . 0.3 OUTLIER -176.64 170.66 2.4 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.529 -0.732 . . . . 0.0 109.631 -179.865 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.664 HD12 ' C ' ' A' ' 26' ' ' SER . 1.8 mp . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.408 ' HB3' ' N ' ' A' ' 60' ' ' PHE . 15.0 m-85 . . . . . 0 N--CA 1.496 1.868 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -82.65 -17.05 7.52 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.048 1.832 . . . . 0.0 111.916 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.8 t -86.56 113.03 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.139 -0.976 . . . . 0.0 110.659 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.465 HD12 ' HA ' ' A' ' 59' ' ' ASN . 1.2 tp -96.39 116.81 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.357 -0.839 . . . . 0.0 108.955 179.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 39' ' ' ARG . 39.2 t -91.3 164.33 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.454 -0.779 . . . . 0.0 109.115 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.486 ' N ' HG12 ' A' ' 38' ' ' VAL . 32.9 ttt180 -102.01 140.76 35.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.561 -0.712 . . . . 0.0 109.386 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.445 ' CE2' ' HB2' ' A' ' 58' ' ' ASN . 91.0 m-85 -137.92 126.88 24.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.559 -0.713 . . . . 0.0 109.647 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -62.47 -27.37 69.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.595 -0.69 . . . . 0.0 109.269 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.73 173.9 0.52 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.584 -0.697 . . . . 0.0 109.573 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 36.8 t . . . . . 0 N--CA 1.493 1.701 0 O-C-N 121.553 -0.717 . . . . 0.0 109.244 179.838 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.411 ' C ' HG23 ' A' ' 57' ' ' THR . 30.9 m-20 . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 120.623 0.249 . . . . 0.0 110.389 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.411 HG23 ' C ' ' A' ' 56' ' ' ASN . 72.1 p -155.06 130.08 9.47 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.181 -0.949 . . . . 0.0 108.984 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.445 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . 0.8 OUTLIER -120.02 148.63 43.33 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.561 -0.712 . . . . 0.0 109.439 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.465 ' HA ' HD12 ' A' ' 37' ' ' ILE . 11.2 m120 -82.9 143.13 30.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.52 -0.737 . . . . 0.0 109.315 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.434 ' CE2' ' HB3' ' A' ' 58' ' ' ASN . 21.4 m-85 -156.63 141.95 17.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.537 -0.727 . . . . 0.0 109.537 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.62 169.06 18.95 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -63.38 -46.23 87.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.513 -0.742 . . . . 0.0 109.454 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 12.7 p-80 -68.93 -18.94 64.17 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.597 -0.689 . . . . 0.0 110.213 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -79.6 -19.65 48.79 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.366 -0.834 . . . . 0.0 110.2 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 19.5 mt -99.37 143.13 29.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.242 -0.911 . . . . 0.0 109.666 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.444 ' HB2' HD23 ' A' ' 11' ' ' LEU . 0.3 OUTLIER -113.02 89.21 3.02 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.759 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.3 t -58.24 115.29 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.495 -0.753 . . . . 0.0 110.018 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.428 HG13 ' O ' ' A' ' 66' ' ' GLU . 28.0 m . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.617 -0.677 . . . . 0.0 109.51 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.42 0 N-CA-C 110.189 -1.165 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.4 t -90.87 -177.36 4.93 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.228 -1.16 . . . . 0.0 109.755 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.7 mtmt -108.59 124.53 50.63 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.504 HG13 ' CG2' ' A' ' 24' ' ' VAL . 34.0 m -118.68 127.16 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.532 -0.73 . . . . 0.0 110.165 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.427 ' HA ' HG22 ' A' ' 21' ' ' VAL . 4.8 tttp -79.48 114.02 18.08 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.475 HG22 ' H ' ' A' ' 12' ' ' ARG . 29.3 mm -59.99 129.62 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.646 -0.659 . . . . 0.0 110.008 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.418 ' HA ' HD13 ' A' ' 11' ' ' LEU . 2.6 mm? -119.62 26.05 9.63 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.659 -0.651 . . . . 0.0 109.567 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.475 ' H ' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -84.88 120.95 27.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.404 -0.81 . . . . 0.0 109.466 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.6 mtpt -59.24 -56.18 25.37 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.497 -0.752 . . . . 0.0 110.004 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -90.31 78.72 6.44 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.483 -0.761 . . . . 0.0 109.921 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.1 p -147.81 141.76 25.88 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.42 -0.8 . . . . 0.0 109.598 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.458 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 21.8 t80 -61.59 -15.6 40.52 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.7 -0.625 . . . . 0.0 110.869 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.495 ' CZ3' ' CD1' ' A' ' 40' ' ' PHE . 11.9 m0 -125.35 35.14 4.8 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.09 -1.006 . . . . 0.0 110.738 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.41 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 20.9 t80 -68.36 130.72 43.72 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.448 -0.783 . . . . 0.0 109.067 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.64 -11.68 62.91 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 120.249 -0.977 . . . . 0.0 110.823 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -109.07 173.94 6.09 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.159 -1.2 . . . . 0.0 109.655 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 22' ' ' GLY . 87.4 t -111.2 162.53 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.483 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -143.07 155.17 25.84 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.7 m -86.13 111.43 20.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.514 -0.992 . . . . 0.0 109.219 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.504 ' CG2' HG13 ' A' ' 8' ' ' VAL . 3.8 t -53.16 140.29 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 121.306 -0.871 . . . . 0.0 109.987 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -109.37 -49.94 3.05 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.544 -0.722 . . . . 0.0 109.706 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -170.96 164.82 7.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.622 -0.674 . . . . 0.0 109.584 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.761 HD12 HG22 ' A' ' 36' ' ' VAL . 38.1 mm . . . . . 0 N--CA 1.494 1.726 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.461 ' HD1' ' HB2' ' A' ' 61' ' ' ALA . 17.6 m-85 . . . . . 0 N--CA 1.494 1.758 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -82.52 -9.53 11.21 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.08 1.854 . . . . 0.0 111.95 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.761 HG22 HD12 ' A' ' 27' ' ' ILE . 21.3 t -93.79 113.46 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 120.962 -1.086 . . . . 0.0 110.261 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.658 HD12 ' HA ' ' A' ' 59' ' ' ASN . 1.6 tp -98.05 116.0 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.17 -0.956 . . . . 0.0 108.78 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 39' ' ' ARG . 40.7 t -92.08 164.58 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.573 -0.704 . . . . 0.0 109.365 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.5 ' N ' HG12 ' A' ' 38' ' ' VAL . 16.5 ttt180 -109.22 149.52 29.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.565 -0.71 . . . . 0.0 109.467 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.495 ' CD1' ' CZ3' ' A' ' 17' ' ' TRP . 61.7 m-85 -146.55 154.71 41.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.581 -0.7 . . . . 0.0 109.486 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -100.82 34.0 2.61 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.409 ' HB3' ' NE1' ' A' ' 17' ' ' TRP . 1.9 tppt? -125.18 55.81 1.37 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.498 HG22 ' OD1' ' A' ' 56' ' ' ASN . 36.8 t . . . . . 0 N--CA 1.494 1.743 0 O-C-N 121.299 -0.876 . . . . 0.0 109.761 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.73 ' O ' HG23 ' A' ' 57' ' ' THR . 3.4 m-20 . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 120.479 0.181 . . . . 0.0 110.547 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.73 HG23 ' O ' ' A' ' 56' ' ' ASN . 0.8 OUTLIER -167.78 132.22 1.8 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.24 -0.913 . . . . 0.0 108.825 179.493 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.439 ' HB2' ' CE1' ' A' ' 40' ' ' PHE . 0.9 OUTLIER -108.39 167.9 9.7 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.522 -0.736 . . . . 0.0 109.357 -179.755 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.658 ' HA ' HD12 ' A' ' 37' ' ' ILE . 5.6 m120 -104.85 141.44 36.51 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.575 -0.703 . . . . 0.0 109.173 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.495 ' HB2' HD21 ' A' ' 65' ' ' LEU . 42.2 m-85 -155.36 146.61 22.75 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.491 -0.756 . . . . 0.0 109.447 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.461 ' HB2' ' HD1' ' A' ' 34' ' ' TYR . . . -83.0 171.0 14.29 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -62.81 -48.73 77.83 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.543 -0.723 . . . . 0.0 109.571 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 16.2 p-80 -68.0 -20.93 65.06 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.557 -0.714 . . . . 0.0 110.225 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -79.57 -20.49 46.87 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.315 -0.866 . . . . 0.0 110.175 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.552 HD13 HG11 ' A' ' 36' ' ' VAL . 7.9 mt -98.98 146.23 26.24 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.264 -0.897 . . . . 0.0 109.669 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.473 ' O ' HG13 ' A' ' 68' ' ' VAL . 31.5 tt0 -120.63 86.79 2.63 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.8 t -50.97 114.35 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.372 -0.83 . . . . 0.0 110.363 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 66' ' ' GLU . 31.4 m . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.556 -0.715 . . . . 0.0 109.562 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.552 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.423 ' O ' HG23 ' A' ' 24' ' ' VAL . 13.2 t -90.4 162.06 15.28 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.375 -1.073 . . . . 0.0 109.377 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.457 ' HE3' HG11 ' A' ' 21' ' ' VAL . 5.6 mtpp -79.77 116.93 20.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.552 -0.718 . . . . 0.0 109.286 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 8' ' ' VAL . 33.2 m -120.04 122.49 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.533 -0.729 . . . . 0.0 109.776 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.472 ' CE ' HD21 ' A' ' 11' ' ' LEU . 10.1 ttpt -79.38 113.72 17.74 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.416 HD12 ' CD2' ' A' ' 60' ' ' PHE . 27.1 mm -61.78 132.23 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.66 -0.65 . . . . 0.0 109.516 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.472 HD21 ' CE ' ' A' ' 9' ' ' LYS . 3.5 mm? -114.9 5.0 14.98 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.504 -0.747 . . . . 0.0 110.694 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.434 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . 0.2 OUTLIER -62.43 124.44 20.95 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.948 -1.095 . . . . 0.0 109.422 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -59.55 -73.95 0.08 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.483 -0.76 . . . . 0.0 109.818 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -76.32 86.19 3.1 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.575 -0.703 . . . . 0.0 109.359 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.98 143.15 28.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.553 -0.717 . . . . 0.0 109.613 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.45 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 20.0 t80 -66.2 -13.62 60.58 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.682 -0.636 . . . . 0.0 110.191 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.55 ' CZ3' ' ND2' ' A' ' 58' ' ' ASN . 13.2 m0 -127.34 25.76 6.09 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.084 -1.01 . . . . 0.0 110.333 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -67.82 127.93 34.62 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.381 -0.824 . . . . 0.0 108.834 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.17 -5.4 49.47 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.639 -0.985 . . . . 0.0 110.639 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -117.72 175.05 5.83 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.111 -1.229 . . . . 0.0 109.359 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 22' ' ' GLY . 54.6 t -108.63 162.5 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.484 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -143.44 154.94 25.82 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.403 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 48.5 m -87.92 111.95 22.0 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.444 -1.033 . . . . 0.0 109.241 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 6' ' ' SER . 47.9 t -51.32 125.41 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.446 -0.784 . . . . 0.0 110.379 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -95.11 -49.98 5.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.716 -0.615 . . . . 0.0 109.441 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.7 ' C ' HD12 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -176.48 175.55 1.74 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.5 -0.75 . . . . 0.0 109.661 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.7 HD12 ' C ' ' A' ' 26' ' ' SER . 1.8 mp . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.418 ' HB3' ' N ' ' A' ' 60' ' ' PHE . 17.5 m-85 . . . . . 0 N--CA 1.494 1.731 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -81.91 -15.97 9.07 Favored 'Trans proline' 0 C--N 1.324 -0.714 0 C-N-CA 122.048 1.832 . . . . 0.0 111.969 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 37' ' ' ILE . 11.7 t -87.22 164.47 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.066 -1.021 . . . . 0.0 109.898 -178.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.603 HD12 ' HA ' ' A' ' 59' ' ' ASN . 1.2 tp -140.62 114.85 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.493 HG12 ' N ' ' A' ' 39' ' ' ARG . 39.5 t -91.45 164.49 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.429 -0.795 . . . . 0.0 109.283 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.493 ' N ' HG12 ' A' ' 38' ' ' VAL . 12.5 ttt85 -105.48 145.14 31.27 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.637 -0.664 . . . . 0.0 109.349 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.505 ' CD2' ' CE3' ' A' ' 17' ' ' TRP . 80.7 m-85 -141.77 136.87 31.14 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.656 -0.653 . . . . 0.0 109.759 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 30.8 m-20 -67.66 -28.19 67.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.551 -0.718 . . . . 0.0 109.094 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.26 165.87 2.46 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.537 -0.727 . . . . 0.0 109.62 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.5 t . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.507 -0.746 . . . . 0.0 109.453 -179.909 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.583 ' N ' HD21 ' A' ' 56' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 120.544 0.212 . . . . 0.0 110.497 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.406 HG23 ' C ' ' A' ' 56' ' ' ASN . 72.6 p -154.76 129.75 9.48 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.155 -0.966 . . . . 0.0 109.202 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.55 ' ND2' ' CZ3' ' A' ' 17' ' ' TRP . 0.9 OUTLIER -117.24 151.22 37.38 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.55 -0.719 . . . . 0.0 109.287 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.603 ' HA ' HD12 ' A' ' 37' ' ' ILE . 5.7 m120 -87.46 134.54 33.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.487 -0.758 . . . . 0.0 109.376 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.448 ' CE2' ' HB3' ' A' ' 58' ' ' ASN . 22.3 m-85 -148.61 150.78 33.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.632 -0.668 . . . . 0.0 109.35 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.9 168.33 17.16 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -64.17 -45.95 86.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.497 -0.752 . . . . 0.0 109.28 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -70.87 -19.75 62.59 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.615 -0.678 . . . . 0.0 110.288 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -79.29 -14.24 59.14 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.292 -0.88 . . . . 0.0 110.215 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.1 mt -103.73 144.38 31.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 109.31 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.439 ' O ' HG13 ' A' ' 68' ' ' VAL . 5.1 tt0 -111.25 87.23 2.49 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.599 -0.688 . . . . 0.0 109.588 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.1 t -58.95 100.88 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.505 -0.747 . . . . 0.0 109.784 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.439 HG13 ' O ' ' A' ' 66' ' ' GLU . 30.7 m . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.625 -0.672 . . . . 0.0 109.598 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.491 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.3 t -90.44 160.88 15.81 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.358 -1.084 . . . . 0.0 109.364 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.4 mtpp -79.88 118.32 21.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.503 -0.748 . . . . 0.0 109.289 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 8' ' ' VAL . 33.0 m -120.3 123.48 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.601 -0.687 . . . . 0.0 109.773 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.461 ' CE ' HD21 ' A' ' 11' ' ' LEU . 4.2 ttpt -79.36 115.13 18.82 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.424 ' CG2' ' CZ ' ' A' ' 60' ' ' PHE . 27.3 mm -62.56 132.14 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.657 -0.652 . . . . 0.0 109.462 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.461 HD21 ' CE ' ' A' ' 9' ' ' LYS . 3.3 mm? -116.5 5.28 13.36 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.489 -0.757 . . . . 0.0 110.786 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.434 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -63.35 124.31 20.94 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.984 -1.072 . . . . 0.0 109.36 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -59.06 -69.31 0.2 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.479 -0.763 . . . . 0.0 109.968 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -81.14 81.87 7.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.602 -0.686 . . . . 0.0 109.337 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.64 143.35 37.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.495 -0.753 . . . . 0.0 109.579 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.449 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 25.4 t80 -64.28 -15.64 60.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.667 -0.646 . . . . 0.0 110.101 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.497 ' CE3' ' CD1' ' A' ' 40' ' ' PHE . 16.2 m0 -129.58 30.71 4.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.254 -0.904 . . . . 0.0 110.242 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.403 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 16.3 t80 -69.17 121.3 16.49 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.45 -8.67 26.41 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 120.205 -0.998 . . . . 0.0 110.63 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -116.36 171.6 7.73 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.065 -1.256 . . . . 0.0 109.512 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 22' ' ' GLY . 60.7 t -104.58 162.63 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.484 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -143.56 153.69 25.04 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 51.8 m -87.91 112.35 22.43 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.566 -0.961 . . . . 0.0 109.239 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.1 t -52.35 127.03 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.458 -0.776 . . . . 0.0 110.186 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -96.48 -49.61 5.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.633 -0.667 . . . . 0.0 109.682 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -173.89 167.8 4.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.638 -0.664 . . . . 0.0 109.748 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.82 HD12 HG22 ' A' ' 36' ' ' VAL . 27.4 mm . . . . . 0 N--CA 1.493 1.703 0 O-C-N 121.609 -0.682 . . . . 0.0 109.255 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.411 ' HB3' ' N ' ' A' ' 60' ' ' PHE . 4.7 m-85 . . . . . 0 N--CA 1.494 1.763 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -82.54 -17.12 7.62 Favored 'Trans proline' 0 C--N 1.325 -0.663 0 C-N-CA 122.131 1.887 . . . . 0.0 111.653 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.82 HG22 HD12 ' A' ' 27' ' ' ILE . 22.0 t -79.6 113.05 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.203 -0.936 . . . . 0.0 110.169 -178.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.696 HD12 ' HA ' ' A' ' 59' ' ' ASN . 1.4 tp -95.45 115.24 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 39' ' ' ARG . 35.3 t -90.8 163.67 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.518 -0.739 . . . . 0.0 109.258 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.49 ' N ' HG12 ' A' ' 38' ' ' VAL . 13.3 ttt180 -106.47 147.95 28.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.595 -0.69 . . . . 0.0 109.221 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.497 ' CD1' ' CE3' ' A' ' 17' ' ' TRP . 79.6 m-85 -144.05 157.62 44.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.553 -0.717 . . . . 0.0 109.502 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -100.07 32.19 3.04 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.413 ' HB3' ' NE1' ' A' ' 17' ' ' TRP . 0.0 OUTLIER -127.33 136.64 52.2 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.519 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.442 HG22 ' OD1' ' A' ' 56' ' ' ASN . 36.2 t . . . . . 0 N--CA 1.493 1.687 0 O-C-N 121.481 -0.762 . . . . 0.0 109.479 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.442 ' OD1' HG22 ' A' ' 43' ' ' VAL . 20.8 m-20 . . . . . 0 N--CA 1.496 1.833 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.413 HG23 ' C ' ' A' ' 56' ' ' ASN . 65.1 p -154.61 132.35 11.45 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.247 -0.908 . . . . 0.0 108.894 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.459 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 3.7 t-20 -124.36 133.24 53.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.538 -0.726 . . . . 0.0 109.872 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.696 ' HA ' HD12 ' A' ' 37' ' ' ILE . 28.6 m-80 -68.74 145.68 53.6 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.597 -0.689 . . . . 0.0 109.453 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.459 ' CE2' ' HB3' ' A' ' 58' ' ' ASN . 14.9 m-85 -158.04 145.91 18.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.634 -0.666 . . . . 0.0 109.343 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.73 169.1 16.56 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -62.71 -48.29 79.9 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.442 -0.786 . . . . 0.0 109.601 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -69.32 -18.1 63.78 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.534 -0.729 . . . . 0.0 110.452 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -79.6 -19.14 50.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.178 -0.951 . . . . 0.0 110.256 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.4 mt -102.34 146.38 28.13 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.272 -0.892 . . . . 0.0 109.496 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.429 ' O ' HG13 ' A' ' 68' ' ' VAL . 3.9 tt0 -116.49 88.11 2.83 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.652 -0.655 . . . . 0.0 109.265 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.3 t -57.92 110.9 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.498 -0.751 . . . . 0.0 109.861 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 66' ' ' GLU . 28.4 m . . . . . 0 N--CA 1.494 1.726 0 O-C-N 121.645 -0.659 . . . . 0.0 109.485 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.669 ' HA ' HG21 ' A' ' 67' ' ' VAL . 59.7 mt 60.13 78.17 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.532 -0.73 . . . . 0.0 109.698 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -87.38 177.84 7.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.551 -0.718 . . . . 0.0 109.473 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 15.1 ttt180 -90.13 126.37 35.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.574 -0.703 . . . . 0.0 109.659 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.68 17.12 78.08 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.7 t -90.57 162.15 15.13 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.249 -1.148 . . . . 0.0 109.416 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.83 115.58 23.56 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.502 -0.749 . . . . 0.0 109.151 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.82 HG12 HG22 ' A' ' 67' ' ' VAL . 28.4 m -116.85 124.54 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.499 -0.751 . . . . 0.0 110.016 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.464 ' CE ' HD21 ' A' ' 11' ' ' LEU . 9.4 ttpt -79.55 113.48 17.73 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.527 HG22 ' H ' ' A' ' 12' ' ' ARG . 35.3 mm -61.13 131.25 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.591 -0.693 . . . . 0.0 109.707 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.464 HD21 ' CE ' ' A' ' 9' ' ' LYS . 3.5 mm? -115.99 27.01 9.55 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.516 -0.74 . . . . 0.0 109.681 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.527 ' H ' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -85.64 119.77 26.34 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.421 -0.8 . . . . 0.0 109.283 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.87 -73.88 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.427 -0.795 . . . . 0.0 110.25 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -76.57 85.89 3.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.53 -0.731 . . . . 0.0 109.377 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.2 t -152.03 139.92 20.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.537 -0.727 . . . . 0.0 109.663 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.458 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 25.1 t80 -63.97 -15.42 59.2 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.686 -0.634 . . . . 0.0 110.366 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.502 ' CZ3' ' CD1' ' A' ' 40' ' ' PHE . 14.3 m0 -125.22 32.19 5.43 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.096 -1.002 . . . . 0.0 110.258 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.414 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 17.0 t80 -69.32 133.6 48.05 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.474 -0.766 . . . . 0.0 109.098 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.56 -12.73 66.04 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -95.04 -171.01 2.32 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.182 -1.187 . . . . 0.0 109.595 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.0 t -132.39 129.73 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -112.36 157.45 14.94 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 52.7 m -89.02 112.01 22.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.601 -0.941 . . . . 0.0 109.345 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 37.5 t -50.24 130.86 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.401 -0.812 . . . . 0.0 110.621 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -102.28 -48.35 4.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.663 -0.648 . . . . 0.0 109.529 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.486 ' C ' HD12 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -174.37 156.16 2.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.594 -0.691 . . . . 0.0 109.601 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.616 ' N ' HD12 ' A' ' 27' ' ' ILE . 1.8 mp -101.39 161.62 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -116.94 119.34 35.02 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.585 -0.697 . . . . 0.0 109.504 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.43 52.31 2.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.572 -0.705 . . . . 0.0 109.315 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.7 t -100.78 -50.67 3.78 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.447 -0.783 . . . . 0.0 109.529 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.62 -2.52 6.08 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.596 HD11 ' HA ' ' A' ' 35' ' ' PRO . 34.3 pt -60.97 -173.06 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.044 -1.268 . . . . 0.0 109.642 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.59 ' O ' ' HB2' ' A' ' 61' ' ' ALA . 16.6 tt -90.04 -25.94 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.508 -0.745 . . . . 0.0 109.903 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.432 ' CE1' HG12 ' A' ' 33' ' ' ILE . 21.0 m-85 -129.29 72.21 81.99 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.41 -0.806 . . . . 0.0 109.412 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.596 ' HA ' HD11 ' A' ' 32' ' ' ILE . 37.1 Cg_endo -81.58 -15.34 9.82 Favored 'Trans proline' 0 C--N 1.325 -0.708 0 C-N-CA 122.007 1.805 . . . . 0.0 111.899 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.568 HG22 HG13 ' A' ' 27' ' ' ILE . 19.9 t -89.39 111.14 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.062 -1.024 . . . . 0.0 110.227 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.1 tp -91.21 117.66 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.322 -0.861 . . . . 0.0 108.725 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.491 HG12 ' N ' ' A' ' 39' ' ' ARG . 44.3 t -94.0 162.98 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.5 -0.75 . . . . 0.0 109.476 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.491 ' N ' HG12 ' A' ' 38' ' ' VAL . 12.0 ttt180 -105.21 152.69 22.54 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.502 ' CD1' ' CZ3' ' A' ' 17' ' ' TRP . 87.3 m-85 -148.86 124.7 10.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.632 -0.667 . . . . 0.0 109.588 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -61.97 -26.18 68.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.497 -0.752 . . . . 0.0 109.214 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.76 160.28 9.66 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.553 -0.717 . . . . 0.0 109.601 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.565 HG11 ' CE2' ' A' ' 45' ' ' TYR . 35.3 t -140.94 162.91 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.491 ' N ' HG12 ' A' ' 43' ' ' VAL . 18.2 t-20 -123.57 136.25 54.43 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.488 -0.757 . . . . 0.0 109.651 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.565 ' CE2' HG11 ' A' ' 43' ' ' VAL . 23.0 m-85 -155.88 28.57 0.37 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.607 -0.683 . . . . 0.0 109.529 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -116.5 97.06 5.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.537 -0.727 . . . . 0.0 109.675 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.71 78.03 0.19 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.401 ' CD2' ' O ' ' A' ' 52' ' ' ALA . 39.6 p90 -120.0 32.55 5.99 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.56 -0.964 . . . . 0.0 109.519 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 60.15 -167.39 0.18 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.535 -0.728 . . . . 0.0 109.688 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -106.74 59.65 0.38 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.1 t -154.16 103.0 2.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.565 -0.962 . . . . 0.0 109.393 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.401 ' O ' ' CD2' ' A' ' 48' ' ' PHE . . . 59.89 -175.09 0.11 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.515 -0.741 . . . . 0.0 109.682 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -155.78 139.31 6.52 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.9 139.16 0.05 OUTLIER Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.56 HD22 ' N ' ' A' ' 55' ' ' LEU . 4.1 mm? -89.35 -61.11 1.77 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.584 -0.95 . . . . 0.0 109.288 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.422 ' CB ' ' O ' ' A' ' 55' ' ' LEU . 9.3 m-20 84.01 -39.75 0.07 Allowed 'General case' 0 N--CA 1.509 2.5 0 O-C-N 122.127 -0.358 . . . . 0.0 110.438 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.3 p -127.79 129.75 47.54 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.029 -1.044 . . . . 0.0 109.062 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.445 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 3.4 m-20 -105.75 174.73 5.76 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.572 -0.705 . . . . 0.0 109.425 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.404 ' O ' ' CD1' ' A' ' 60' ' ' PHE . 3.5 m-80 -112.0 140.09 46.96 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.457 ' HB2' HD21 ' A' ' 65' ' ' LEU . 58.1 m-85 -154.82 147.69 24.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.6 -0.687 . . . . 0.0 109.505 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.59 ' HB2' ' O ' ' A' ' 33' ' ' ILE . . . -82.5 173.2 12.2 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -63.4 -50.57 69.33 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.521 -0.737 . . . . 0.0 109.452 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.44 ' CD2' ' HG2' ' A' ' 64' ' ' GLU . 30.8 p-80 -69.09 -17.11 63.82 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.594 -0.691 . . . . 0.0 110.289 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.44 ' HG2' ' CD2' ' A' ' 63' ' ' HIS . 3.4 mm-40 -79.42 -20.89 46.44 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.251 -0.906 . . . . 0.0 110.054 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.457 HD21 ' HB2' ' A' ' 60' ' ' PHE . 8.3 mt -100.71 146.95 26.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.379 -0.826 . . . . 0.0 109.537 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.454 ' HB2' HD23 ' A' ' 11' ' ' LEU . 10.2 tt0 -117.88 81.48 1.67 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.617 -0.677 . . . . 0.0 109.221 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.82 HG22 HG12 ' A' ' 8' ' ' VAL . 42.0 t -57.88 115.31 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.446 -0.784 . . . . 0.0 109.784 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.42 HG13 ' O ' ' A' ' 66' ' ' GLU . 30.0 m -111.76 -30.42 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.621 -0.675 . . . . 0.0 109.566 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.396 0 CA-C-O 118.029 -1.429 . . . . 0.0 109.568 179.994 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.439 ' HA ' HG21 ' A' ' 67' ' ' VAL . 36.8 mm -108.9 131.4 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.528 -0.732 . . . . 0.0 109.44 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -80.99 161.1 24.4 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.578 -0.701 . . . . 0.0 109.538 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 14.3 ttp180 -90.06 130.04 36.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.582 -0.698 . . . . 0.0 109.481 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 59.77 19.63 50.07 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.2 t -90.55 162.99 14.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.228 -1.16 . . . . 0.0 109.421 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.5 mmtp -79.88 116.51 20.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.513 -0.742 . . . . 0.0 109.239 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 8' ' ' VAL . 30.4 m -118.32 126.85 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.492 -0.755 . . . . 0.0 109.892 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.659 ' CE ' HD21 ' A' ' 11' ' ' LEU . 20.3 ttpt -79.26 125.56 29.64 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.588 ' C ' HD22 ' A' ' 11' ' ' LEU . 26.6 mm -73.86 131.74 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.695 -0.628 . . . . 0.0 109.548 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.659 HD21 ' CE ' ' A' ' 9' ' ' LYS . 4.2 mm? -121.94 27.42 8.1 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.489 -0.757 . . . . 0.0 109.934 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.433 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -89.33 113.06 24.29 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.432 -0.792 . . . . 0.0 109.383 179.83 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.77 -55.4 26.72 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.475 -0.765 . . . . 0.0 110.239 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -84.9 77.19 10.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.544 -0.722 . . . . 0.0 109.382 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.98 137.93 20.24 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.554 -0.717 . . . . 0.0 109.699 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.455 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 16.8 t80 -64.05 -15.31 59.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.782 -0.574 . . . . 0.0 110.245 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.501 ' CE3' ' CD1' ' A' ' 40' ' ' PHE . 10.8 m0 -124.06 33.82 5.2 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.147 -0.971 . . . . 0.0 110.113 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.411 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 47.7 t80 -68.81 133.37 48.21 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.52 -0.738 . . . . 0.0 109.014 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.13 -18.89 55.9 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.42 158.03 15.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -1.142 . . . . 0.0 109.568 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 22' ' ' GLY . 70.0 t -97.08 162.12 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.47 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -143.72 172.64 24.92 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.2 m -102.72 115.36 30.43 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.562 -0.963 . . . . 0.0 109.42 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.4 ' CG2' ' CG1' ' A' ' 8' ' ' VAL . 46.9 t -52.82 113.65 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.277 -0.889 . . . . 0.0 110.005 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.608 ' HB2' ' CG ' ' A' ' 39' ' ' ARG . . . -82.03 -48.38 11.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.659 -0.651 . . . . 0.0 109.777 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.1 m -167.78 156.69 9.57 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.499 -0.751 . . . . 0.0 110.026 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.815 ' CD1' HG13 ' A' ' 36' ' ' VAL . 32.1 mm -114.35 165.03 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.461 ' N ' HG22 ' A' ' 27' ' ' ILE . 2.2 t70 -102.3 -169.14 1.63 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.486 -0.759 . . . . 0.0 109.35 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -96.78 28.65 3.35 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.659 -0.651 . . . . 0.0 109.829 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 18.4 t 59.44 83.22 0.13 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.465 -0.772 . . . . 0.0 109.736 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -154.32 -45.35 0.02 OUTLIER Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.589 HD11 ' HA ' ' A' ' 35' ' ' PRO . 19.0 pt -84.99 -173.62 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.632 -0.922 . . . . 0.0 109.568 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.473 HG22 ' CE1' ' A' ' 34' ' ' TYR . 75.1 mt -72.9 -56.73 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.681 -0.637 . . . . 0.0 109.52 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.473 ' CE1' HG22 ' A' ' 33' ' ' ILE . 22.1 m-85 -115.89 89.47 24.36 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.706 -0.621 . . . . 0.0 109.521 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.589 ' HA ' HD11 ' A' ' 32' ' ' ILE . 37.4 Cg_endo -81.87 4.24 7.19 Favored 'Trans proline' 0 C--N 1.323 -0.776 0 C-N-CA 122.037 1.825 . . . . 0.0 112.021 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.815 HG13 ' CD1' ' A' ' 27' ' ' ILE . 22.2 t -112.86 112.79 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.977 -1.077 . . . . 0.0 110.505 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -101.41 116.53 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.136 -0.977 . . . . 0.0 108.904 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 39' ' ' ARG . 20.4 t -92.9 164.33 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.499 -0.751 . . . . 0.0 109.008 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.608 ' CG ' ' HB2' ' A' ' 25' ' ' ALA . 6.8 mtt180 -110.14 149.35 30.2 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.545 -0.722 . . . . 0.0 109.386 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.501 ' CD1' ' CE3' ' A' ' 17' ' ' TRP . 59.6 m-85 -142.57 138.54 30.89 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.595 -0.69 . . . . 0.0 109.543 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -62.88 -28.0 69.74 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.582 -0.699 . . . . 0.0 109.573 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.405 ' HB3' ' NE1' ' A' ' 17' ' ' TRP . 0.7 OUTLIER -59.5 162.28 5.09 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.474 -0.766 . . . . 0.0 109.688 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.406 HG11 ' CE2' ' A' ' 45' ' ' TYR . 31.3 t -145.13 132.28 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.588 -0.695 . . . . 0.0 109.488 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -108.11 115.18 29.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.534 -0.729 . . . . 0.0 109.488 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.406 ' CE2' HG11 ' A' ' 43' ' ' VAL . 29.9 m-85 -109.68 105.74 15.12 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.593 -0.692 . . . . 0.0 109.503 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -97.29 -34.68 10.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.539 -0.725 . . . . 0.0 109.461 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -167.77 111.32 0.43 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 21.3 p90 -134.61 138.82 44.86 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.574 -0.956 . . . . 0.0 109.514 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.2 t -98.66 35.44 1.83 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.534 -0.729 . . . . 0.0 109.496 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 166.12 -103.8 0.21 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 30.6 t -132.71 -69.21 0.58 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.568 -0.96 . . . . 0.0 109.48 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 60.16 -168.42 0.16 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.489 -0.757 . . . . 0.0 109.655 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.2 -37.53 2.29 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.65 -152.21 21.78 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.629 ' N ' HD12 ' A' ' 55' ' ' LEU . 7.1 mp -78.71 -77.44 0.17 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.61 -0.935 . . . . 0.0 109.408 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.406 ' C ' HG23 ' A' ' 57' ' ' THR . 7.4 m120 63.26 13.5 7.01 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.472 -0.768 . . . . 0.0 110.692 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.406 HG23 ' C ' ' A' ' 56' ' ' ASN . 59.4 p -154.78 129.65 9.4 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.156 -0.965 . . . . 0.0 109.383 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.439 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 13.1 t-20 -109.01 153.92 22.93 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.499 -0.751 . . . . 0.0 109.477 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.429 ' O ' ' CD1' ' A' ' 60' ' ' PHE . 1.8 m120 -97.63 130.87 44.61 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.555 -0.716 . . . . 0.0 109.531 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.439 ' CE2' ' HB3' ' A' ' 58' ' ' ASN . 32.9 m-85 -146.71 151.02 36.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.648 -0.657 . . . . 0.0 109.273 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.452 ' HB2' ' HD1' ' A' ' 34' ' ' TYR . . . -83.99 174.4 10.36 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -64.66 -42.96 95.05 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.51 -0.744 . . . . 0.0 109.511 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.531 ' CE1' ' HG3' ' A' ' 64' ' ' GLU . 22.4 p80 -71.74 -23.25 61.58 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.628 -0.67 . . . . 0.0 110.21 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.531 ' HG3' ' CE1' ' A' ' 63' ' ' HIS . 12.4 mt-10 -79.74 -0.49 34.49 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.333 -0.855 . . . . 0.0 110.666 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.468 ' CD1' HG11 ' A' ' 36' ' ' VAL . 13.2 mt -120.8 146.13 46.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.072 -1.018 . . . . 0.0 109.453 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -116.33 91.36 3.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.593 -0.692 . . . . 0.0 109.452 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.439 HG21 ' HA ' ' A' ' 2' ' ' ILE . 43.0 t -60.15 95.02 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.474 -0.766 . . . . 0.0 109.596 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.6 m -82.02 -28.86 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.647 -0.658 . . . . 0.0 109.704 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.384 0 CA-C-O 117.998 -1.446 . . . . 0.0 109.575 179.998 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.6 mm -102.33 128.65 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.573 -0.704 . . . . 0.0 109.492 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -85.28 161.41 19.54 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.604 -0.685 . . . . 0.0 109.502 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.8 ttt85 -90.1 130.54 36.25 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.548 -0.72 . . . . 0.0 109.633 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 59.12 19.71 46.75 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 31.0 t -90.73 162.0 15.09 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.34 -1.094 . . . . 0.0 109.513 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 56.1 mttt -80.57 111.31 16.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.511 -0.743 . . . . 0.0 109.169 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 8' ' ' VAL . 25.6 m -112.75 127.77 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.485 -0.76 . . . . 0.0 109.88 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.72 ' CE ' HD21 ' A' ' 11' ' ' LEU . 28.2 ttpt -79.15 127.67 32.32 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.685 ' C ' HD22 ' A' ' 11' ' ' LEU . 27.8 mm -76.45 132.3 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.642 -0.661 . . . . 0.0 109.326 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.72 HD21 ' CE ' ' A' ' 9' ' ' LYS . 4.4 mm? -124.51 28.92 6.45 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.509 -0.744 . . . . 0.0 109.875 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.411 ' O ' ' CD1' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -89.55 115.72 27.17 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.502 -0.749 . . . . 0.0 109.503 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.7 mmtm -53.03 -62.02 1.92 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.472 -0.768 . . . . 0.0 110.273 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -80.59 82.19 6.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.605 -0.684 . . . . 0.0 109.292 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.2 t -154.43 137.19 15.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.558 -0.714 . . . . 0.0 109.616 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.457 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 15.7 t80 -63.08 -16.32 59.55 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.665 -0.647 . . . . 0.0 110.183 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.495 ' CE3' ' CD2' ' A' ' 40' ' ' PHE . 9.0 m0 -123.91 35.73 4.77 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.188 -0.945 . . . . 0.0 110.0 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.411 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 26.6 t80 -70.17 118.65 13.26 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.63 -20.46 29.64 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.09 158.07 15.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -1.127 . . . . 0.0 109.563 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.474 HG12 ' N ' ' A' ' 22' ' ' GLY . 66.6 t -95.75 162.54 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.474 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -143.45 173.18 24.53 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.5 m -105.61 113.43 26.99 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.407 -1.055 . . . . 0.0 109.488 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 37.7 t -51.28 117.49 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.286 -0.884 . . . . 0.0 110.409 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -89.8 -45.53 9.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.679 -0.638 . . . . 0.0 109.824 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -173.36 165.68 4.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.509 -0.744 . . . . 0.0 109.907 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.832 HD12 HG22 ' A' ' 36' ' ' VAL . 33.8 mm -115.11 144.05 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -93.55 89.15 6.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.56 -0.713 . . . . 0.0 109.476 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.4 mmtm -63.28 98.76 0.16 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.67 -0.644 . . . . 0.0 109.426 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -161.33 -44.05 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.608 -0.683 . . . . 0.0 109.488 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.1 6.69 10.76 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.779 HD11 ' HA ' ' A' ' 35' ' ' PRO . 41.0 pt -61.16 -171.73 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.236 -1.155 . . . . 0.0 109.775 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.69 HG22 ' CE1' ' A' ' 34' ' ' TYR . 62.3 mt -82.57 -50.76 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.532 -0.73 . . . . 0.0 110.18 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.69 ' CE1' HG22 ' A' ' 33' ' ' ILE . 16.8 m-85 -123.97 78.86 58.22 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.498 -0.751 . . . . 0.0 109.752 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.779 ' HA ' HD11 ' A' ' 32' ' ' ILE . 37.8 Cg_endo -84.27 -21.61 3.64 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.266 1.977 . . . . 0.0 111.961 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.832 HG22 HD12 ' A' ' 27' ' ' ILE . 21.6 t -79.84 111.19 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.225 -0.922 . . . . 0.0 110.728 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.456 HD12 ' CG ' ' A' ' 59' ' ' ASN . 0.7 OUTLIER -96.25 117.93 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.332 -0.855 . . . . 0.0 108.758 178.897 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 39' ' ' ARG . 21.7 t -96.17 163.77 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.462 -0.774 . . . . 0.0 108.977 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.477 ' N ' HG12 ' A' ' 38' ' ' VAL . 6.7 mtt180 -105.06 149.08 26.12 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.449 -0.782 . . . . 0.0 109.338 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.495 ' CD2' ' CE3' ' A' ' 17' ' ' TRP . 82.0 m-85 -143.47 135.94 27.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.609 -0.682 . . . . 0.0 109.566 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -62.96 -28.93 70.42 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.576 -0.703 . . . . 0.0 109.392 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.27 162.18 6.3 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.605 -0.685 . . . . 0.0 109.614 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.2 t -146.87 120.53 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.558 -0.714 . . . . 0.0 109.482 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -103.0 108.15 19.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.609 -0.682 . . . . 0.0 109.469 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -94.74 88.36 5.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.54 -0.725 . . . . 0.0 109.454 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -134.12 114.18 12.86 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.584 -0.698 . . . . 0.0 109.451 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.93 48.84 1.7 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -119.63 136.85 54.22 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.624 -0.927 . . . . 0.0 109.452 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.2 m -160.76 31.02 0.15 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.552 -0.718 . . . . 0.0 109.477 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 143.95 -78.67 0.26 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.7 t -104.94 90.3 3.42 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.619 -0.93 . . . . 0.0 109.46 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -118.89 -73.39 0.65 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.575 -0.703 . . . . 0.0 109.483 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.77 -33.48 6.05 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.538 ' C ' HD12 ' A' ' 55' ' ' LEU . . . 99.01 -166.66 21.34 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.639 ' N ' HD12 ' A' ' 55' ' ' LEU . 6.8 mp -115.83 -77.04 0.57 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.556 -0.967 . . . . 0.0 109.402 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.407 ' C ' HG23 ' A' ' 57' ' ' THR . 7.2 m120 63.68 13.01 7.03 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.517 -0.74 . . . . 0.0 110.717 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.407 HG23 ' C ' ' A' ' 56' ' ' ASN . 72.4 p -154.72 130.39 9.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.151 -0.968 . . . . 0.0 109.206 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.448 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 1.0 OUTLIER -118.39 125.82 50.79 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.444 -0.785 . . . . 0.0 109.67 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.456 ' CG ' HD12 ' A' ' 37' ' ' ILE . 6.7 m-20 -64.01 149.84 46.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.555 -0.716 . . . . 0.0 109.19 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.448 ' CE2' ' HB3' ' A' ' 58' ' ' ASN . 14.5 m-85 -160.57 147.91 15.85 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.463 ' HB2' ' HD1' ' A' ' 34' ' ' TYR . . . -82.82 167.19 18.34 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -62.98 -46.52 87.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.476 -0.765 . . . . 0.0 109.444 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.43 ' CD2' ' HG3' ' A' ' 64' ' ' GLU . 10.2 p-80 -68.7 -20.56 64.42 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.581 -0.7 . . . . 0.0 110.191 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.43 ' HG3' ' CD2' ' A' ' 63' ' ' HIS . 35.7 mt-10 -79.36 -19.7 49.59 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.265 -0.897 . . . . 0.0 110.196 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.418 ' CD1' HG11 ' A' ' 36' ' ' VAL . 14.2 mt -100.92 154.06 18.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.296 -0.877 . . . . 0.0 109.532 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.474 ' O ' HG13 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -124.67 88.75 2.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.547 -0.721 . . . . 0.0 109.393 179.946 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.0 t -57.75 105.81 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.465 -0.772 . . . . 0.0 109.851 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 66' ' ' GLU . 30.3 m -114.4 30.29 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.709 -0.62 . . . . 0.0 109.557 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.484 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.898 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.533 ' HA ' HG21 ' A' ' 67' ' ' VAL . 2.5 mp -76.12 105.06 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.569 -0.707 . . . . 0.0 109.491 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -89.34 177.65 6.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.689 -0.632 . . . . 0.0 109.439 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 19.2 mtm180 -90.02 125.37 35.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.558 -0.714 . . . . 0.0 109.609 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.92 10.7 80.49 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.0 t -90.42 160.54 16.0 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.169 -1.195 . . . . 0.0 109.48 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.3 mttt -88.59 118.33 28.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.51 -0.744 . . . . 0.0 109.219 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.731 HG12 HG22 ' A' ' 67' ' ' VAL . 33.1 m -118.86 126.16 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.581 -0.699 . . . . 0.0 109.937 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.456 ' CE ' HD21 ' A' ' 11' ' ' LEU . 8.8 ttpt -79.49 116.66 19.85 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.417 HD12 ' CD2' ' A' ' 60' ' ' PHE . 24.3 mm -62.78 131.94 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.651 -0.656 . . . . 0.0 109.539 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.456 HD21 ' CE ' ' A' ' 9' ' ' LYS . 3.6 mm? -114.91 3.36 14.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.498 -0.751 . . . . 0.0 110.598 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.423 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -62.53 120.54 11.32 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.075 -1.016 . . . . 0.0 109.363 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -56.45 -76.48 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.473 -0.767 . . . . 0.0 110.174 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -70.71 89.33 0.74 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.543 -0.723 . . . . 0.0 109.326 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.37 141.88 19.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.573 -0.705 . . . . 0.0 109.801 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.454 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 20.2 t80 -66.75 -13.41 61.36 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.691 -0.631 . . . . 0.0 110.187 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.501 ' CE3' ' CD1' ' A' ' 40' ' ' PHE . 13.8 m0 -126.04 25.73 6.69 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.112 -0.992 . . . . 0.0 110.336 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.406 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 18.9 t80 -67.0 137.11 56.26 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.449 -0.782 . . . . 0.0 109.065 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.36 -9.33 77.64 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -106.24 -169.85 1.64 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.195 -1.179 . . . . 0.0 109.52 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 22' ' ' GLY . 62.2 t -128.06 162.54 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.477 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -145.58 175.1 25.3 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.6 m -106.92 115.14 29.68 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.537 -0.979 . . . . 0.0 109.349 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.0 t -50.3 115.18 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.344 -0.847 . . . . 0.0 110.635 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.554 ' HB2' ' CG ' ' A' ' 39' ' ' ARG . . . -85.35 -47.23 10.22 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.668 -0.645 . . . . 0.0 109.733 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -172.05 160.15 5.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.516 -0.74 . . . . 0.0 109.871 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.817 HD12 HG22 ' A' ' 36' ' ' VAL . 33.1 mm -109.6 154.84 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -109.5 89.75 3.1 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.523 -0.736 . . . . 0.0 109.403 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.6 tptm -63.12 92.4 0.05 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.551 -0.718 . . . . 0.0 109.488 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.6 m -152.98 -45.62 0.1 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.614 -0.679 . . . . 0.0 109.417 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.86 4.39 10.44 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.837 HD11 ' HA ' ' A' ' 35' ' ' PRO . 40.1 pt -61.21 -171.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.158 -1.201 . . . . 0.0 109.717 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.614 ' O ' ' HB2' ' A' ' 61' ' ' ALA . 87.7 mt -88.39 -35.35 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.488 -0.757 . . . . 0.0 110.241 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.452 ' CE2' ' CG2' ' A' ' 33' ' ' ILE . 18.7 m-85 -130.84 70.44 82.55 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.359 -0.838 . . . . 0.0 109.805 -178.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.837 ' HA ' HD11 ' A' ' 32' ' ' ILE . 37.5 Cg_endo -81.64 -14.22 10.33 Favored 'Trans proline' 0 C--N 1.324 -0.76 0 C-N-CA 122.126 1.884 . . . . 0.0 111.991 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.817 HG22 HD12 ' A' ' 27' ' ' ILE . 24.3 t -94.33 110.72 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.004 -1.06 . . . . 0.0 110.558 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.661 HD12 ' HA ' ' A' ' 59' ' ' ASN . 0.8 OUTLIER -96.15 116.63 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.226 -0.922 . . . . 0.0 108.969 179.093 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 39' ' ' ARG . 21.6 t -92.4 164.6 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.481 -0.762 . . . . 0.0 109.131 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.554 ' CG ' ' HB2' ' A' ' 25' ' ' ALA . 3.3 mtt85 -106.87 146.52 30.87 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.518 -0.739 . . . . 0.0 109.382 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.501 ' CD1' ' CE3' ' A' ' 17' ' ' TRP . 69.0 m-85 -140.26 135.22 32.08 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.583 -0.698 . . . . 0.0 109.589 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -62.7 -27.24 69.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.535 -0.728 . . . . 0.0 109.443 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.26 168.27 1.51 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.509 -0.744 . . . . 0.0 109.686 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.406 HG22 ' OD1' ' A' ' 56' ' ' ASN . 33.3 t -150.26 118.52 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.593 -0.692 . . . . 0.0 109.453 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -86.57 87.9 7.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.532 -0.73 . . . . 0.0 109.521 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.407 ' O ' ' CE1' ' A' ' 48' ' ' PHE . 6.8 m-85 -77.35 -27.56 52.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.529 -0.732 . . . . 0.0 109.678 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 39.1 t30 60.71 -90.15 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.616 -0.678 . . . . 0.0 109.669 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.51 40.74 0.04 OUTLIER Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.407 ' CE1' ' O ' ' A' ' 45' ' ' TYR . 39.3 p90 -119.01 35.45 4.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.506 -0.996 . . . . 0.0 109.448 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.38 163.94 0.06 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.58 -0.7 . . . . 0.0 109.679 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -78.17 -94.44 0.26 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.9 -89.09 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.631 -0.923 . . . . 0.0 109.705 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.12 167.1 20.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.064 -1.022 . . . . 0.0 109.443 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.05 140.55 30.1 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -63.16 -167.81 0.9 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.636 ' N ' HD12 ' A' ' 55' ' ' LEU . 6.9 mp -80.4 -75.99 0.24 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.593 -0.945 . . . . 0.0 109.365 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.409 ' C ' HG23 ' A' ' 57' ' ' THR . 33.4 m-80 61.62 15.78 7.14 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.476 -0.765 . . . . 0.0 110.589 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.409 HG23 ' C ' ' A' ' 56' ' ' ASN . 81.2 p -154.56 129.94 9.77 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.281 -0.887 . . . . 0.0 109.424 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.437 ' HB2' ' CE1' ' A' ' 40' ' ' PHE . 1.6 m-20 -123.99 120.55 32.79 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.528 -0.733 . . . . 0.0 109.509 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.661 ' HA ' HD12 ' A' ' 37' ' ' ILE . 8.4 p30 -62.55 152.72 34.02 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.553 -0.717 . . . . 0.0 109.365 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 58' ' ' ASN . 17.1 m-85 -161.4 141.85 10.9 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.614 ' HB2' ' O ' ' A' ' 33' ' ' ILE . . . -73.13 160.12 32.48 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -60.29 -41.84 94.24 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.478 -0.764 . . . . 0.0 109.682 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.499 ' CE1' ' HB3' ' A' ' 61' ' ' ALA . 20.8 p80 -70.63 -21.97 62.57 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.545 -0.722 . . . . 0.0 110.088 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -79.7 -12.88 59.78 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.397 -0.814 . . . . 0.0 110.393 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.3 mt -103.31 140.17 37.78 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.147 -0.971 . . . . 0.0 109.53 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.7 86.71 2.49 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.609 -0.682 . . . . 0.0 109.345 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.731 HG22 HG12 ' A' ' 8' ' ' VAL . 44.0 t -58.38 117.19 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.453 -0.779 . . . . 0.0 109.732 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.0 m -111.49 -30.36 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.69 -0.632 . . . . 0.0 109.55 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.43 0 CA-C-O 117.993 -1.449 . . . . 0.0 109.562 -179.996 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.619 HG23 HG11 ' A' ' 8' ' ' VAL . 2.7 mp -86.38 119.14 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.492 -0.755 . . . . 0.0 109.464 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -89.67 178.67 6.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.623 -0.673 . . . . 0.0 109.528 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 27.7 ttm105 -90.17 140.67 29.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.606 -0.684 . . . . 0.0 109.651 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 59.95 20.38 53.21 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.0 t -90.47 -178.07 5.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.325 -1.103 . . . . 0.0 109.465 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.5 mttt -109.26 112.82 25.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.518 -0.739 . . . . 0.0 109.042 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.73 HG12 HG22 ' A' ' 67' ' ' VAL . 29.2 m -117.09 128.39 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.497 -0.752 . . . . 0.0 110.231 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.685 ' CE ' HD21 ' A' ' 11' ' ' LEU . 25.3 ttpt -79.57 127.16 31.81 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.656 ' C ' HD22 ' A' ' 11' ' ' LEU . 26.1 mm -75.02 132.69 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.719 -0.613 . . . . 0.0 109.418 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.685 HD21 ' CE ' ' A' ' 9' ' ' LYS . 4.3 mm? -124.35 27.73 6.92 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.468 -0.77 . . . . 0.0 110.149 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.406 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -86.97 124.64 33.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.464 -0.773 . . . . 0.0 109.092 179.596 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.6 mtpt -57.6 -70.3 0.14 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.437 -0.789 . . . . 0.0 110.015 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -76.93 85.67 3.48 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.545 -0.722 . . . . 0.0 109.438 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.9 t -151.78 138.92 19.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.526 -0.734 . . . . 0.0 109.627 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.433 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 20.8 t80 -63.79 -15.15 58.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.694 -0.628 . . . . 0.0 110.319 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.497 ' CE3' ' CD2' ' A' ' 40' ' ' PHE . 12.8 m0 -126.48 32.33 5.2 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.18 -0.95 . . . . 0.0 110.386 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.403 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 19.5 t80 -71.04 114.46 9.12 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 118.21 -11.4 12.99 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 120.152 -1.023 . . . . 0.0 110.759 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.26 171.2 7.76 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.084 -1.245 . . . . 0.0 109.512 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 22' ' ' GLY . 59.5 t -103.25 162.43 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.481 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -141.27 157.14 25.98 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 51.0 m -90.74 112.24 23.93 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.56 -0.965 . . . . 0.0 109.368 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.2 t -50.56 131.9 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.357 -0.839 . . . . 0.0 110.522 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.05 -48.53 3.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.728 -0.607 . . . . 0.0 109.713 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.43 -178.02 0.9 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.592 -0.693 . . . . 0.0 109.666 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.715 HD12 HG22 ' A' ' 36' ' ' VAL . 34.1 mm -121.56 163.7 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.472 ' N ' HG22 ' A' ' 27' ' ' ILE . 2.3 t0 -96.45 44.99 1.06 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.525 -0.734 . . . . 0.0 109.356 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp 57.25 21.13 6.33 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.723 -0.611 . . . . 0.0 110.424 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 m 57.83 81.89 0.14 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.232 -0.918 . . . . 0.0 109.867 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -141.63 -75.81 0.04 OUTLIER Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.41 HD11 ' O ' ' A' ' 34' ' ' TYR . 25.2 pt -61.92 167.55 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.573 -0.957 . . . . 0.0 109.678 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.551 HG23 ' CD2' ' A' ' 34' ' ' TYR . 6.7 tp -62.41 -27.84 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.648 -0.657 . . . . 0.0 109.554 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.551 ' CD2' HG23 ' A' ' 33' ' ' ILE . 16.4 m-85 -127.16 75.87 76.58 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.478 -0.764 . . . . 0.0 109.026 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -83.26 -20.07 5.2 Favored 'Trans proline' 0 C--N 1.324 -0.722 0 C-N-CA 122.047 1.831 . . . . 0.0 111.735 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.715 HG22 HD12 ' A' ' 27' ' ' ILE . 18.1 t -79.98 110.92 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.248 -0.908 . . . . 0.0 110.497 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.416 HD12 ' HA ' ' A' ' 59' ' ' ASN . 0.6 OUTLIER -96.26 117.23 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.053 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.487 HG12 ' N ' ' A' ' 39' ' ' ARG . 34.5 t -93.35 163.69 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.533 -0.73 . . . . 0.0 109.218 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.487 ' N ' HG12 ' A' ' 38' ' ' VAL . 31.3 ttt180 -105.1 149.36 25.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.637 -0.664 . . . . 0.0 109.368 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.497 ' CD2' ' CE3' ' A' ' 17' ' ' TRP . 82.2 m-85 -145.73 129.27 17.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.584 -0.698 . . . . 0.0 109.582 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -62.56 -28.77 70.1 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.517 -0.74 . . . . 0.0 109.3 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.41 ' HB3' ' NE1' ' A' ' 17' ' ' TRP . 4.9 tptm -60.71 161.52 7.77 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.638 -0.664 . . . . 0.0 109.469 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.1 t -130.42 122.97 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.56 -0.713 . . . . 0.0 109.446 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.401 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 33.5 t30 -97.05 174.33 6.81 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.562 -0.711 . . . . 0.0 109.432 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.401 ' CG ' ' O ' ' A' ' 44' ' ' ASN . 54.9 m-85 -155.54 112.75 3.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.61 -0.681 . . . . 0.0 109.493 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -101.56 33.34 2.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.626 -0.672 . . . . 0.0 109.475 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.17 69.42 0.83 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -77.6 149.32 34.81 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.656 -0.908 . . . . 0.0 109.449 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.9 t -131.27 31.33 4.39 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.6 -0.687 . . . . 0.0 109.493 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.95 -168.18 13.3 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.1 m 59.91 175.3 0.09 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.513 -0.992 . . . . 0.0 109.742 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -106.96 97.81 7.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.555 -0.715 . . . . 0.0 109.424 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -121.3 -91.38 1.16 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.659 ' C ' HD12 ' A' ' 55' ' ' LEU . . . 67.4 -175.61 25.08 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.659 HD12 ' C ' ' A' ' 54' ' ' GLY . 9.7 mp -116.31 -76.4 0.57 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.552 -0.97 . . . . 0.0 109.409 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.4 m120 64.76 12.0 7.31 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.487 -0.758 . . . . 0.0 110.761 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.8 p -155.32 129.76 9.04 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.187 -0.946 . . . . 0.0 109.134 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.449 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 11.3 t-20 -119.39 124.89 47.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.545 -0.722 . . . . 0.0 109.782 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.425 ' O ' ' CD1' ' A' ' 60' ' ' PHE . 8.2 m120 -63.86 148.86 48.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.581 -0.7 . . . . 0.0 109.31 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.449 ' CE2' ' HB3' ' A' ' 58' ' ' ASN . 14.7 m-85 -159.79 146.01 15.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.6 -0.688 . . . . 0.0 109.41 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.46 ' HB2' ' HD1' ' A' ' 34' ' ' TYR . . . -80.09 168.42 19.17 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.591 ' HA ' HD11 ' A' ' 2' ' ' ILE . 2.5 mp0 -62.66 -46.8 86.53 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.46 -0.775 . . . . 0.0 109.58 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -70.81 -17.22 62.76 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.52 -0.737 . . . . 0.0 110.279 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -79.72 -15.04 58.27 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.251 -0.906 . . . . 0.0 110.37 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.528 ' CD1' HG11 ' A' ' 36' ' ' VAL . 11.0 mt -105.07 154.37 20.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.32 -0.863 . . . . 0.0 109.421 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.505 ' O ' HG13 ' A' ' 68' ' ' VAL . 6.1 tp10 -127.87 84.28 2.23 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.73 HG22 HG12 ' A' ' 8' ' ' VAL . 45.1 t -56.04 113.05 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.432 -0.792 . . . . 0.0 109.897 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 66' ' ' GLU . 30.0 m -120.95 30.17 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.605 -0.684 . . . . 0.0 109.562 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.408 0 CA-C-O 117.968 -1.462 . . . . 0.0 109.589 -179.985 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.6 mm -114.23 129.59 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.592 -0.692 . . . . 0.0 109.478 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.421 ' O ' HG11 ' A' ' 24' ' ' VAL . 3.6 mm-40 -87.87 163.84 16.19 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.648 -0.658 . . . . 0.0 109.375 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.0 ttt-85 -90.03 133.27 34.92 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.556 -0.715 . . . . 0.0 109.469 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.69 21.29 57.89 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.442 ' OG ' HG13 ' A' ' 67' ' ' VAL . 28.4 t -90.5 159.98 16.23 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.319 -1.107 . . . . 0.0 109.566 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.0 mttp -84.6 98.74 10.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.561 -0.712 . . . . 0.0 109.177 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.781 HG12 HG22 ' A' ' 67' ' ' VAL . 26.6 m -99.59 125.41 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.569 -0.707 . . . . 0.0 110.211 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.42 ' CE ' HD21 ' A' ' 11' ' ' LEU . 5.5 tttp -79.23 113.2 17.17 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.484 HG22 ' H ' ' A' ' 12' ' ' ARG . 37.1 mm -61.67 130.48 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.627 -0.671 . . . . 0.0 109.747 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.497 ' HA ' HD13 ' A' ' 11' ' ' LEU . 2.7 mm? -119.01 27.88 8.61 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.81 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.484 ' H ' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -87.04 120.44 28.31 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.452 -0.78 . . . . 0.0 109.261 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.18 -67.2 0.34 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.409 -0.807 . . . . 0.0 109.947 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -80.37 82.68 6.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.479 -0.763 . . . . 0.0 109.416 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -147.99 139.51 23.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.587 -0.696 . . . . 0.0 109.541 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.457 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 20.0 t80 -64.4 -17.41 63.74 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.678 -0.638 . . . . 0.0 110.181 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.5 ' CE3' ' CD1' ' A' ' 40' ' ' PHE . 11.2 m0 -124.25 32.8 5.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.211 -0.931 . . . . 0.0 109.956 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.409 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 13.8 t80 -68.6 134.63 50.25 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.542 -0.724 . . . . 0.0 109.124 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.65 -17.2 58.29 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -100.17 160.12 14.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.238 -1.154 . . . . 0.0 109.647 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 22' ' ' GLY . 60.0 t -95.79 162.73 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.484 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -144.61 154.4 25.78 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 51.6 m -86.92 112.29 21.64 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.553 -0.969 . . . . 0.0 109.223 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 6' ' ' SER . 25.3 t -50.59 128.29 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.383 -0.823 . . . . 0.0 110.652 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.24 -49.93 4.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.557 -0.715 . . . . 0.0 109.226 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.676 ' C ' HD12 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -176.73 171.21 2.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.588 -0.695 . . . . 0.0 109.624 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.676 HD12 ' C ' ' A' ' 26' ' ' SER . 1.8 mp -112.12 163.48 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.408 ' N ' HG22 ' A' ' 27' ' ' ILE . 6.7 t0 -136.95 78.52 1.7 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.558 -0.714 . . . . 0.0 109.517 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.3 mmmt -63.09 92.38 0.05 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.529 -0.732 . . . . 0.0 109.4 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.1 m -124.5 -53.31 1.69 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.589 -0.695 . . . . 0.0 109.638 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 152.81 -23.01 0.81 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.487 HD11 ' HA ' ' A' ' 35' ' ' PRO . 36.8 pt -57.47 173.36 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.31 -1.112 . . . . 0.0 110.008 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.473 HG23 ' CD2' ' A' ' 34' ' ' TYR . 1.3 tp -76.32 -34.01 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.585 -0.697 . . . . 0.0 109.676 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.473 ' CD2' HG23 ' A' ' 33' ' ' ILE . 17.4 m-85 -120.03 81.18 27.45 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.49 -0.756 . . . . 0.0 109.454 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.487 ' HA ' HD11 ' A' ' 32' ' ' ILE . 37.3 Cg_endo -81.76 -13.49 10.56 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.008 1.806 . . . . 0.0 111.925 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 37' ' ' ILE . 14.1 t -90.04 163.65 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.137 -0.977 . . . . 0.0 109.988 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.653 HD12 ' HA ' ' A' ' 59' ' ' ASN . 1.3 tp -139.22 116.37 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 39' ' ' ARG . 30.9 t -93.22 163.68 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.506 -0.746 . . . . 0.0 109.477 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.486 ' N ' HG12 ' A' ' 38' ' ' VAL . 28.5 ttt180 -106.42 149.37 27.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.58 -0.7 . . . . 0.0 109.233 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.5 ' CD1' ' CE3' ' A' ' 17' ' ' TRP . 85.1 m-85 -143.88 158.63 43.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.604 -0.685 . . . . 0.0 109.757 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -100.47 31.75 3.33 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -118.71 158.75 24.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.689 -0.632 . . . . 0.0 109.353 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.429 ' CG1' ' CZ ' ' A' ' 45' ' ' TYR . 38.3 t -142.03 116.68 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.588 -0.695 . . . . 0.0 109.272 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -79.79 106.29 11.71 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.489 -0.757 . . . . 0.0 109.701 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.429 ' CZ ' ' CG1' ' A' ' 43' ' ' VAL . 82.1 m-85 -95.23 43.55 1.09 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.693 -0.629 . . . . 0.0 109.503 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -137.58 -54.85 0.68 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.435 -0.791 . . . . 0.0 109.481 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.25 81.54 1.73 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -131.68 133.7 45.15 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.678 -0.895 . . . . 0.0 109.469 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.6 p -130.68 112.72 13.36 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.552 -0.718 . . . . 0.0 109.533 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 129.8 -126.44 5.08 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -112.78 -33.1 6.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.564 -0.962 . . . . 0.0 109.499 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -114.59 159.97 19.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.569 -0.707 . . . . 0.0 109.542 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -145.72 -154.69 6.23 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.89 117.7 0.03 OUTLIER Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.698 HD22 ' N ' ' A' ' 55' ' ' LEU . 2.6 mm? -106.77 130.8 54.42 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.486 -1.008 . . . . 0.0 109.125 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.402 ' C ' HG23 ' A' ' 57' ' ' THR . 3.8 m120 -117.48 20.5 13.53 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.613 -0.679 . . . . 0.0 109.612 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.402 HG23 ' C ' ' A' ' 56' ' ' ASN . 66.3 p -154.3 130.42 10.33 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.361 -0.837 . . . . 0.0 108.887 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.467 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 4.6 m-20 -115.63 136.94 52.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.543 -0.723 . . . . 0.0 109.685 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.653 ' HA ' HD12 ' A' ' 37' ' ' ILE . 6.6 m120 -74.89 133.79 41.75 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.571 -0.706 . . . . 0.0 109.475 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.467 ' CE2' ' HB3' ' A' ' 58' ' ' ASN . 28.7 m-85 -145.71 152.13 39.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.58 -0.7 . . . . 0.0 109.555 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.77 167.75 17.85 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -64.06 -46.82 82.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.468 -0.77 . . . . 0.0 109.241 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -71.75 -18.15 62.15 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.611 -0.681 . . . . 0.0 110.399 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -79.4 -11.49 59.92 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.278 -0.889 . . . . 0.0 110.274 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.9 mt -107.43 144.34 34.5 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.231 -0.918 . . . . 0.0 109.243 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.604 ' O ' HG13 ' A' ' 68' ' ' VAL . 5.5 tp10 -119.49 83.95 2.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.617 -0.677 . . . . 0.0 109.337 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.781 HG22 HG12 ' A' ' 8' ' ' VAL . 47.0 t -51.65 97.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.323 -0.861 . . . . 0.0 110.064 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.604 HG13 ' O ' ' A' ' 66' ' ' GLU . 30.8 m -97.45 36.14 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.595 -0.69 . . . . 0.0 109.588 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.488 0 CA-C-O 118.024 -1.431 . . . . 0.0 109.59 179.962 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.575 HD11 ' HA ' ' A' ' 62' ' ' GLU . 37.5 mt -70.4 89.64 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.572 -0.705 . . . . 0.0 109.372 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -81.16 -179.16 7.23 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.628 -0.67 . . . . 0.0 109.369 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -89.97 141.88 28.24 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.599 -0.688 . . . . 0.0 109.505 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.69 21.29 57.89 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.8 t -90.53 -177.48 5.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.317 -1.108 . . . . 0.0 109.414 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.9 mttp -109.8 118.8 37.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.526 -0.734 . . . . 0.0 109.24 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 8' ' ' VAL . 34.4 m -122.96 123.66 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.557 -0.714 . . . . 0.0 109.959 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.415 ' HE2' HD21 ' A' ' 11' ' ' LEU . 9.4 ttpt -79.62 115.15 19.07 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.2 mm -61.49 132.26 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.611 -0.68 . . . . 0.0 109.629 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.464 ' HA ' HD13 ' A' ' 11' ' ' LEU . 3.6 mm? -113.6 1.52 14.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.552 -0.718 . . . . 0.0 110.602 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.411 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . 1.8 tmt_? -62.23 119.67 9.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.088 -1.007 . . . . 0.0 109.398 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -56.02 -75.33 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.46 -0.775 . . . . 0.0 110.185 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -69.89 89.78 0.6 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.523 -0.735 . . . . 0.0 109.276 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.3 141.13 14.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.602 -0.686 . . . . 0.0 109.833 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.458 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 20.2 t80 -66.72 -13.06 60.89 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.73 -0.606 . . . . 0.0 110.247 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.458 ' NE1' ' CD2' ' A' ' 16' ' ' TYR . 11.5 m0 -125.04 26.77 6.89 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.066 -1.021 . . . . 0.0 110.334 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.411 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 19.4 t80 -68.07 137.56 55.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.4 -0.812 . . . . 0.0 109.163 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.55 -10.47 69.48 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.786 -0.925 . . . . 0.0 110.786 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.16 -169.58 1.72 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.108 -1.231 . . . . 0.0 109.483 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 22' ' ' GLY . 60.1 t -127.85 162.68 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.476 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -145.75 156.48 26.99 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 49.3 m -89.73 112.78 24.17 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.558 -0.966 . . . . 0.0 109.225 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.0 t -47.77 125.21 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.527 -0.733 . . . . 0.0 110.927 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.1 -46.49 5.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.669 -0.644 . . . . 0.0 109.615 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.664 ' C ' HD12 ' A' ' 27' ' ' ILE . 0.3 OUTLIER -176.64 170.66 2.4 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.529 -0.732 . . . . 0.0 109.631 -179.865 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.664 HD12 ' C ' ' A' ' 26' ' ' SER . 1.8 mp -111.95 162.58 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -125.98 74.47 1.43 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.507 -0.746 . . . . 0.0 109.512 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.1 tptt -63.46 92.36 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.484 -0.76 . . . . 0.0 109.449 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.6 t -137.0 -45.24 0.57 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.564 -0.71 . . . . 0.0 109.658 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.24 -20.36 1.91 Allowed Glycine 0 N--CA 1.495 2.571 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.629 HD11 ' HA ' ' A' ' 35' ' ' PRO . 33.8 pt -56.75 174.63 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.296 -1.12 . . . . 0.0 110.112 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.606 ' O ' ' HB2' ' A' ' 61' ' ' ALA . 7.7 tp -90.12 -17.57 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.556 -0.715 . . . . 0.0 110.318 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.478 ' CD2' HG23 ' A' ' 33' ' ' ILE . 15.0 m-85 -130.46 69.31 82.11 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.148 -0.97 . . . . 0.0 109.692 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.629 ' HA ' HD11 ' A' ' 32' ' ' ILE . 37.8 Cg_endo -82.65 -17.05 7.52 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.048 1.832 . . . . 0.0 111.916 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.8 t -86.56 113.03 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.139 -0.976 . . . . 0.0 110.659 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.465 HD12 ' HA ' ' A' ' 59' ' ' ASN . 1.2 tp -96.39 116.81 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.357 -0.839 . . . . 0.0 108.955 179.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 39' ' ' ARG . 39.2 t -91.3 164.33 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.454 -0.779 . . . . 0.0 109.115 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.486 ' N ' HG12 ' A' ' 38' ' ' VAL . 32.9 ttt180 -102.01 140.76 35.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.561 -0.712 . . . . 0.0 109.386 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.445 ' CE2' ' HB2' ' A' ' 58' ' ' ASN . 91.0 m-85 -137.92 126.88 24.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.559 -0.713 . . . . 0.0 109.647 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -62.47 -27.37 69.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.595 -0.69 . . . . 0.0 109.269 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.73 173.9 0.52 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.584 -0.697 . . . . 0.0 109.573 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 36.8 t -150.77 114.37 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.553 -0.717 . . . . 0.0 109.244 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -94.15 144.13 25.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.52 -0.737 . . . . 0.0 109.405 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.431 ' CE1' ' HA3' ' A' ' 54' ' ' GLY . 14.5 m-85 -139.72 165.05 28.3 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.574 -0.704 . . . . 0.0 109.572 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -149.1 82.83 1.44 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.619 -0.676 . . . . 0.0 109.318 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.86 29.27 74.7 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.96 -172.09 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.565 -0.961 . . . . 0.0 110.247 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.1 t -164.53 31.54 0.07 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.591 -0.693 . . . . 0.0 109.407 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 153.86 -161.09 29.75 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 61.0 107.67 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.535 -0.979 . . . . 0.0 109.712 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.22 -60.46 3.54 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.538 -0.726 . . . . 0.0 109.59 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.9 143.64 32.56 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.431 ' HA3' ' CE1' ' A' ' 45' ' ' TYR . . . -141.05 116.86 1.17 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 60.41 -89.98 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.698 -0.884 . . . . 0.0 109.898 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.411 ' C ' HG23 ' A' ' 57' ' ' THR . 30.9 m-20 61.98 15.56 7.36 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.935 -1.103 . . . . 0.0 110.389 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.411 HG23 ' C ' ' A' ' 56' ' ' ASN . 72.1 p -155.06 130.08 9.47 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.181 -0.949 . . . . 0.0 108.984 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.445 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . 0.8 OUTLIER -120.02 148.63 43.33 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.561 -0.712 . . . . 0.0 109.439 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.465 ' HA ' HD12 ' A' ' 37' ' ' ILE . 11.2 m120 -82.9 143.13 30.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.52 -0.737 . . . . 0.0 109.315 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.434 ' CE2' ' HB3' ' A' ' 58' ' ' ASN . 21.4 m-85 -156.63 141.95 17.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.537 -0.727 . . . . 0.0 109.537 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.606 ' HB2' ' O ' ' A' ' 33' ' ' ILE . . . -77.62 169.06 18.95 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.575 ' HA ' HD11 ' A' ' 2' ' ' ILE . 18.6 mt-10 -63.38 -46.23 87.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.513 -0.742 . . . . 0.0 109.454 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 12.7 p-80 -68.93 -18.94 64.17 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.597 -0.689 . . . . 0.0 110.213 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -79.6 -19.65 48.79 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.366 -0.834 . . . . 0.0 110.2 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 19.5 mt -99.37 143.13 29.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.242 -0.911 . . . . 0.0 109.666 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.444 ' HB2' HD23 ' A' ' 11' ' ' LEU . 0.3 OUTLIER -113.02 89.21 3.02 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.759 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.3 t -58.24 115.29 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.495 -0.753 . . . . 0.0 110.018 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.428 HG13 ' O ' ' A' ' 66' ' ' GLU . 28.0 m -119.6 29.22 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.617 -0.677 . . . . 0.0 109.51 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.402 0 CA-C-O 118.013 -1.437 . . . . 0.0 109.525 -179.936 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.605 HD12 ' HG2' ' A' ' 62' ' ' GLU . 54.3 mt 60.42 50.38 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.5 -0.75 . . . . 0.0 109.547 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -79.95 170.94 15.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.498 -0.751 . . . . 0.0 109.282 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.14 151.82 21.41 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.552 -0.718 . . . . 0.0 109.692 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.65 -16.81 59.24 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.189 -1.165 . . . . 0.0 110.189 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.4 t -90.87 -177.36 4.93 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.228 -1.16 . . . . 0.0 109.755 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.7 mtmt -108.59 124.53 50.63 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.504 HG13 ' CG2' ' A' ' 24' ' ' VAL . 34.0 m -118.68 127.16 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.532 -0.73 . . . . 0.0 110.165 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.427 ' HA ' HG22 ' A' ' 21' ' ' VAL . 4.8 tttp -79.48 114.02 18.08 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.475 HG22 ' H ' ' A' ' 12' ' ' ARG . 29.3 mm -59.99 129.62 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.646 -0.659 . . . . 0.0 110.008 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.418 ' HA ' HD13 ' A' ' 11' ' ' LEU . 2.6 mm? -119.62 26.05 9.63 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.659 -0.651 . . . . 0.0 109.567 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.475 ' H ' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -84.88 120.95 27.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.404 -0.81 . . . . 0.0 109.466 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.6 mtpt -59.24 -56.18 25.37 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.497 -0.752 . . . . 0.0 110.004 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -90.31 78.72 6.44 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.483 -0.761 . . . . 0.0 109.921 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.1 p -147.81 141.76 25.88 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.42 -0.8 . . . . 0.0 109.598 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.458 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 21.8 t80 -61.59 -15.6 40.52 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.7 -0.625 . . . . 0.0 110.869 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.495 ' CZ3' ' CD1' ' A' ' 40' ' ' PHE . 11.9 m0 -125.35 35.14 4.8 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.09 -1.006 . . . . 0.0 110.738 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.41 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 20.9 t80 -68.36 130.72 43.72 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.448 -0.783 . . . . 0.0 109.067 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.64 -11.68 62.91 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 120.249 -0.977 . . . . 0.0 110.823 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -109.07 173.94 6.09 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.159 -1.2 . . . . 0.0 109.655 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 22' ' ' GLY . 87.4 t -111.2 162.53 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.483 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -143.07 155.17 25.84 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.7 m -86.13 111.43 20.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.514 -0.992 . . . . 0.0 109.219 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.504 ' CG2' HG13 ' A' ' 8' ' ' VAL . 3.8 t -53.16 140.29 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 121.306 -0.871 . . . . 0.0 109.987 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -109.37 -49.94 3.05 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.544 -0.722 . . . . 0.0 109.706 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -170.96 164.82 7.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.622 -0.674 . . . . 0.0 109.584 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.761 HD12 HG22 ' A' ' 36' ' ' VAL . 38.1 mm -112.14 163.29 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.469 ' N ' HG22 ' A' ' 27' ' ' ILE . 2.1 t0 -101.47 -171.93 2.07 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.637 -0.665 . . . . 0.0 109.323 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -99.64 37.41 1.6 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.448 -0.782 . . . . 0.0 109.536 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.1 t 60.15 32.11 20.79 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.478 -0.764 . . . . 0.0 109.676 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.38 -30.76 48.69 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.557 HD11 ' O ' ' A' ' 34' ' ' TYR . 16.3 pt -124.21 -174.82 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.563 -0.963 . . . . 0.0 109.511 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.497 HG23 ' CD2' ' A' ' 34' ' ' TYR . 16.1 tt -78.37 -27.78 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.537 -0.727 . . . . 0.0 109.488 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.557 ' O ' HD11 ' A' ' 32' ' ' ILE . 17.6 m-85 -121.65 80.1 39.53 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.473 -0.767 . . . . 0.0 109.373 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -82.52 -9.53 11.21 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.08 1.854 . . . . 0.0 111.95 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.761 HG22 HD12 ' A' ' 27' ' ' ILE . 21.3 t -93.79 113.46 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 120.962 -1.086 . . . . 0.0 110.261 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.658 HD12 ' HA ' ' A' ' 59' ' ' ASN . 1.6 tp -98.05 116.0 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.17 -0.956 . . . . 0.0 108.78 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 39' ' ' ARG . 40.7 t -92.08 164.58 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.573 -0.704 . . . . 0.0 109.365 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.5 ' N ' HG12 ' A' ' 38' ' ' VAL . 16.5 ttt180 -109.22 149.52 29.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.565 -0.71 . . . . 0.0 109.467 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.495 ' CD1' ' CZ3' ' A' ' 17' ' ' TRP . 61.7 m-85 -146.55 154.71 41.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.581 -0.7 . . . . 0.0 109.486 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -100.82 34.0 2.61 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.409 ' HB3' ' NE1' ' A' ' 17' ' ' TRP . 1.9 tppt? -125.18 55.81 1.37 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.498 HG22 ' OD1' ' A' ' 56' ' ' ASN . 36.8 t -59.12 114.1 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.299 -0.876 . . . . 0.0 109.761 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -80.3 153.11 28.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.62 -0.675 . . . . 0.0 109.513 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -138.77 78.38 1.67 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.542 -0.724 . . . . 0.0 109.451 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -96.74 -63.68 1.12 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.509 -0.744 . . . . 0.0 109.526 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.421 ' O ' ' CG ' ' A' ' 48' ' ' PHE . . . -163.82 -82.24 0.04 OUTLIER Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.421 ' CG ' ' O ' ' A' ' 47' ' ' GLY . 42.8 p90 40.82 31.09 0.11 Allowed 'General case' 0 N--CA 1.509 2.524 0 O-C-N 122.136 -0.626 . . . . 0.0 111.568 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.6 t -63.03 125.19 23.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.487 -0.758 . . . . 0.0 109.51 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.95 30.68 3.87 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 t -176.11 97.99 0.06 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.552 -0.97 . . . . 0.0 109.532 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 60.14 179.26 0.09 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.456 -0.777 . . . . 0.0 109.612 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.56 -30.26 3.86 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -159.6 166.22 34.79 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.654 ' N ' HD12 ' A' ' 55' ' ' LEU . 6.4 mp -87.9 -74.24 0.46 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.614 -0.933 . . . . 0.0 109.441 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.73 ' O ' HG23 ' A' ' 57' ' ' THR . 3.4 m-20 64.53 13.38 8.16 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.543 -0.723 . . . . 0.0 110.547 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.73 HG23 ' O ' ' A' ' 56' ' ' ASN . 0.8 OUTLIER -167.78 132.22 1.8 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.24 -0.913 . . . . 0.0 108.825 179.493 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.439 ' HB2' ' CE1' ' A' ' 40' ' ' PHE . 0.9 OUTLIER -108.39 167.9 9.7 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.522 -0.736 . . . . 0.0 109.357 -179.755 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.658 ' HA ' HD12 ' A' ' 37' ' ' ILE . 5.6 m120 -104.85 141.44 36.51 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.575 -0.703 . . . . 0.0 109.173 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.495 ' HB2' HD21 ' A' ' 65' ' ' LEU . 42.2 m-85 -155.36 146.61 22.75 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.491 -0.756 . . . . 0.0 109.447 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.461 ' HB2' ' HD1' ' A' ' 34' ' ' TYR . . . -83.0 171.0 14.29 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.605 ' HG2' HD12 ' A' ' 2' ' ' ILE . 5.7 mt-10 -62.81 -48.73 77.83 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.543 -0.723 . . . . 0.0 109.571 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 16.2 p-80 -68.0 -20.93 65.06 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.557 -0.714 . . . . 0.0 110.225 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -79.57 -20.49 46.87 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.315 -0.866 . . . . 0.0 110.175 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.552 HD13 HG11 ' A' ' 36' ' ' VAL . 7.9 mt -98.98 146.23 26.24 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.264 -0.897 . . . . 0.0 109.669 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.473 ' O ' HG13 ' A' ' 68' ' ' VAL . 31.5 tt0 -120.63 86.79 2.63 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.8 t -50.97 114.35 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.372 -0.83 . . . . 0.0 110.363 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 66' ' ' GLU . 31.4 m -106.9 -29.58 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.556 -0.715 . . . . 0.0 109.562 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.461 0 CA-C-O 117.958 -1.468 . . . . 0.0 109.531 -179.992 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.0 mm -106.06 133.51 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.575 -0.703 . . . . 0.0 109.538 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.431 ' O ' HG11 ' A' ' 24' ' ' VAL . 5.8 mt-10 -80.05 161.54 25.32 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.488 -0.758 . . . . 0.0 109.421 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -90.05 128.94 36.4 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.581 -0.699 . . . . 0.0 109.569 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.57 20.91 56.91 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.423 ' O ' HG23 ' A' ' 24' ' ' VAL . 13.2 t -90.4 162.06 15.28 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.375 -1.073 . . . . 0.0 109.377 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.457 ' HE3' HG11 ' A' ' 21' ' ' VAL . 5.6 mtpp -79.77 116.93 20.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.552 -0.718 . . . . 0.0 109.286 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 8' ' ' VAL . 33.2 m -120.04 122.49 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.533 -0.729 . . . . 0.0 109.776 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.472 ' CE ' HD21 ' A' ' 11' ' ' LEU . 10.1 ttpt -79.38 113.72 17.74 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.416 HD12 ' CD2' ' A' ' 60' ' ' PHE . 27.1 mm -61.78 132.23 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.66 -0.65 . . . . 0.0 109.516 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.472 HD21 ' CE ' ' A' ' 9' ' ' LYS . 3.5 mm? -114.9 5.0 14.98 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.504 -0.747 . . . . 0.0 110.694 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.434 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . 0.2 OUTLIER -62.43 124.44 20.95 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.948 -1.095 . . . . 0.0 109.422 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -59.55 -73.95 0.08 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.483 -0.76 . . . . 0.0 109.818 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -76.32 86.19 3.1 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.575 -0.703 . . . . 0.0 109.359 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.98 143.15 28.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.553 -0.717 . . . . 0.0 109.613 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.45 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 20.0 t80 -66.2 -13.62 60.58 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.682 -0.636 . . . . 0.0 110.191 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.55 ' CZ3' ' ND2' ' A' ' 58' ' ' ASN . 13.2 m0 -127.34 25.76 6.09 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.084 -1.01 . . . . 0.0 110.333 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -67.82 127.93 34.62 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.381 -0.824 . . . . 0.0 108.834 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.17 -5.4 49.47 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.639 -0.985 . . . . 0.0 110.639 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -117.72 175.05 5.83 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.111 -1.229 . . . . 0.0 109.359 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 22' ' ' GLY . 54.6 t -108.63 162.5 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.484 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -143.44 154.94 25.82 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.403 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 48.5 m -87.92 111.95 22.0 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.444 -1.033 . . . . 0.0 109.241 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.431 HG11 ' O ' ' A' ' 3' ' ' GLU . 47.9 t -51.32 125.41 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.446 -0.784 . . . . 0.0 110.379 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -95.11 -49.98 5.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.716 -0.615 . . . . 0.0 109.441 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.7 ' C ' HD12 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -176.48 175.55 1.74 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.5 -0.75 . . . . 0.0 109.661 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.7 HD12 ' C ' ' A' ' 26' ' ' SER . 1.8 mp -113.65 164.36 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.417 ' N ' HG22 ' A' ' 27' ' ' ILE . 9.5 t0 -135.62 96.17 3.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.477 -0.764 . . . . 0.0 109.546 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.5 mmtm -71.64 89.2 0.99 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.642 -0.661 . . . . 0.0 109.282 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.5 m -123.25 -58.37 1.63 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.593 -0.692 . . . . 0.0 109.603 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.67 -21.67 1.03 Allowed Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.099 -1.201 . . . . 0.0 110.099 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 29.8 pt -57.65 163.66 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.212 -1.17 . . . . 0.0 110.019 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.472 HG23 ' CD2' ' A' ' 34' ' ' TYR . 5.0 tt -69.22 -26.27 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.595 -0.691 . . . . 0.0 109.759 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.472 ' CD2' HG23 ' A' ' 33' ' ' ILE . 17.5 m-85 -121.65 78.82 38.74 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.402 -0.811 . . . . 0.0 109.312 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -81.91 -15.97 9.07 Favored 'Trans proline' 0 C--N 1.324 -0.714 0 C-N-CA 122.048 1.832 . . . . 0.0 111.969 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 37' ' ' ILE . 11.7 t -87.22 164.47 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.066 -1.021 . . . . 0.0 109.898 -178.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.603 HD12 ' HA ' ' A' ' 59' ' ' ASN . 1.2 tp -140.62 114.85 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.493 HG12 ' N ' ' A' ' 39' ' ' ARG . 39.5 t -91.45 164.49 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.429 -0.795 . . . . 0.0 109.283 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.493 ' N ' HG12 ' A' ' 38' ' ' VAL . 12.5 ttt85 -105.48 145.14 31.27 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.637 -0.664 . . . . 0.0 109.349 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.505 ' CD2' ' CE3' ' A' ' 17' ' ' TRP . 80.7 m-85 -141.77 136.87 31.14 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.656 -0.653 . . . . 0.0 109.759 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 30.8 m-20 -67.66 -28.19 67.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.551 -0.718 . . . . 0.0 109.094 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.26 165.87 2.46 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.537 -0.727 . . . . 0.0 109.62 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.717 HG11 ' CZ ' ' A' ' 45' ' ' TYR . 31.5 t -149.16 120.32 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.507 -0.746 . . . . 0.0 109.453 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -93.1 92.8 7.96 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.599 -0.688 . . . . 0.0 109.482 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.717 ' CZ ' HG11 ' A' ' 43' ' ' VAL . 66.9 m-85 -80.95 -58.73 2.95 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.58 -0.7 . . . . 0.0 109.446 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 60.03 32.6 21.13 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.545 -0.722 . . . . 0.0 109.674 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.434 ' O ' ' CG ' ' A' ' 48' ' ' PHE . . . 122.65 176.29 14.91 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.434 ' CG ' ' O ' ' A' ' 47' ' ' GLY . 42.6 p90 40.82 31.12 0.11 Allowed 'General case' 0 N--CA 1.509 2.513 0 O-C-N 122.052 -0.675 . . . . 0.0 111.6 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.8 t -63.49 96.98 0.13 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.562 -0.711 . . . . 0.0 109.425 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -151.34 36.42 0.87 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 59.97 -167.5 0.17 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.505 -0.997 . . . . 0.0 109.745 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 63.23 -89.0 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.597 -0.689 . . . . 0.0 109.727 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.93 142.03 44.43 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 173.69 165.5 30.52 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.643 ' N ' HD12 ' A' ' 55' ' ' LEU . 6.8 mp -97.9 -76.96 0.51 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.615 -0.932 . . . . 0.0 109.381 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.406 ' C ' HG23 ' A' ' 57' ' ' THR . 3.0 m120 61.6 15.98 7.3 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.505 -0.747 . . . . 0.0 110.497 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.406 HG23 ' C ' ' A' ' 56' ' ' ASN . 72.6 p -154.76 129.75 9.48 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.155 -0.966 . . . . 0.0 109.202 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.55 ' ND2' ' CZ3' ' A' ' 17' ' ' TRP . 0.9 OUTLIER -117.24 151.22 37.38 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.55 -0.719 . . . . 0.0 109.287 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.603 ' HA ' HD12 ' A' ' 37' ' ' ILE . 5.7 m120 -87.46 134.54 33.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.487 -0.758 . . . . 0.0 109.376 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.448 ' CE2' ' HB3' ' A' ' 58' ' ' ASN . 22.3 m-85 -148.61 150.78 33.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.632 -0.668 . . . . 0.0 109.35 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.9 168.33 17.16 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -64.17 -45.95 86.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.497 -0.752 . . . . 0.0 109.28 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -70.87 -19.75 62.59 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.615 -0.678 . . . . 0.0 110.288 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -79.29 -14.24 59.14 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.292 -0.88 . . . . 0.0 110.215 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.1 mt -103.73 144.38 31.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 109.31 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.439 ' O ' HG13 ' A' ' 68' ' ' VAL . 5.1 tt0 -111.25 87.23 2.49 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.599 -0.688 . . . . 0.0 109.588 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.1 t -58.95 100.88 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.505 -0.747 . . . . 0.0 109.784 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.439 HG13 ' O ' ' A' ' 66' ' ' GLU . 30.7 m -103.6 -29.06 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.625 -0.672 . . . . 0.0 109.598 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.377 0 CA-C-O 117.986 -1.452 . . . . 0.0 109.564 -179.994 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 39.2 mm -101.43 136.11 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.571 -0.706 . . . . 0.0 109.404 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -79.93 162.22 25.08 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.577 -0.702 . . . . 0.0 109.529 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -90.07 129.27 36.39 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.644 -0.66 . . . . 0.0 109.523 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.71 18.97 54.22 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.3 t -90.44 160.88 15.81 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.358 -1.084 . . . . 0.0 109.364 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.4 mtpp -79.88 118.32 21.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.503 -0.748 . . . . 0.0 109.289 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 8' ' ' VAL . 33.0 m -120.3 123.48 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.601 -0.687 . . . . 0.0 109.773 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.461 ' CE ' HD21 ' A' ' 11' ' ' LEU . 4.2 ttpt -79.36 115.13 18.82 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.424 ' CG2' ' CZ ' ' A' ' 60' ' ' PHE . 27.3 mm -62.56 132.14 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.657 -0.652 . . . . 0.0 109.462 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.461 HD21 ' CE ' ' A' ' 9' ' ' LYS . 3.3 mm? -116.5 5.28 13.36 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.489 -0.757 . . . . 0.0 110.786 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.434 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -63.35 124.31 20.94 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.984 -1.072 . . . . 0.0 109.36 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -59.06 -69.31 0.2 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.479 -0.763 . . . . 0.0 109.968 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -81.14 81.87 7.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.602 -0.686 . . . . 0.0 109.337 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.64 143.35 37.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.495 -0.753 . . . . 0.0 109.579 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.449 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 25.4 t80 -64.28 -15.64 60.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.667 -0.646 . . . . 0.0 110.101 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.497 ' CE3' ' CD1' ' A' ' 40' ' ' PHE . 16.2 m0 -129.58 30.71 4.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.254 -0.904 . . . . 0.0 110.242 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.403 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 16.3 t80 -69.17 121.3 16.49 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.45 -8.67 26.41 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 120.205 -0.998 . . . . 0.0 110.63 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -116.36 171.6 7.73 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.065 -1.256 . . . . 0.0 109.512 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 22' ' ' GLY . 60.7 t -104.58 162.63 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.484 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -143.56 153.69 25.04 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 51.8 m -87.91 112.35 22.43 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.566 -0.961 . . . . 0.0 109.239 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.1 t -52.35 127.03 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.458 -0.776 . . . . 0.0 110.186 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -96.48 -49.61 5.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.633 -0.667 . . . . 0.0 109.682 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -173.89 167.8 4.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.638 -0.664 . . . . 0.0 109.748 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.82 HD12 HG22 ' A' ' 36' ' ' VAL . 27.4 mm -113.73 164.3 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.609 -0.682 . . . . 0.0 109.255 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.459 ' N ' HG22 ' A' ' 27' ' ' ILE . 0.6 OUTLIER -101.15 44.65 1.0 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.58 -0.7 . . . . 0.0 109.283 179.831 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? 57.17 21.36 6.45 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.665 -0.647 . . . . 0.0 110.399 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 31.1 t 57.02 81.74 0.13 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.213 -0.929 . . . . 0.0 109.872 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -135.09 -70.88 0.07 OUTLIER Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.495 HD11 ' HA ' ' A' ' 35' ' ' PRO . 17.8 pt -69.64 178.04 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.547 -0.972 . . . . 0.0 109.907 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.582 ' O ' ' HB2' ' A' ' 61' ' ' ALA . 61.6 mt -68.65 -32.78 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.65 -0.656 . . . . 0.0 109.474 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.465 ' CE1' ' CG2' ' A' ' 33' ' ' ILE . 4.7 m-85 -131.97 70.4 80.68 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.547 -0.721 . . . . 0.0 109.101 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.495 ' HA ' HD11 ' A' ' 32' ' ' ILE . 37.6 Cg_endo -82.54 -17.12 7.62 Favored 'Trans proline' 0 C--N 1.325 -0.663 0 C-N-CA 122.131 1.887 . . . . 0.0 111.653 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.82 HG22 HD12 ' A' ' 27' ' ' ILE . 22.0 t -79.6 113.05 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.203 -0.936 . . . . 0.0 110.169 -178.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.696 HD12 ' HA ' ' A' ' 59' ' ' ASN . 1.4 tp -95.45 115.24 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 39' ' ' ARG . 35.3 t -90.8 163.67 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.518 -0.739 . . . . 0.0 109.258 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.49 ' N ' HG12 ' A' ' 38' ' ' VAL . 13.3 ttt180 -106.47 147.95 28.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.595 -0.69 . . . . 0.0 109.221 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.497 ' CD1' ' CE3' ' A' ' 17' ' ' TRP . 79.6 m-85 -144.05 157.62 44.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.553 -0.717 . . . . 0.0 109.502 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -100.07 32.19 3.04 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.413 ' HB3' ' NE1' ' A' ' 17' ' ' TRP . 0.0 OUTLIER -127.33 136.64 52.2 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.519 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.696 HG11 ' CZ ' ' A' ' 45' ' ' TYR . 36.2 t -108.91 141.88 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.481 -0.762 . . . . 0.0 109.479 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -119.68 96.54 5.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.528 -0.732 . . . . 0.0 109.458 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.696 ' CZ ' HG11 ' A' ' 43' ' ' VAL . 82.1 m-85 -83.72 88.19 7.07 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.569 -0.707 . . . . 0.0 109.495 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -97.92 122.02 40.53 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.619 -0.676 . . . . 0.0 109.489 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.25 73.98 0.57 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -121.62 134.87 55.0 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.541 -0.976 . . . . 0.0 109.507 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.5 m -161.13 31.09 0.14 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.607 -0.683 . . . . 0.0 109.517 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 124.19 49.09 0.21 Allowed Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.8 m -154.26 151.77 29.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.555 -0.968 . . . . 0.0 109.482 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -111.28 177.21 4.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.606 -0.684 . . . . 0.0 109.565 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.82 91.46 2.17 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.598 ' C ' HD12 ' A' ' 55' ' ' LEU . . . -88.49 -162.83 38.69 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.622 ' N ' HD12 ' A' ' 55' ' ' LEU . 7.5 mp -115.73 -76.3 0.58 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.605 -0.938 . . . . 0.0 109.513 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.442 ' OD1' HG22 ' A' ' 43' ' ' VAL . 20.8 m-20 61.58 16.81 8.0 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.489 -0.757 . . . . 0.0 110.32 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.413 HG23 ' C ' ' A' ' 56' ' ' ASN . 65.1 p -154.61 132.35 11.45 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.247 -0.908 . . . . 0.0 108.894 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.459 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 3.7 t-20 -124.36 133.24 53.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.538 -0.726 . . . . 0.0 109.872 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.696 ' HA ' HD12 ' A' ' 37' ' ' ILE . 28.6 m-80 -68.74 145.68 53.6 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.597 -0.689 . . . . 0.0 109.453 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.459 ' CE2' ' HB3' ' A' ' 58' ' ' ASN . 14.9 m-85 -158.04 145.91 18.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.634 -0.666 . . . . 0.0 109.343 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.582 ' HB2' ' O ' ' A' ' 33' ' ' ILE . . . -82.73 169.1 16.56 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -62.71 -48.29 79.9 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.442 -0.786 . . . . 0.0 109.601 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -69.32 -18.1 63.78 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.534 -0.729 . . . . 0.0 110.452 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -79.6 -19.14 50.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.178 -0.951 . . . . 0.0 110.256 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.4 mt -102.34 146.38 28.13 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.272 -0.892 . . . . 0.0 109.496 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.429 ' O ' HG13 ' A' ' 68' ' ' VAL . 3.9 tt0 -116.49 88.11 2.83 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.652 -0.655 . . . . 0.0 109.265 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.3 t -57.92 110.9 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.498 -0.751 . . . . 0.0 109.861 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 66' ' ' GLU . 28.4 m -109.67 -29.87 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.645 -0.659 . . . . 0.0 109.485 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.434 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.98 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.512 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.7 t -90.57 162.15 15.13 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.249 -1.148 . . . . 0.0 109.416 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.83 115.58 23.56 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.502 -0.749 . . . . 0.0 109.151 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.82 HG12 HG22 ' A' ' 67' ' ' VAL . 28.4 m -116.85 124.54 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.499 -0.751 . . . . 0.0 110.016 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.464 ' CE ' HD21 ' A' ' 11' ' ' LEU . 9.4 ttpt -79.55 113.48 17.73 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.527 HG22 ' H ' ' A' ' 12' ' ' ARG . 35.3 mm -61.13 131.25 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.591 -0.693 . . . . 0.0 109.707 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.464 HD21 ' CE ' ' A' ' 9' ' ' LYS . 3.5 mm? -115.99 27.01 9.55 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.516 -0.74 . . . . 0.0 109.681 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.527 ' H ' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -85.64 119.77 26.34 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.421 -0.8 . . . . 0.0 109.283 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.87 -73.88 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.427 -0.795 . . . . 0.0 110.25 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -76.57 85.89 3.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.53 -0.731 . . . . 0.0 109.377 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.2 t -152.03 139.92 20.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.537 -0.727 . . . . 0.0 109.663 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.458 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 25.1 t80 -63.97 -15.42 59.2 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.686 -0.634 . . . . 0.0 110.366 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.502 ' CZ3' ' CD1' ' A' ' 40' ' ' PHE . 14.3 m0 -125.22 32.19 5.43 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.096 -1.002 . . . . 0.0 110.258 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.414 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 17.0 t80 -69.32 133.6 48.05 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.474 -0.766 . . . . 0.0 109.098 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.56 -12.73 66.04 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -95.04 -171.01 2.32 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.182 -1.187 . . . . 0.0 109.595 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.0 t -132.39 129.73 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -112.36 157.45 14.94 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 52.7 m -89.02 112.01 22.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.601 -0.941 . . . . 0.0 109.345 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 37.5 t -50.24 130.86 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.401 -0.812 . . . . 0.0 110.621 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -102.28 -48.35 4.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.663 -0.648 . . . . 0.0 109.529 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.486 ' C ' HD12 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -174.37 156.16 2.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.594 -0.691 . . . . 0.0 109.601 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.616 HD12 ' N ' ' A' ' 27' ' ' ILE . 1.8 mp . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.403 ' HB3' ' N ' ' A' ' 60' ' ' PHE . 21.0 m-85 . . . . . 0 N--CA 1.494 1.772 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -81.58 -15.34 9.82 Favored 'Trans proline' 0 C--N 1.325 -0.708 0 C-N-CA 122.007 1.805 . . . . 0.0 111.899 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.568 HG22 HG13 ' A' ' 27' ' ' ILE . 19.9 t -89.39 111.14 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.062 -1.024 . . . . 0.0 110.227 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.1 tp -91.21 117.66 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.322 -0.861 . . . . 0.0 108.725 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.491 HG12 ' N ' ' A' ' 39' ' ' ARG . 44.3 t -94.0 162.98 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.5 -0.75 . . . . 0.0 109.476 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.491 ' N ' HG12 ' A' ' 38' ' ' VAL . 12.0 ttt180 -105.21 152.69 22.54 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.502 ' CD1' ' CZ3' ' A' ' 17' ' ' TRP . 87.3 m-85 -148.86 124.7 10.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.632 -0.667 . . . . 0.0 109.588 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -61.97 -26.18 68.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.497 -0.752 . . . . 0.0 109.214 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.76 160.28 9.66 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.553 -0.717 . . . . 0.0 109.601 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.3 t . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.828 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 . . . . . 0 N--CA 1.509 2.5 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.3 p -127.79 129.75 47.54 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.029 -1.044 . . . . 0.0 109.062 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.445 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 3.4 m-20 -105.75 174.73 5.76 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.572 -0.705 . . . . 0.0 109.425 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.404 ' O ' ' CD1' ' A' ' 60' ' ' PHE . 3.5 m-80 -112.0 140.09 46.96 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.457 ' HB2' HD21 ' A' ' 65' ' ' LEU . 58.1 m-85 -154.82 147.69 24.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.6 -0.687 . . . . 0.0 109.505 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.407 ' HB3' ' HG3' ' A' ' 64' ' ' GLU . . . -82.5 173.2 12.2 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -63.4 -50.57 69.33 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.521 -0.737 . . . . 0.0 109.452 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.44 ' CD2' ' HG2' ' A' ' 64' ' ' GLU . 30.8 p-80 -69.09 -17.11 63.82 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.594 -0.691 . . . . 0.0 110.289 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.44 ' HG2' ' CD2' ' A' ' 63' ' ' HIS . 3.4 mm-40 -79.42 -20.89 46.44 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.251 -0.906 . . . . 0.0 110.054 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.457 HD21 ' HB2' ' A' ' 60' ' ' PHE . 8.3 mt -100.71 146.95 26.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.379 -0.826 . . . . 0.0 109.537 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.454 ' HB2' HD23 ' A' ' 11' ' ' LEU . 10.2 tt0 -117.88 81.48 1.67 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.617 -0.677 . . . . 0.0 109.221 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.82 HG22 HG12 ' A' ' 8' ' ' VAL . 42.0 t -57.88 115.31 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.446 -0.784 . . . . 0.0 109.784 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.42 HG13 ' O ' ' A' ' 66' ' ' GLU . 30.0 m . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.621 -0.675 . . . . 0.0 109.566 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.567 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.2 t -90.55 162.99 14.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.228 -1.16 . . . . 0.0 109.421 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.5 mmtp -79.88 116.51 20.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.513 -0.742 . . . . 0.0 109.239 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 8' ' ' VAL . 30.4 m -118.32 126.85 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.492 -0.755 . . . . 0.0 109.892 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.659 ' CE ' HD21 ' A' ' 11' ' ' LEU . 20.3 ttpt -79.26 125.56 29.64 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.588 ' C ' HD22 ' A' ' 11' ' ' LEU . 26.6 mm -73.86 131.74 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.695 -0.628 . . . . 0.0 109.548 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.659 HD21 ' CE ' ' A' ' 9' ' ' LYS . 4.2 mm? -121.94 27.42 8.1 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.489 -0.757 . . . . 0.0 109.934 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.433 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -89.33 113.06 24.29 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.432 -0.792 . . . . 0.0 109.383 179.83 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.77 -55.4 26.72 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.475 -0.765 . . . . 0.0 110.239 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -84.9 77.19 10.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.544 -0.722 . . . . 0.0 109.382 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.98 137.93 20.24 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.554 -0.717 . . . . 0.0 109.699 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.455 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 16.8 t80 -64.05 -15.31 59.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.782 -0.574 . . . . 0.0 110.245 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.501 ' CE3' ' CD1' ' A' ' 40' ' ' PHE . 10.8 m0 -124.06 33.82 5.2 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.147 -0.971 . . . . 0.0 110.113 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.411 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 47.7 t80 -68.81 133.37 48.21 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.52 -0.738 . . . . 0.0 109.014 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.13 -18.89 55.9 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.42 158.03 15.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -1.142 . . . . 0.0 109.568 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 22' ' ' GLY . 70.0 t -97.08 162.12 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.47 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -143.72 172.64 24.92 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.2 m -102.72 115.36 30.43 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.562 -0.963 . . . . 0.0 109.42 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.4 ' CG2' ' CG1' ' A' ' 8' ' ' VAL . 46.9 t -52.82 113.65 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.277 -0.889 . . . . 0.0 110.005 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.608 ' HB2' ' CG ' ' A' ' 39' ' ' ARG . . . -82.03 -48.38 11.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.659 -0.651 . . . . 0.0 109.777 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.1 m -167.78 156.69 9.57 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.499 -0.751 . . . . 0.0 110.026 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.815 ' CD1' HG13 ' A' ' 36' ' ' VAL . 32.1 mm . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.452 ' HD1' ' HB2' ' A' ' 61' ' ' ALA . 22.1 m-85 . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -81.87 4.24 7.19 Favored 'Trans proline' 0 C--N 1.323 -0.776 0 C-N-CA 122.037 1.825 . . . . 0.0 112.021 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.815 HG13 ' CD1' ' A' ' 27' ' ' ILE . 22.2 t -112.86 112.79 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.977 -1.077 . . . . 0.0 110.505 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -101.41 116.53 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.136 -0.977 . . . . 0.0 108.904 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 39' ' ' ARG . 20.4 t -92.9 164.33 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.499 -0.751 . . . . 0.0 109.008 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.608 ' CG ' ' HB2' ' A' ' 25' ' ' ALA . 6.8 mtt180 -110.14 149.35 30.2 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.545 -0.722 . . . . 0.0 109.386 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.501 ' CD1' ' CE3' ' A' ' 17' ' ' TRP . 59.6 m-85 -142.57 138.54 30.89 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.595 -0.69 . . . . 0.0 109.543 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -62.88 -28.0 69.74 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.582 -0.699 . . . . 0.0 109.573 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.405 ' HB3' ' NE1' ' A' ' 17' ' ' TRP . 0.7 OUTLIER -59.5 162.28 5.09 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.474 -0.766 . . . . 0.0 109.688 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.3 t . . . . . 0 N--CA 1.493 1.705 0 O-C-N 121.588 -0.695 . . . . 0.0 109.488 179.963 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.406 ' C ' HG23 ' A' ' 57' ' ' THR . 7.4 m120 . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 120.423 0.154 . . . . 0.0 110.692 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.406 HG23 ' C ' ' A' ' 56' ' ' ASN . 59.4 p -154.78 129.65 9.4 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.156 -0.965 . . . . 0.0 109.383 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.439 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 13.1 t-20 -109.01 153.92 22.93 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.499 -0.751 . . . . 0.0 109.477 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.429 ' O ' ' CD1' ' A' ' 60' ' ' PHE . 6.2 m-80 -97.63 130.87 44.61 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.555 -0.716 . . . . 0.0 109.531 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.439 ' CE2' ' HB3' ' A' ' 58' ' ' ASN . 32.9 m-85 -146.71 151.02 36.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.648 -0.657 . . . . 0.0 109.273 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.452 ' HB2' ' HD1' ' A' ' 34' ' ' TYR . . . -83.99 174.4 10.36 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -64.66 -42.96 95.05 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.51 -0.744 . . . . 0.0 109.511 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.429 ' CD2' ' HG3' ' A' ' 64' ' ' GLU . 8.7 p-80 -71.74 -23.25 61.58 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.628 -0.67 . . . . 0.0 110.21 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.429 ' HG3' ' CD2' ' A' ' 63' ' ' HIS . 12.4 mt-10 -79.74 -0.49 34.49 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.333 -0.855 . . . . 0.0 110.666 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.468 ' CD1' HG11 ' A' ' 36' ' ' VAL . 13.2 mt -120.8 146.13 46.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.072 -1.018 . . . . 0.0 109.453 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -116.33 91.36 3.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.593 -0.692 . . . . 0.0 109.452 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 43.0 t -60.15 95.02 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.474 -0.766 . . . . 0.0 109.596 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 N--CA 1.493 1.705 0 O-C-N 121.647 -0.658 . . . . 0.0 109.704 -179.908 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.524 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 31.0 t -90.73 162.0 15.09 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.34 -1.094 . . . . 0.0 109.513 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 56.1 mttt -80.57 111.31 16.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.511 -0.743 . . . . 0.0 109.169 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 8' ' ' VAL . 25.6 m -112.75 127.77 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.485 -0.76 . . . . 0.0 109.88 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.72 ' CE ' HD21 ' A' ' 11' ' ' LEU . 28.2 ttpt -79.15 127.67 32.32 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.685 ' C ' HD22 ' A' ' 11' ' ' LEU . 27.8 mm -76.45 132.3 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.642 -0.661 . . . . 0.0 109.326 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.72 HD21 ' CE ' ' A' ' 9' ' ' LYS . 4.4 mm? -124.51 28.92 6.45 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.509 -0.744 . . . . 0.0 109.875 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.411 ' O ' ' CD1' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -89.55 115.72 27.17 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.502 -0.749 . . . . 0.0 109.503 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.7 mmtm -53.03 -62.02 1.92 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.472 -0.768 . . . . 0.0 110.273 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -80.59 82.19 6.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.605 -0.684 . . . . 0.0 109.292 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.2 t -154.43 137.19 15.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.558 -0.714 . . . . 0.0 109.616 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.457 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 15.7 t80 -63.08 -16.32 59.55 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.665 -0.647 . . . . 0.0 110.183 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.495 ' CE3' ' CD2' ' A' ' 40' ' ' PHE . 9.0 m0 -123.91 35.73 4.77 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.188 -0.945 . . . . 0.0 110.0 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.411 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 26.6 t80 -70.17 118.65 13.26 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.63 -20.46 29.64 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.09 158.07 15.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -1.127 . . . . 0.0 109.563 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.474 HG12 ' N ' ' A' ' 22' ' ' GLY . 66.6 t -95.75 162.54 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.474 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -143.45 173.18 24.53 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.5 m -105.61 113.43 26.99 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.407 -1.055 . . . . 0.0 109.488 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 37.7 t -51.28 117.49 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.286 -0.884 . . . . 0.0 110.409 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -89.8 -45.53 9.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.679 -0.638 . . . . 0.0 109.824 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -173.36 165.68 4.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.509 -0.744 . . . . 0.0 109.907 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.832 HD12 HG22 ' A' ' 36' ' ' VAL . 33.8 mm . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.463 ' HD1' ' HB2' ' A' ' 61' ' ' ALA . 16.8 m-85 . . . . . 0 N--CA 1.496 1.863 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -84.27 -21.61 3.64 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.266 1.977 . . . . 0.0 111.961 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.832 HG22 HD12 ' A' ' 27' ' ' ILE . 21.6 t -79.84 111.19 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.225 -0.922 . . . . 0.0 110.728 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.456 HD12 ' CG ' ' A' ' 59' ' ' ASN . 0.7 OUTLIER -96.25 117.93 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.332 -0.855 . . . . 0.0 108.758 178.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 39' ' ' ARG . 21.7 t -96.17 163.77 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.462 -0.774 . . . . 0.0 108.977 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.477 ' N ' HG12 ' A' ' 38' ' ' VAL . 6.7 mtt180 -105.06 149.08 26.12 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.449 -0.782 . . . . 0.0 109.338 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.495 ' CD2' ' CE3' ' A' ' 17' ' ' TRP . 82.0 m-85 -143.47 135.94 27.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.609 -0.682 . . . . 0.0 109.566 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -62.96 -28.93 70.42 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.576 -0.703 . . . . 0.0 109.392 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.27 162.18 6.3 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.605 -0.685 . . . . 0.0 109.614 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.2 t . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.558 -0.714 . . . . 0.0 109.482 179.964 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.407 ' C ' HG23 ' A' ' 57' ' ' THR . 7.2 m120 . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 120.385 0.136 . . . . 0.0 110.717 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.407 HG23 ' C ' ' A' ' 56' ' ' ASN . 72.4 p -154.72 130.39 9.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.151 -0.968 . . . . 0.0 109.206 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.448 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 1.0 OUTLIER -118.39 125.82 50.79 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.444 -0.785 . . . . 0.0 109.67 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.456 ' CG ' HD12 ' A' ' 37' ' ' ILE . 6.7 m-20 -64.01 149.84 46.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.555 -0.716 . . . . 0.0 109.19 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.448 ' CE2' ' HB3' ' A' ' 58' ' ' ASN . 14.5 m-85 -160.57 147.91 15.85 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.463 ' HB2' ' HD1' ' A' ' 34' ' ' TYR . . . -82.82 167.19 18.34 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -62.98 -46.52 87.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.476 -0.765 . . . . 0.0 109.444 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.43 ' CD2' ' HG3' ' A' ' 64' ' ' GLU . 10.2 p-80 -68.7 -20.56 64.42 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.581 -0.7 . . . . 0.0 110.191 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.43 ' HG3' ' CD2' ' A' ' 63' ' ' HIS . 35.7 mt-10 -79.36 -19.7 49.59 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.265 -0.897 . . . . 0.0 110.196 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.418 ' CD1' HG11 ' A' ' 36' ' ' VAL . 14.2 mt -100.92 154.06 18.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.296 -0.877 . . . . 0.0 109.532 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.474 ' O ' HG13 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -124.67 88.75 2.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.547 -0.721 . . . . 0.0 109.393 179.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.0 t -57.75 105.81 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.465 -0.772 . . . . 0.0 109.851 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 66' ' ' GLU . 30.3 m . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.709 -0.62 . . . . 0.0 109.557 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.548 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.0 t -90.42 160.54 16.0 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.169 -1.195 . . . . 0.0 109.48 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.3 mttt -88.59 118.33 28.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.51 -0.744 . . . . 0.0 109.219 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.731 HG12 HG22 ' A' ' 67' ' ' VAL . 33.1 m -118.86 126.16 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.581 -0.699 . . . . 0.0 109.937 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.456 ' CE ' HD21 ' A' ' 11' ' ' LEU . 8.8 ttpt -79.49 116.66 19.85 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.417 HD12 ' CD2' ' A' ' 60' ' ' PHE . 24.3 mm -62.78 131.94 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.651 -0.656 . . . . 0.0 109.539 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.456 HD21 ' CE ' ' A' ' 9' ' ' LYS . 3.6 mm? -114.91 3.36 14.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.498 -0.751 . . . . 0.0 110.598 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.423 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -62.53 120.54 11.32 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.075 -1.016 . . . . 0.0 109.363 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -56.45 -76.48 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.473 -0.767 . . . . 0.0 110.174 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -70.71 89.33 0.74 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.543 -0.723 . . . . 0.0 109.326 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.37 141.88 19.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.573 -0.705 . . . . 0.0 109.801 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.454 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 20.2 t80 -66.75 -13.41 61.36 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.691 -0.631 . . . . 0.0 110.187 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.501 ' CE3' ' CD1' ' A' ' 40' ' ' PHE . 13.8 m0 -126.04 25.73 6.69 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.112 -0.992 . . . . 0.0 110.336 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.406 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 18.9 t80 -67.0 137.11 56.26 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.449 -0.782 . . . . 0.0 109.065 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.36 -9.33 77.64 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -106.24 -169.85 1.64 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.195 -1.179 . . . . 0.0 109.52 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 22' ' ' GLY . 62.2 t -128.06 162.54 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.477 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -145.58 175.1 25.3 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.6 m -106.92 115.14 29.68 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.537 -0.979 . . . . 0.0 109.349 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.0 t -50.3 115.18 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.344 -0.847 . . . . 0.0 110.635 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.554 ' HB2' ' CG ' ' A' ' 39' ' ' ARG . . . -85.35 -47.23 10.22 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.668 -0.645 . . . . 0.0 109.733 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -172.05 160.15 5.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.516 -0.74 . . . . 0.0 109.871 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.817 HD12 HG22 ' A' ' 36' ' ' VAL . 33.1 mm . . . . . 0 N--CA 1.492 1.664 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.4 ' HB3' ' N ' ' A' ' 60' ' ' PHE . 18.7 m-85 . . . . . 0 N--CA 1.496 1.853 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -81.64 -14.22 10.33 Favored 'Trans proline' 0 C--N 1.324 -0.76 0 C-N-CA 122.126 1.884 . . . . 0.0 111.991 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.817 HG22 HD12 ' A' ' 27' ' ' ILE . 24.3 t -94.33 110.72 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.004 -1.06 . . . . 0.0 110.558 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.661 HD12 ' HA ' ' A' ' 59' ' ' ASN . 0.8 OUTLIER -96.15 116.63 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.226 -0.922 . . . . 0.0 108.969 179.093 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 39' ' ' ARG . 21.6 t -92.4 164.6 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.481 -0.762 . . . . 0.0 109.131 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.554 ' CG ' ' HB2' ' A' ' 25' ' ' ALA . 3.3 mtt85 -106.87 146.52 30.87 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.518 -0.739 . . . . 0.0 109.382 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.501 ' CD1' ' CE3' ' A' ' 17' ' ' TRP . 69.0 m-85 -140.26 135.22 32.08 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.583 -0.698 . . . . 0.0 109.589 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -62.7 -27.24 69.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.535 -0.728 . . . . 0.0 109.443 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.26 168.27 1.51 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.509 -0.744 . . . . 0.0 109.686 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.406 HG22 ' OD1' ' A' ' 56' ' ' ASN . 33.3 t . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.593 -0.692 . . . . 0.0 109.453 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.409 ' C ' HG23 ' A' ' 57' ' ' THR . 33.4 m-80 . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 120.423 0.154 . . . . 0.0 110.589 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.409 HG23 ' C ' ' A' ' 56' ' ' ASN . 81.2 p -154.56 129.94 9.77 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.281 -0.887 . . . . 0.0 109.424 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.437 ' HB2' ' CE1' ' A' ' 40' ' ' PHE . 1.6 m-20 -123.99 120.55 32.79 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.528 -0.733 . . . . 0.0 109.509 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.661 ' HA ' HD12 ' A' ' 37' ' ' ILE . 0.7 OUTLIER -62.55 152.72 34.02 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.553 -0.717 . . . . 0.0 109.365 179.755 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 58' ' ' ASN . 17.1 m-85 -161.4 141.85 10.9 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.466 ' HB1' ' CE1' ' A' ' 63' ' ' HIS . . . -73.13 160.12 32.48 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -60.29 -41.84 94.24 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.478 -0.764 . . . . 0.0 109.682 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.466 ' CE1' ' HB1' ' A' ' 61' ' ' ALA . 7.6 p-80 -70.63 -21.97 62.57 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.545 -0.722 . . . . 0.0 110.088 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -79.7 -12.88 59.78 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.397 -0.814 . . . . 0.0 110.393 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.3 mt -103.31 140.17 37.78 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.147 -0.971 . . . . 0.0 109.53 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.7 86.71 2.49 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.609 -0.682 . . . . 0.0 109.345 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.731 HG22 HG12 ' A' ' 8' ' ' VAL . 44.0 t -58.38 117.19 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.453 -0.779 . . . . 0.0 109.732 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.0 m . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.69 -0.632 . . . . 0.0 109.55 -179.985 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.519 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.0 t -90.47 -178.07 5.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.325 -1.103 . . . . 0.0 109.465 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.5 mttt -109.26 112.82 25.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.518 -0.739 . . . . 0.0 109.042 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.73 HG12 HG22 ' A' ' 67' ' ' VAL . 29.2 m -117.09 128.39 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.497 -0.752 . . . . 0.0 110.231 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.685 ' CE ' HD21 ' A' ' 11' ' ' LEU . 25.3 ttpt -79.57 127.16 31.81 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.656 ' C ' HD22 ' A' ' 11' ' ' LEU . 26.1 mm -75.02 132.69 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.719 -0.613 . . . . 0.0 109.418 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.685 HD21 ' CE ' ' A' ' 9' ' ' LYS . 4.3 mm? -124.35 27.73 6.92 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.468 -0.77 . . . . 0.0 110.149 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.406 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -86.97 124.64 33.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.464 -0.773 . . . . 0.0 109.092 179.596 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.6 mtpt -57.6 -70.3 0.14 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.437 -0.789 . . . . 0.0 110.015 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -76.93 85.67 3.48 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.545 -0.722 . . . . 0.0 109.438 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.9 t -151.78 138.92 19.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.526 -0.734 . . . . 0.0 109.627 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.433 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 20.8 t80 -63.79 -15.15 58.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.694 -0.628 . . . . 0.0 110.319 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.497 ' CE3' ' CD2' ' A' ' 40' ' ' PHE . 12.8 m0 -126.48 32.33 5.2 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.18 -0.95 . . . . 0.0 110.386 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.403 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 19.5 t80 -71.04 114.46 9.12 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 118.21 -11.4 12.99 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 120.152 -1.023 . . . . 0.0 110.759 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.26 171.2 7.76 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.084 -1.245 . . . . 0.0 109.512 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 22' ' ' GLY . 59.5 t -103.25 162.43 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.481 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -141.27 157.14 25.98 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 51.0 m -90.74 112.24 23.93 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.56 -0.965 . . . . 0.0 109.368 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.2 t -50.56 131.9 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.357 -0.839 . . . . 0.0 110.522 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.05 -48.53 3.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.728 -0.607 . . . . 0.0 109.713 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.43 -178.02 0.9 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.592 -0.693 . . . . 0.0 109.666 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.715 HD12 HG22 ' A' ' 36' ' ' VAL . 34.1 mm . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.46 ' HD1' ' HB2' ' A' ' 61' ' ' ALA . 16.4 m-85 . . . . . 0 N--CA 1.494 1.746 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -83.26 -20.07 5.2 Favored 'Trans proline' 0 C--N 1.324 -0.722 0 C-N-CA 122.047 1.831 . . . . 0.0 111.735 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.715 HG22 HD12 ' A' ' 27' ' ' ILE . 18.1 t -79.98 110.92 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.248 -0.908 . . . . 0.0 110.497 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.416 HD12 ' HA ' ' A' ' 59' ' ' ASN . 0.6 OUTLIER -96.26 117.23 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.053 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.487 HG12 ' N ' ' A' ' 39' ' ' ARG . 34.5 t -93.35 163.69 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.533 -0.73 . . . . 0.0 109.218 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.487 ' N ' HG12 ' A' ' 38' ' ' VAL . 31.3 ttt180 -105.1 149.36 25.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.637 -0.664 . . . . 0.0 109.368 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.497 ' CD2' ' CE3' ' A' ' 17' ' ' TRP . 82.2 m-85 -145.73 129.27 17.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.584 -0.698 . . . . 0.0 109.582 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -62.56 -28.77 70.1 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.517 -0.74 . . . . 0.0 109.3 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.41 ' HB3' ' NE1' ' A' ' 17' ' ' TRP . 4.9 tptm -60.71 161.52 7.77 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.638 -0.664 . . . . 0.0 109.469 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.1 t . . . . . 0 N--CA 1.494 1.733 0 O-C-N 121.56 -0.713 . . . . 0.0 109.446 179.955 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.4 m120 . . . . . 0 N--CA 1.498 1.925 0 CA-C-O 120.362 0.125 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.8 p -155.32 129.76 9.04 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.187 -0.946 . . . . 0.0 109.134 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.449 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 11.3 t-20 -119.39 124.89 47.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.545 -0.722 . . . . 0.0 109.782 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.425 ' O ' ' CD1' ' A' ' 60' ' ' PHE . 8.2 m120 -63.86 148.86 48.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.581 -0.7 . . . . 0.0 109.31 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.449 ' CE2' ' HB3' ' A' ' 58' ' ' ASN . 14.7 m-85 -159.79 146.01 15.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.6 -0.688 . . . . 0.0 109.41 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.46 ' HB2' ' HD1' ' A' ' 34' ' ' TYR . . . -80.09 168.42 19.17 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -62.66 -46.8 86.53 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.46 -0.775 . . . . 0.0 109.58 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -70.81 -17.22 62.76 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.52 -0.737 . . . . 0.0 110.279 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -79.72 -15.04 58.27 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.251 -0.906 . . . . 0.0 110.37 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.528 ' CD1' HG11 ' A' ' 36' ' ' VAL . 11.0 mt -105.07 154.37 20.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.32 -0.863 . . . . 0.0 109.421 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.505 ' O ' HG13 ' A' ' 68' ' ' VAL . 6.1 tp10 -127.87 84.28 2.23 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.73 HG22 HG12 ' A' ' 8' ' ' VAL . 45.1 t -56.04 113.05 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.432 -0.792 . . . . 0.0 109.897 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 66' ' ' GLU . 30.0 m . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.605 -0.684 . . . . 0.0 109.562 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.547 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.442 ' OG ' HG13 ' A' ' 67' ' ' VAL . 28.4 t -90.5 159.98 16.23 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.319 -1.107 . . . . 0.0 109.566 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.0 mttp -84.6 98.74 10.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.561 -0.712 . . . . 0.0 109.177 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.781 HG12 HG22 ' A' ' 67' ' ' VAL . 26.6 m -99.59 125.41 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.569 -0.707 . . . . 0.0 110.211 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.42 ' CE ' HD21 ' A' ' 11' ' ' LEU . 5.5 tttp -79.23 113.2 17.17 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.484 HG22 ' H ' ' A' ' 12' ' ' ARG . 37.1 mm -61.67 130.48 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.627 -0.671 . . . . 0.0 109.747 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.497 HD13 ' HA ' ' A' ' 11' ' ' LEU . 2.7 mm? -119.01 27.88 8.61 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.81 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.484 ' H ' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -87.04 120.44 28.31 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.452 -0.78 . . . . 0.0 109.261 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.18 -67.2 0.34 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.409 -0.807 . . . . 0.0 109.947 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -80.37 82.68 6.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.479 -0.763 . . . . 0.0 109.416 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -147.99 139.51 23.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.587 -0.696 . . . . 0.0 109.541 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.457 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 20.0 t80 -64.4 -17.41 63.74 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.678 -0.638 . . . . 0.0 110.181 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.5 ' CE3' ' CD1' ' A' ' 40' ' ' PHE . 11.2 m0 -124.25 32.8 5.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.211 -0.931 . . . . 0.0 109.956 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.409 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 13.8 t80 -68.6 134.63 50.25 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.542 -0.724 . . . . 0.0 109.124 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.65 -17.2 58.29 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -100.17 160.12 14.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.238 -1.154 . . . . 0.0 109.647 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 22' ' ' GLY . 60.0 t -95.79 162.73 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.484 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -144.61 154.4 25.78 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 51.6 m -86.92 112.29 21.64 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.553 -0.969 . . . . 0.0 109.223 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 6' ' ' SER . 25.3 t -50.59 128.29 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.383 -0.823 . . . . 0.0 110.652 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.24 -49.93 4.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.557 -0.715 . . . . 0.0 109.226 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.676 ' C ' HD12 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -176.73 171.21 2.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.588 -0.695 . . . . 0.0 109.624 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.676 HD12 ' C ' ' A' ' 26' ' ' SER . 1.8 mp . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.413 ' HB3' ' N ' ' A' ' 60' ' ' PHE . 17.4 m-85 . . . . . 0 N--CA 1.496 1.84 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -81.76 -13.49 10.56 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.008 1.806 . . . . 0.0 111.925 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 37' ' ' ILE . 14.1 t -90.04 163.65 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.137 -0.977 . . . . 0.0 109.988 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.653 HD12 ' HA ' ' A' ' 59' ' ' ASN . 1.3 tp -139.22 116.37 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 39' ' ' ARG . 30.9 t -93.22 163.68 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.506 -0.746 . . . . 0.0 109.477 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.486 ' N ' HG12 ' A' ' 38' ' ' VAL . 28.5 ttt180 -106.42 149.37 27.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.58 -0.7 . . . . 0.0 109.233 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.5 ' CD1' ' CE3' ' A' ' 17' ' ' TRP . 85.1 m-85 -143.88 158.63 43.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.604 -0.685 . . . . 0.0 109.757 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -100.47 31.75 3.33 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -118.71 158.75 24.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.689 -0.632 . . . . 0.0 109.353 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.3 t . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.588 -0.695 . . . . 0.0 109.272 179.886 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.402 ' C ' HG23 ' A' ' 57' ' ' THR . 3.8 m120 . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.402 HG23 ' C ' ' A' ' 56' ' ' ASN . 66.3 p -154.3 130.42 10.33 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.361 -0.837 . . . . 0.0 108.887 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.467 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 4.6 m-20 -115.63 136.94 52.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.543 -0.723 . . . . 0.0 109.685 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.653 ' HA ' HD12 ' A' ' 37' ' ' ILE . 6.6 m120 -74.89 133.79 41.75 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.571 -0.706 . . . . 0.0 109.475 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.467 ' CE2' ' HB3' ' A' ' 58' ' ' ASN . 28.7 m-85 -145.71 152.13 39.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.58 -0.7 . . . . 0.0 109.555 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.77 167.75 17.85 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -64.06 -46.82 82.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.468 -0.77 . . . . 0.0 109.241 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -71.75 -18.15 62.15 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.611 -0.681 . . . . 0.0 110.399 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -79.4 -11.49 59.92 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.278 -0.889 . . . . 0.0 110.274 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.9 mt -107.43 144.34 34.5 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.231 -0.918 . . . . 0.0 109.243 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.604 ' O ' HG13 ' A' ' 68' ' ' VAL . 5.5 tp10 -119.49 83.95 2.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.617 -0.677 . . . . 0.0 109.337 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.781 HG22 HG12 ' A' ' 8' ' ' VAL . 47.0 t -51.65 97.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.323 -0.861 . . . . 0.0 110.064 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.604 HG13 ' O ' ' A' ' 66' ' ' GLU . 30.8 m . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.595 -0.69 . . . . 0.0 109.588 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.532 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.8 t -90.53 -177.48 5.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.317 -1.108 . . . . 0.0 109.414 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.9 mttp -109.8 118.8 37.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.526 -0.734 . . . . 0.0 109.24 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 8' ' ' VAL . 34.4 m -122.96 123.66 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.557 -0.714 . . . . 0.0 109.959 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.415 ' HE2' HD21 ' A' ' 11' ' ' LEU . 9.4 ttpt -79.62 115.15 19.07 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.2 mm -61.49 132.26 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.611 -0.68 . . . . 0.0 109.629 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.464 ' HA ' HD13 ' A' ' 11' ' ' LEU . 3.6 mm? -113.6 1.52 14.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.552 -0.718 . . . . 0.0 110.602 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.411 ' O ' ' CD1' ' A' ' 18' ' ' TYR . 1.8 tmt_? -62.23 119.67 9.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.088 -1.007 . . . . 0.0 109.398 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -56.02 -75.33 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.46 -0.775 . . . . 0.0 110.185 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -69.89 89.78 0.6 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.523 -0.735 . . . . 0.0 109.276 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.3 141.13 14.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.602 -0.686 . . . . 0.0 109.833 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.458 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 20.2 t80 -66.72 -13.06 60.89 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.73 -0.606 . . . . 0.0 110.247 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.458 ' NE1' ' CD2' ' A' ' 16' ' ' TYR . 11.5 m0 -125.04 26.77 6.89 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.066 -1.021 . . . . 0.0 110.334 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.411 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 19.4 t80 -68.07 137.56 55.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.4 -0.812 . . . . 0.0 109.163 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.55 -10.47 69.48 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.786 -0.925 . . . . 0.0 110.786 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.16 -169.58 1.72 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.108 -1.231 . . . . 0.0 109.483 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 22' ' ' GLY . 60.1 t -127.85 162.68 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.476 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -145.75 156.48 26.99 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 49.3 m -89.73 112.78 24.17 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.558 -0.966 . . . . 0.0 109.225 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.0 t -47.77 125.21 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.527 -0.733 . . . . 0.0 110.927 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.1 -46.49 5.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.669 -0.644 . . . . 0.0 109.615 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.664 ' C ' HD12 ' A' ' 27' ' ' ILE . 0.3 OUTLIER -176.64 170.66 2.4 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.529 -0.732 . . . . 0.0 109.631 -179.865 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.664 HD12 ' C ' ' A' ' 26' ' ' SER . 1.8 mp . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.408 ' HB3' ' N ' ' A' ' 60' ' ' PHE . 15.0 m-85 . . . . . 0 N--CA 1.496 1.868 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -82.65 -17.05 7.52 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.048 1.832 . . . . 0.0 111.916 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.8 t -86.56 113.03 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.139 -0.976 . . . . 0.0 110.659 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.465 HD12 ' HA ' ' A' ' 59' ' ' ASN . 1.2 tp -96.39 116.81 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.357 -0.839 . . . . 0.0 108.955 179.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 39' ' ' ARG . 39.2 t -91.3 164.33 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.454 -0.779 . . . . 0.0 109.115 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.486 ' N ' HG12 ' A' ' 38' ' ' VAL . 32.9 ttt180 -102.01 140.76 35.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.561 -0.712 . . . . 0.0 109.386 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.445 ' CE2' ' HB2' ' A' ' 58' ' ' ASN . 91.0 m-85 -137.92 126.88 24.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.559 -0.713 . . . . 0.0 109.647 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -62.47 -27.37 69.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.595 -0.69 . . . . 0.0 109.269 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.73 173.9 0.52 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.584 -0.697 . . . . 0.0 109.573 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 36.8 t . . . . . 0 N--CA 1.493 1.701 0 O-C-N 121.553 -0.717 . . . . 0.0 109.244 179.838 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.411 ' C ' HG23 ' A' ' 57' ' ' THR . 30.9 m-20 . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 120.623 0.249 . . . . 0.0 110.389 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.411 HG23 ' C ' ' A' ' 56' ' ' ASN . 72.1 p -155.06 130.08 9.47 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.181 -0.949 . . . . 0.0 108.984 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.445 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . 0.8 OUTLIER -120.02 148.63 43.33 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.561 -0.712 . . . . 0.0 109.439 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.465 ' HA ' HD12 ' A' ' 37' ' ' ILE . 11.2 m120 -82.9 143.13 30.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.52 -0.737 . . . . 0.0 109.315 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.434 ' CE2' ' HB3' ' A' ' 58' ' ' ASN . 21.4 m-85 -156.63 141.95 17.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.537 -0.727 . . . . 0.0 109.537 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.62 169.06 18.95 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -63.38 -46.23 87.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.513 -0.742 . . . . 0.0 109.454 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 12.7 p-80 -68.93 -18.94 64.17 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.597 -0.689 . . . . 0.0 110.213 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -79.6 -19.65 48.79 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.366 -0.834 . . . . 0.0 110.2 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 19.5 mt -99.37 143.13 29.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.242 -0.911 . . . . 0.0 109.666 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.444 ' HB2' HD23 ' A' ' 11' ' ' LEU . 0.3 OUTLIER -113.02 89.21 3.02 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.759 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.3 t -58.24 115.29 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.495 -0.753 . . . . 0.0 110.018 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.428 HG13 ' O ' ' A' ' 66' ' ' GLU . 28.0 m . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.617 -0.677 . . . . 0.0 109.51 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.42 0 N-CA-C 110.189 -1.165 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.4 t -90.87 -177.36 4.93 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.228 -1.16 . . . . 0.0 109.755 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.7 mtmt -108.59 124.53 50.63 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.504 HG13 ' CG2' ' A' ' 24' ' ' VAL . 34.0 m -118.68 127.16 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.532 -0.73 . . . . 0.0 110.165 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.427 ' HA ' HG22 ' A' ' 21' ' ' VAL . 4.8 tttp -79.48 114.02 18.08 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.475 HG22 ' H ' ' A' ' 12' ' ' ARG . 29.3 mm -59.99 129.62 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.646 -0.659 . . . . 0.0 110.008 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.418 ' HA ' HD13 ' A' ' 11' ' ' LEU . 2.6 mm? -119.62 26.05 9.63 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.659 -0.651 . . . . 0.0 109.567 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.475 ' H ' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -84.88 120.95 27.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.404 -0.81 . . . . 0.0 109.466 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.6 mtpt -59.24 -56.18 25.37 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.497 -0.752 . . . . 0.0 110.004 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -90.31 78.72 6.44 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.483 -0.761 . . . . 0.0 109.921 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.1 p -147.81 141.76 25.88 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.42 -0.8 . . . . 0.0 109.598 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.458 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 21.8 t80 -61.59 -15.6 40.52 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.7 -0.625 . . . . 0.0 110.869 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.495 ' CZ3' ' CD1' ' A' ' 40' ' ' PHE . 11.9 m0 -125.35 35.14 4.8 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.09 -1.006 . . . . 0.0 110.738 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.41 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 20.9 t80 -68.36 130.72 43.72 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.448 -0.783 . . . . 0.0 109.067 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.64 -11.68 62.91 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 120.249 -0.977 . . . . 0.0 110.823 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -109.07 173.94 6.09 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.159 -1.2 . . . . 0.0 109.655 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 22' ' ' GLY . 87.4 t -111.2 162.53 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.483 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -143.07 155.17 25.84 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.7 m -86.13 111.43 20.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.514 -0.992 . . . . 0.0 109.219 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.504 ' CG2' HG13 ' A' ' 8' ' ' VAL . 3.8 t -53.16 140.29 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 121.306 -0.871 . . . . 0.0 109.987 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -109.37 -49.94 3.05 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.544 -0.722 . . . . 0.0 109.706 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -170.96 164.82 7.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.622 -0.674 . . . . 0.0 109.584 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.761 HD12 HG22 ' A' ' 36' ' ' VAL . 38.1 mm . . . . . 0 N--CA 1.494 1.726 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.461 ' HD1' ' HB2' ' A' ' 61' ' ' ALA . 17.6 m-85 . . . . . 0 N--CA 1.494 1.758 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -82.52 -9.53 11.21 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.08 1.854 . . . . 0.0 111.95 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.761 HG22 HD12 ' A' ' 27' ' ' ILE . 21.3 t -93.79 113.46 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 120.962 -1.086 . . . . 0.0 110.261 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.658 HD12 ' HA ' ' A' ' 59' ' ' ASN . 1.6 tp -98.05 116.0 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.17 -0.956 . . . . 0.0 108.78 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 39' ' ' ARG . 40.7 t -92.08 164.58 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.573 -0.704 . . . . 0.0 109.365 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.5 ' N ' HG12 ' A' ' 38' ' ' VAL . 16.5 ttt180 -109.22 149.52 29.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.565 -0.71 . . . . 0.0 109.467 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.495 ' CD1' ' CZ3' ' A' ' 17' ' ' TRP . 61.7 m-85 -146.55 154.71 41.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.581 -0.7 . . . . 0.0 109.486 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -100.82 34.0 2.61 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.409 ' HB3' ' NE1' ' A' ' 17' ' ' TRP . 1.9 tppt? -125.18 55.81 1.37 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.498 HG22 ' OD1' ' A' ' 56' ' ' ASN . 36.8 t . . . . . 0 N--CA 1.494 1.743 0 O-C-N 121.299 -0.876 . . . . 0.0 109.761 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.73 ' O ' HG23 ' A' ' 57' ' ' THR . 3.4 m-20 . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 120.479 0.181 . . . . 0.0 110.547 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.73 HG23 ' O ' ' A' ' 56' ' ' ASN . 0.8 OUTLIER -167.78 132.22 1.8 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.24 -0.913 . . . . 0.0 108.825 179.493 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.45 ' ND2' ' CZ3' ' A' ' 17' ' ' TRP . 0.3 OUTLIER -108.39 167.9 9.7 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.522 -0.736 . . . . 0.0 109.357 -179.755 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.658 ' HA ' HD12 ' A' ' 37' ' ' ILE . 5.6 m120 -104.85 141.44 36.51 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.575 -0.703 . . . . 0.0 109.173 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.495 ' HB2' HD21 ' A' ' 65' ' ' LEU . 42.2 m-85 -155.36 146.61 22.75 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.491 -0.756 . . . . 0.0 109.447 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.461 ' HB2' ' HD1' ' A' ' 34' ' ' TYR . . . -83.0 171.0 14.29 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -62.81 -48.73 77.83 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.543 -0.723 . . . . 0.0 109.571 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 16.2 p-80 -68.0 -20.93 65.06 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.557 -0.714 . . . . 0.0 110.225 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -79.57 -20.49 46.87 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.315 -0.866 . . . . 0.0 110.175 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.552 HD13 HG11 ' A' ' 36' ' ' VAL . 7.9 mt -98.98 146.23 26.24 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.264 -0.897 . . . . 0.0 109.669 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.473 ' O ' HG13 ' A' ' 68' ' ' VAL . 31.5 tt0 -120.63 86.79 2.63 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.8 t -50.97 114.35 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.372 -0.83 . . . . 0.0 110.363 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 66' ' ' GLU . 31.4 m . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.556 -0.715 . . . . 0.0 109.562 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.552 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.423 ' O ' HG23 ' A' ' 24' ' ' VAL . 13.2 t -90.4 162.06 15.28 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.375 -1.073 . . . . 0.0 109.377 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.457 ' HE3' HG11 ' A' ' 21' ' ' VAL . 5.6 mtpp -79.77 116.93 20.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.552 -0.718 . . . . 0.0 109.286 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 8' ' ' VAL . 33.2 m -120.04 122.49 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.533 -0.729 . . . . 0.0 109.776 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.472 ' CE ' HD21 ' A' ' 11' ' ' LEU . 10.1 ttpt -79.38 113.72 17.74 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.416 HD12 ' CD2' ' A' ' 60' ' ' PHE . 27.1 mm -61.78 132.23 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.66 -0.65 . . . . 0.0 109.516 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.472 HD21 ' CE ' ' A' ' 9' ' ' LYS . 3.5 mm? -114.9 5.0 14.98 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.504 -0.747 . . . . 0.0 110.694 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.434 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . 0.2 OUTLIER -62.43 124.44 20.95 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.948 -1.095 . . . . 0.0 109.422 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -59.55 -73.95 0.08 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.483 -0.76 . . . . 0.0 109.818 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -76.32 86.19 3.1 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.575 -0.703 . . . . 0.0 109.359 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.98 143.15 28.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.553 -0.717 . . . . 0.0 109.613 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.45 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 20.0 t80 -66.2 -13.62 60.58 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.682 -0.636 . . . . 0.0 110.191 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.505 ' CE3' ' CD2' ' A' ' 40' ' ' PHE . 13.2 m0 -127.34 25.76 6.09 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.084 -1.01 . . . . 0.0 110.333 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -67.82 127.93 34.62 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.381 -0.824 . . . . 0.0 108.834 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.17 -5.4 49.47 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.639 -0.985 . . . . 0.0 110.639 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -117.72 175.05 5.83 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.111 -1.229 . . . . 0.0 109.359 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 22' ' ' GLY . 54.6 t -108.63 162.5 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.484 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -143.44 154.94 25.82 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.403 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 48.5 m -87.92 111.95 22.0 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.444 -1.033 . . . . 0.0 109.241 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 6' ' ' SER . 47.9 t -51.32 125.41 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.446 -0.784 . . . . 0.0 110.379 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -95.11 -49.98 5.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.716 -0.615 . . . . 0.0 109.441 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.7 ' C ' HD12 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -176.48 175.55 1.74 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.5 -0.75 . . . . 0.0 109.661 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.7 HD12 ' C ' ' A' ' 26' ' ' SER . 1.8 mp . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.418 ' HB3' ' N ' ' A' ' 60' ' ' PHE . 17.5 m-85 . . . . . 0 N--CA 1.494 1.731 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -81.91 -15.97 9.07 Favored 'Trans proline' 0 C--N 1.324 -0.714 0 C-N-CA 122.048 1.832 . . . . 0.0 111.969 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 37' ' ' ILE . 11.7 t -87.22 164.47 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.066 -1.021 . . . . 0.0 109.898 -178.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.603 HD12 ' HA ' ' A' ' 59' ' ' ASN . 1.2 tp -140.62 114.85 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.493 HG12 ' N ' ' A' ' 39' ' ' ARG . 39.5 t -91.45 164.49 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.429 -0.795 . . . . 0.0 109.283 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.493 ' N ' HG12 ' A' ' 38' ' ' VAL . 12.5 ttt85 -105.48 145.14 31.27 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.637 -0.664 . . . . 0.0 109.349 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.505 ' CD2' ' CE3' ' A' ' 17' ' ' TRP . 80.7 m-85 -141.77 136.87 31.14 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.656 -0.653 . . . . 0.0 109.759 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 30.8 m-20 -67.66 -28.19 67.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.551 -0.718 . . . . 0.0 109.094 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.26 165.87 2.46 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.537 -0.727 . . . . 0.0 109.62 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.5 t . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.507 -0.746 . . . . 0.0 109.453 -179.909 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.406 ' C ' HG23 ' A' ' 57' ' ' THR . 3.0 m120 . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 120.544 0.212 . . . . 0.0 110.497 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.406 HG23 ' C ' ' A' ' 56' ' ' ASN . 72.6 p -154.76 129.75 9.48 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.155 -0.966 . . . . 0.0 109.202 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.448 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -117.24 151.22 37.38 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.55 -0.719 . . . . 0.0 109.287 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.603 ' HA ' HD12 ' A' ' 37' ' ' ILE . 5.7 m120 -87.46 134.54 33.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.487 -0.758 . . . . 0.0 109.376 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.448 ' CE2' ' HB3' ' A' ' 58' ' ' ASN . 22.3 m-85 -148.61 150.78 33.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.632 -0.668 . . . . 0.0 109.35 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.9 168.33 17.16 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -64.17 -45.95 86.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.497 -0.752 . . . . 0.0 109.28 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -70.87 -19.75 62.59 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.615 -0.678 . . . . 0.0 110.288 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -79.29 -14.24 59.14 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.292 -0.88 . . . . 0.0 110.215 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.1 mt -103.73 144.38 31.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 109.31 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.439 ' O ' HG13 ' A' ' 68' ' ' VAL . 5.1 tt0 -111.25 87.23 2.49 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.599 -0.688 . . . . 0.0 109.588 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.1 t -58.95 100.88 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.505 -0.747 . . . . 0.0 109.784 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.439 HG13 ' O ' ' A' ' 66' ' ' GLU . 30.7 m . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.625 -0.672 . . . . 0.0 109.598 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.491 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.3 t -90.44 160.88 15.81 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.358 -1.084 . . . . 0.0 109.364 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.4 mtpp -79.88 118.32 21.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.503 -0.748 . . . . 0.0 109.289 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 8' ' ' VAL . 33.0 m -120.3 123.48 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.601 -0.687 . . . . 0.0 109.773 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.461 ' CE ' HD21 ' A' ' 11' ' ' LEU . 4.2 ttpt -79.36 115.13 18.82 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.424 ' CG2' ' CZ ' ' A' ' 60' ' ' PHE . 27.3 mm -62.56 132.14 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.657 -0.652 . . . . 0.0 109.462 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.461 HD21 ' CE ' ' A' ' 9' ' ' LYS . 3.3 mm? -116.5 5.28 13.36 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.489 -0.757 . . . . 0.0 110.786 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.434 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -63.35 124.31 20.94 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.984 -1.072 . . . . 0.0 109.36 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -59.06 -69.31 0.2 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.479 -0.763 . . . . 0.0 109.968 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -81.14 81.87 7.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.602 -0.686 . . . . 0.0 109.337 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.64 143.35 37.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.495 -0.753 . . . . 0.0 109.579 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.449 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 25.4 t80 -64.28 -15.64 60.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.667 -0.646 . . . . 0.0 110.101 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.497 ' CE3' ' CD1' ' A' ' 40' ' ' PHE . 16.2 m0 -129.58 30.71 4.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.254 -0.904 . . . . 0.0 110.242 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.403 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 16.3 t80 -69.17 121.3 16.49 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.45 -8.67 26.41 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 120.205 -0.998 . . . . 0.0 110.63 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -116.36 171.6 7.73 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.065 -1.256 . . . . 0.0 109.512 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 22' ' ' GLY . 60.7 t -104.58 162.63 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.484 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -143.56 153.69 25.04 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 51.8 m -87.91 112.35 22.43 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.566 -0.961 . . . . 0.0 109.239 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.1 t -52.35 127.03 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.458 -0.776 . . . . 0.0 110.186 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -96.48 -49.61 5.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.633 -0.667 . . . . 0.0 109.682 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -173.89 167.8 4.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.638 -0.664 . . . . 0.0 109.748 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.82 HD12 HG22 ' A' ' 36' ' ' VAL . 27.4 mm . . . . . 0 N--CA 1.493 1.703 0 O-C-N 121.609 -0.682 . . . . 0.0 109.255 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.411 ' HB3' ' N ' ' A' ' 60' ' ' PHE . 4.7 m-85 . . . . . 0 N--CA 1.494 1.763 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -82.54 -17.12 7.62 Favored 'Trans proline' 0 C--N 1.325 -0.663 0 C-N-CA 122.131 1.887 . . . . 0.0 111.653 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.82 HG22 HD12 ' A' ' 27' ' ' ILE . 22.0 t -79.6 113.05 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.203 -0.936 . . . . 0.0 110.169 -178.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.696 HD12 ' HA ' ' A' ' 59' ' ' ASN . 1.4 tp -95.45 115.24 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 39' ' ' ARG . 35.3 t -90.8 163.67 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.518 -0.739 . . . . 0.0 109.258 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.49 ' N ' HG12 ' A' ' 38' ' ' VAL . 13.3 ttt180 -106.47 147.95 28.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.595 -0.69 . . . . 0.0 109.221 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.497 ' CD1' ' CE3' ' A' ' 17' ' ' TRP . 79.6 m-85 -144.05 157.62 44.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.553 -0.717 . . . . 0.0 109.502 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -100.07 32.19 3.04 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.413 ' HB3' ' NE1' ' A' ' 17' ' ' TRP . 0.0 OUTLIER -127.33 136.64 52.2 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.519 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.442 HG22 ' OD1' ' A' ' 56' ' ' ASN . 36.2 t . . . . . 0 N--CA 1.493 1.687 0 O-C-N 121.481 -0.762 . . . . 0.0 109.479 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.442 ' OD1' HG22 ' A' ' 43' ' ' VAL . 20.8 m-20 . . . . . 0 N--CA 1.496 1.833 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.413 HG23 ' C ' ' A' ' 56' ' ' ASN . 65.1 p -154.61 132.35 11.45 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.247 -0.908 . . . . 0.0 108.894 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.459 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 3.7 t-20 -124.36 133.24 53.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.538 -0.726 . . . . 0.0 109.872 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.696 ' HA ' HD12 ' A' ' 37' ' ' ILE . 28.6 m-80 -68.74 145.68 53.6 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.597 -0.689 . . . . 0.0 109.453 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.459 ' CE2' ' HB3' ' A' ' 58' ' ' ASN . 14.9 m-85 -158.04 145.91 18.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.634 -0.666 . . . . 0.0 109.343 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.73 169.1 16.56 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -62.71 -48.29 79.9 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.442 -0.786 . . . . 0.0 109.601 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -69.32 -18.1 63.78 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.534 -0.729 . . . . 0.0 110.452 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -79.6 -19.14 50.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.178 -0.951 . . . . 0.0 110.256 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.4 mt -102.34 146.38 28.13 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.272 -0.892 . . . . 0.0 109.496 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.429 ' O ' HG13 ' A' ' 68' ' ' VAL . 3.9 tt0 -116.49 88.11 2.83 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.652 -0.655 . . . . 0.0 109.265 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.3 t -57.92 110.9 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.498 -0.751 . . . . 0.0 109.861 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 66' ' ' GLU . 28.4 m . . . . . 0 N--CA 1.494 1.726 0 O-C-N 121.645 -0.659 . . . . 0.0 109.485 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.669 ' HA ' HG21 ' A' ' 67' ' ' VAL . 59.7 mt 60.13 78.17 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.532 -0.73 . . . . 0.0 109.698 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -87.38 177.84 7.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.551 -0.718 . . . . 0.0 109.473 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 15.1 ttt180 -90.13 126.37 35.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.574 -0.703 . . . . 0.0 109.659 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.68 17.12 78.08 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.7 t -90.57 162.15 15.13 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.249 -1.148 . . . . 0.0 109.416 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.83 115.58 23.56 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.502 -0.749 . . . . 0.0 109.151 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.82 HG12 HG22 ' A' ' 67' ' ' VAL . 28.4 m -116.85 124.54 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.499 -0.751 . . . . 0.0 110.016 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.464 ' CE ' HD21 ' A' ' 11' ' ' LEU . 9.4 ttpt -79.55 113.48 17.73 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.527 HG22 ' H ' ' A' ' 12' ' ' ARG . 35.3 mm -61.13 131.25 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.591 -0.693 . . . . 0.0 109.707 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.464 HD21 ' CE ' ' A' ' 9' ' ' LYS . 3.5 mm? -115.99 27.01 9.55 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.516 -0.74 . . . . 0.0 109.681 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.527 ' H ' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -85.64 119.77 26.34 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.421 -0.8 . . . . 0.0 109.283 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.87 -73.88 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.427 -0.795 . . . . 0.0 110.25 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -76.57 85.89 3.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.53 -0.731 . . . . 0.0 109.377 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.2 t -152.03 139.92 20.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.537 -0.727 . . . . 0.0 109.663 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.458 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 25.1 t80 -63.97 -15.42 59.2 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.686 -0.634 . . . . 0.0 110.366 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.502 ' CZ3' ' CD1' ' A' ' 40' ' ' PHE . 14.3 m0 -125.22 32.19 5.43 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.096 -1.002 . . . . 0.0 110.258 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.414 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 17.0 t80 -69.32 133.6 48.05 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.474 -0.766 . . . . 0.0 109.098 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.56 -12.73 66.04 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -95.04 -171.01 2.32 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.182 -1.187 . . . . 0.0 109.595 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.0 t -132.39 129.73 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -112.36 157.45 14.94 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 52.7 m -89.02 112.01 22.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.601 -0.941 . . . . 0.0 109.345 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 37.5 t -50.24 130.86 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.401 -0.812 . . . . 0.0 110.621 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -102.28 -48.35 4.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.663 -0.648 . . . . 0.0 109.529 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.486 ' C ' HD12 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -174.37 156.16 2.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.594 -0.691 . . . . 0.0 109.601 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.616 HD12 ' N ' ' A' ' 27' ' ' ILE . 1.8 mp -101.39 161.62 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -116.94 119.34 35.02 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.585 -0.697 . . . . 0.0 109.504 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.43 52.31 2.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.572 -0.705 . . . . 0.0 109.315 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.7 t -100.78 -50.67 3.78 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.447 -0.783 . . . . 0.0 109.529 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.62 -2.52 6.08 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.596 HD11 ' HA ' ' A' ' 35' ' ' PRO . 34.3 pt -60.97 -173.06 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.044 -1.268 . . . . 0.0 109.642 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.59 ' O ' ' HB2' ' A' ' 61' ' ' ALA . 16.6 tt -90.04 -25.94 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.508 -0.745 . . . . 0.0 109.903 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.432 ' CE1' HG12 ' A' ' 33' ' ' ILE . 21.0 m-85 -129.29 72.21 81.99 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.41 -0.806 . . . . 0.0 109.412 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.596 ' HA ' HD11 ' A' ' 32' ' ' ILE . 37.1 Cg_endo -81.58 -15.34 9.82 Favored 'Trans proline' 0 C--N 1.325 -0.708 0 C-N-CA 122.007 1.805 . . . . 0.0 111.899 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.568 HG22 HG13 ' A' ' 27' ' ' ILE . 19.9 t -89.39 111.14 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.062 -1.024 . . . . 0.0 110.227 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.1 tp -91.21 117.66 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.322 -0.861 . . . . 0.0 108.725 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.491 HG12 ' N ' ' A' ' 39' ' ' ARG . 44.3 t -94.0 162.98 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.5 -0.75 . . . . 0.0 109.476 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.491 ' N ' HG12 ' A' ' 38' ' ' VAL . 12.0 ttt180 -105.21 152.69 22.54 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.502 ' CD1' ' CZ3' ' A' ' 17' ' ' TRP . 87.3 m-85 -148.86 124.7 10.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.632 -0.667 . . . . 0.0 109.588 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -61.97 -26.18 68.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.497 -0.752 . . . . 0.0 109.214 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.76 160.28 9.66 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.553 -0.717 . . . . 0.0 109.601 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.565 HG11 ' CE2' ' A' ' 45' ' ' TYR . 35.3 t -140.94 162.91 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.491 ' N ' HG12 ' A' ' 43' ' ' VAL . 18.2 t-20 -123.57 136.25 54.43 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.488 -0.757 . . . . 0.0 109.651 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.565 ' CE2' HG11 ' A' ' 43' ' ' VAL . 23.0 m-85 -155.88 28.57 0.37 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.607 -0.683 . . . . 0.0 109.529 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -116.5 97.06 5.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.537 -0.727 . . . . 0.0 109.675 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.71 78.03 0.19 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.401 ' CD2' ' O ' ' A' ' 52' ' ' ALA . 39.6 p90 -120.0 32.55 5.99 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.56 -0.964 . . . . 0.0 109.519 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 60.15 -167.39 0.18 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.535 -0.728 . . . . 0.0 109.688 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -106.74 59.65 0.38 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.1 t -154.16 103.0 2.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.565 -0.962 . . . . 0.0 109.393 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.401 ' O ' ' CD2' ' A' ' 48' ' ' PHE . . . 59.89 -175.09 0.11 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.515 -0.741 . . . . 0.0 109.682 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -155.78 139.31 6.52 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.9 139.16 0.05 OUTLIER Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.56 ' N ' HD22 ' A' ' 55' ' ' LEU . 4.1 mm? -89.35 -61.11 1.77 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.584 -0.95 . . . . 0.0 109.288 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.422 ' CB ' ' O ' ' A' ' 55' ' ' LEU . 9.3 m-20 84.01 -39.75 0.07 Allowed 'General case' 0 N--CA 1.509 2.5 0 O-C-N 122.127 -0.358 . . . . 0.0 110.438 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.3 p -127.79 129.75 47.54 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.029 -1.044 . . . . 0.0 109.062 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.445 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 3.4 m-20 -105.75 174.73 5.76 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.572 -0.705 . . . . 0.0 109.425 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.404 ' O ' ' CD1' ' A' ' 60' ' ' PHE . 3.5 m-80 -112.0 140.09 46.96 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.457 ' HB2' HD21 ' A' ' 65' ' ' LEU . 58.1 m-85 -154.82 147.69 24.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.6 -0.687 . . . . 0.0 109.505 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.59 ' HB2' ' O ' ' A' ' 33' ' ' ILE . . . -82.5 173.2 12.2 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -63.4 -50.57 69.33 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.521 -0.737 . . . . 0.0 109.452 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.44 ' CD2' ' HG2' ' A' ' 64' ' ' GLU . 30.8 p-80 -69.09 -17.11 63.82 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.594 -0.691 . . . . 0.0 110.289 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.44 ' HG2' ' CD2' ' A' ' 63' ' ' HIS . 3.4 mm-40 -79.42 -20.89 46.44 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.251 -0.906 . . . . 0.0 110.054 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.457 HD21 ' HB2' ' A' ' 60' ' ' PHE . 8.3 mt -100.71 146.95 26.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.379 -0.826 . . . . 0.0 109.537 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.454 ' HB2' HD23 ' A' ' 11' ' ' LEU . 10.2 tt0 -117.88 81.48 1.67 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.617 -0.677 . . . . 0.0 109.221 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.82 HG22 HG12 ' A' ' 8' ' ' VAL . 42.0 t -57.88 115.31 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.446 -0.784 . . . . 0.0 109.784 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.42 HG13 ' O ' ' A' ' 66' ' ' GLU . 30.0 m -111.76 -30.42 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.621 -0.675 . . . . 0.0 109.566 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.396 0 CA-C-O 118.029 -1.429 . . . . 0.0 109.568 179.994 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.439 ' HA ' HG21 ' A' ' 67' ' ' VAL . 36.8 mm -108.9 131.4 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.528 -0.732 . . . . 0.0 109.44 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -80.99 161.1 24.4 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.578 -0.701 . . . . 0.0 109.538 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 14.3 ttp180 -90.06 130.04 36.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.582 -0.698 . . . . 0.0 109.481 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 59.77 19.63 50.07 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.2 t -90.55 162.99 14.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.228 -1.16 . . . . 0.0 109.421 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.5 mmtp -79.88 116.51 20.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.513 -0.742 . . . . 0.0 109.239 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 8' ' ' VAL . 30.4 m -118.32 126.85 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.492 -0.755 . . . . 0.0 109.892 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.659 ' CE ' HD21 ' A' ' 11' ' ' LEU . 20.3 ttpt -79.26 125.56 29.64 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.588 ' C ' HD22 ' A' ' 11' ' ' LEU . 26.6 mm -73.86 131.74 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.695 -0.628 . . . . 0.0 109.548 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.659 HD21 ' CE ' ' A' ' 9' ' ' LYS . 4.2 mm? -121.94 27.42 8.1 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.489 -0.757 . . . . 0.0 109.934 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.433 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -89.33 113.06 24.29 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.432 -0.792 . . . . 0.0 109.383 179.83 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.77 -55.4 26.72 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.475 -0.765 . . . . 0.0 110.239 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -84.9 77.19 10.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.544 -0.722 . . . . 0.0 109.382 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.98 137.93 20.24 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.554 -0.717 . . . . 0.0 109.699 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.455 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 16.8 t80 -64.05 -15.31 59.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.782 -0.574 . . . . 0.0 110.245 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.501 ' CE3' ' CD1' ' A' ' 40' ' ' PHE . 10.8 m0 -124.06 33.82 5.2 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.147 -0.971 . . . . 0.0 110.113 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.411 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 47.7 t80 -68.81 133.37 48.21 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.52 -0.738 . . . . 0.0 109.014 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.13 -18.89 55.9 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.42 158.03 15.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -1.142 . . . . 0.0 109.568 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 22' ' ' GLY . 70.0 t -97.08 162.12 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.47 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -143.72 172.64 24.92 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.2 m -102.72 115.36 30.43 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.562 -0.963 . . . . 0.0 109.42 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.4 ' CG2' ' CG1' ' A' ' 8' ' ' VAL . 46.9 t -52.82 113.65 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.277 -0.889 . . . . 0.0 110.005 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.608 ' HB2' ' CG ' ' A' ' 39' ' ' ARG . . . -82.03 -48.38 11.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.659 -0.651 . . . . 0.0 109.777 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.1 m -167.78 156.69 9.57 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.499 -0.751 . . . . 0.0 110.026 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.815 ' CD1' HG13 ' A' ' 36' ' ' VAL . 32.1 mm -114.35 165.03 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.461 ' N ' HG22 ' A' ' 27' ' ' ILE . 2.2 t70 -102.3 -169.14 1.63 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.486 -0.759 . . . . 0.0 109.35 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -96.78 28.65 3.35 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.659 -0.651 . . . . 0.0 109.829 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 18.4 t 59.44 83.22 0.13 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.465 -0.772 . . . . 0.0 109.736 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -154.32 -45.35 0.02 OUTLIER Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.589 HD11 ' HA ' ' A' ' 35' ' ' PRO . 19.0 pt -84.99 -173.62 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.632 -0.922 . . . . 0.0 109.568 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.473 HG22 ' CE1' ' A' ' 34' ' ' TYR . 75.1 mt -72.9 -56.73 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.681 -0.637 . . . . 0.0 109.52 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.473 ' CE1' HG22 ' A' ' 33' ' ' ILE . 22.1 m-85 -115.89 89.47 24.36 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.706 -0.621 . . . . 0.0 109.521 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.589 ' HA ' HD11 ' A' ' 32' ' ' ILE . 37.4 Cg_endo -81.87 4.24 7.19 Favored 'Trans proline' 0 C--N 1.323 -0.776 0 C-N-CA 122.037 1.825 . . . . 0.0 112.021 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.815 HG13 ' CD1' ' A' ' 27' ' ' ILE . 22.2 t -112.86 112.79 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.977 -1.077 . . . . 0.0 110.505 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -101.41 116.53 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.136 -0.977 . . . . 0.0 108.904 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 39' ' ' ARG . 20.4 t -92.9 164.33 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.499 -0.751 . . . . 0.0 109.008 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.608 ' CG ' ' HB2' ' A' ' 25' ' ' ALA . 6.8 mtt180 -110.14 149.35 30.2 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.545 -0.722 . . . . 0.0 109.386 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.501 ' CD1' ' CE3' ' A' ' 17' ' ' TRP . 59.6 m-85 -142.57 138.54 30.89 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.595 -0.69 . . . . 0.0 109.543 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -62.88 -28.0 69.74 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.582 -0.699 . . . . 0.0 109.573 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.405 ' HB3' ' NE1' ' A' ' 17' ' ' TRP . 0.7 OUTLIER -59.5 162.28 5.09 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.474 -0.766 . . . . 0.0 109.688 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.406 HG11 ' CE2' ' A' ' 45' ' ' TYR . 31.3 t -145.13 132.28 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.588 -0.695 . . . . 0.0 109.488 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -108.11 115.18 29.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.534 -0.729 . . . . 0.0 109.488 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.406 ' CE2' HG11 ' A' ' 43' ' ' VAL . 29.9 m-85 -109.68 105.74 15.12 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.593 -0.692 . . . . 0.0 109.503 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -97.29 -34.68 10.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.539 -0.725 . . . . 0.0 109.461 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -167.77 111.32 0.43 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 21.3 p90 -134.61 138.82 44.86 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.574 -0.956 . . . . 0.0 109.514 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.2 t -98.66 35.44 1.83 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.534 -0.729 . . . . 0.0 109.496 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 166.12 -103.8 0.21 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 30.6 t -132.71 -69.21 0.58 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.568 -0.96 . . . . 0.0 109.48 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 60.16 -168.42 0.16 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.489 -0.757 . . . . 0.0 109.655 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.2 -37.53 2.29 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.65 -152.21 21.78 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.629 HD12 ' N ' ' A' ' 55' ' ' LEU . 7.1 mp -78.71 -77.44 0.17 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.61 -0.935 . . . . 0.0 109.408 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.406 ' C ' HG23 ' A' ' 57' ' ' THR . 7.4 m120 63.26 13.5 7.01 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.472 -0.768 . . . . 0.0 110.692 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.406 HG23 ' C ' ' A' ' 56' ' ' ASN . 59.4 p -154.78 129.65 9.4 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.156 -0.965 . . . . 0.0 109.383 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.439 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 13.1 t-20 -109.01 153.92 22.93 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.499 -0.751 . . . . 0.0 109.477 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.429 ' O ' ' CD1' ' A' ' 60' ' ' PHE . 6.2 m-80 -97.63 130.87 44.61 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.555 -0.716 . . . . 0.0 109.531 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.439 ' CE2' ' HB3' ' A' ' 58' ' ' ASN . 32.9 m-85 -146.71 151.02 36.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.648 -0.657 . . . . 0.0 109.273 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.452 ' HB2' ' HD1' ' A' ' 34' ' ' TYR . . . -83.99 174.4 10.36 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -64.66 -42.96 95.05 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.51 -0.744 . . . . 0.0 109.511 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.429 ' CD2' ' HG3' ' A' ' 64' ' ' GLU . 8.7 p-80 -71.74 -23.25 61.58 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.628 -0.67 . . . . 0.0 110.21 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.429 ' HG3' ' CD2' ' A' ' 63' ' ' HIS . 12.4 mt-10 -79.74 -0.49 34.49 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.333 -0.855 . . . . 0.0 110.666 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.468 ' CD1' HG11 ' A' ' 36' ' ' VAL . 13.2 mt -120.8 146.13 46.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.072 -1.018 . . . . 0.0 109.453 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -116.33 91.36 3.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.593 -0.692 . . . . 0.0 109.452 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.439 HG21 ' HA ' ' A' ' 2' ' ' ILE . 43.0 t -60.15 95.02 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.474 -0.766 . . . . 0.0 109.596 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.6 m -82.02 -28.86 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.647 -0.658 . . . . 0.0 109.704 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.384 0 CA-C-O 117.998 -1.446 . . . . 0.0 109.575 179.998 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.6 mm -102.33 128.65 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.573 -0.704 . . . . 0.0 109.492 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -85.28 161.41 19.54 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.604 -0.685 . . . . 0.0 109.502 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.8 ttt85 -90.1 130.54 36.25 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.548 -0.72 . . . . 0.0 109.633 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 59.12 19.71 46.75 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 31.0 t -90.73 162.0 15.09 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.34 -1.094 . . . . 0.0 109.513 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 56.1 mttt -80.57 111.31 16.87 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.511 -0.743 . . . . 0.0 109.169 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 8' ' ' VAL . 25.6 m -112.75 127.77 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.485 -0.76 . . . . 0.0 109.88 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.72 ' CE ' HD21 ' A' ' 11' ' ' LEU . 28.2 ttpt -79.15 127.67 32.32 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.685 ' C ' HD22 ' A' ' 11' ' ' LEU . 27.8 mm -76.45 132.3 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.642 -0.661 . . . . 0.0 109.326 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.72 HD21 ' CE ' ' A' ' 9' ' ' LYS . 4.4 mm? -124.51 28.92 6.45 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.509 -0.744 . . . . 0.0 109.875 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.411 ' O ' ' CD1' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -89.55 115.72 27.17 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.502 -0.749 . . . . 0.0 109.503 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.7 mmtm -53.03 -62.02 1.92 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.472 -0.768 . . . . 0.0 110.273 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -80.59 82.19 6.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.605 -0.684 . . . . 0.0 109.292 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.2 t -154.43 137.19 15.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.558 -0.714 . . . . 0.0 109.616 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.457 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 15.7 t80 -63.08 -16.32 59.55 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.665 -0.647 . . . . 0.0 110.183 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.495 ' CE3' ' CD2' ' A' ' 40' ' ' PHE . 9.0 m0 -123.91 35.73 4.77 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.188 -0.945 . . . . 0.0 110.0 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.411 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 26.6 t80 -70.17 118.65 13.26 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.63 -20.46 29.64 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.09 158.07 15.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -1.127 . . . . 0.0 109.563 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.474 HG12 ' N ' ' A' ' 22' ' ' GLY . 66.6 t -95.75 162.54 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.474 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -143.45 173.18 24.53 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 31.5 m -105.61 113.43 26.99 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.407 -1.055 . . . . 0.0 109.488 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 37.7 t -51.28 117.49 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.286 -0.884 . . . . 0.0 110.409 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -89.8 -45.53 9.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.679 -0.638 . . . . 0.0 109.824 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -173.36 165.68 4.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.509 -0.744 . . . . 0.0 109.907 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.832 HD12 HG22 ' A' ' 36' ' ' VAL . 33.8 mm -115.11 144.05 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -93.55 89.15 6.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.56 -0.713 . . . . 0.0 109.476 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.4 mmtm -63.28 98.76 0.16 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.67 -0.644 . . . . 0.0 109.426 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -161.33 -44.05 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.608 -0.683 . . . . 0.0 109.488 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.1 6.69 10.76 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.779 HD11 ' HA ' ' A' ' 35' ' ' PRO . 41.0 pt -61.16 -171.73 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.236 -1.155 . . . . 0.0 109.775 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.69 HG22 ' CE1' ' A' ' 34' ' ' TYR . 62.3 mt -82.57 -50.76 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.532 -0.73 . . . . 0.0 110.18 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.69 ' CE1' HG22 ' A' ' 33' ' ' ILE . 16.8 m-85 -123.97 78.86 58.22 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.498 -0.751 . . . . 0.0 109.752 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.779 ' HA ' HD11 ' A' ' 32' ' ' ILE . 37.8 Cg_endo -84.27 -21.61 3.64 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.266 1.977 . . . . 0.0 111.961 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.832 HG22 HD12 ' A' ' 27' ' ' ILE . 21.6 t -79.84 111.19 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.225 -0.922 . . . . 0.0 110.728 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.456 HD12 ' CG ' ' A' ' 59' ' ' ASN . 0.7 OUTLIER -96.25 117.93 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.332 -0.855 . . . . 0.0 108.758 178.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 39' ' ' ARG . 21.7 t -96.17 163.77 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.462 -0.774 . . . . 0.0 108.977 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.477 ' N ' HG12 ' A' ' 38' ' ' VAL . 6.7 mtt180 -105.06 149.08 26.12 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.449 -0.782 . . . . 0.0 109.338 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.495 ' CD2' ' CE3' ' A' ' 17' ' ' TRP . 82.0 m-85 -143.47 135.94 27.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.609 -0.682 . . . . 0.0 109.566 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -62.96 -28.93 70.42 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.576 -0.703 . . . . 0.0 109.392 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.27 162.18 6.3 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.605 -0.685 . . . . 0.0 109.614 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.2 t -146.87 120.53 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.558 -0.714 . . . . 0.0 109.482 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -103.0 108.15 19.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.609 -0.682 . . . . 0.0 109.469 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -94.74 88.36 5.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.54 -0.725 . . . . 0.0 109.454 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -134.12 114.18 12.86 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.584 -0.698 . . . . 0.0 109.451 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.93 48.84 1.7 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -119.63 136.85 54.22 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.624 -0.927 . . . . 0.0 109.452 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.2 m -160.76 31.02 0.15 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.552 -0.718 . . . . 0.0 109.477 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 143.95 -78.67 0.26 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.7 t -104.94 90.3 3.42 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.619 -0.93 . . . . 0.0 109.46 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -118.89 -73.39 0.65 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.575 -0.703 . . . . 0.0 109.483 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.77 -33.48 6.05 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.538 ' C ' HD12 ' A' ' 55' ' ' LEU . . . 99.01 -166.66 21.34 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.639 HD12 ' N ' ' A' ' 55' ' ' LEU . 6.8 mp -115.83 -77.04 0.57 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.556 -0.967 . . . . 0.0 109.402 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.407 ' C ' HG23 ' A' ' 57' ' ' THR . 7.2 m120 63.68 13.01 7.03 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.517 -0.74 . . . . 0.0 110.717 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.407 HG23 ' C ' ' A' ' 56' ' ' ASN . 72.4 p -154.72 130.39 9.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.151 -0.968 . . . . 0.0 109.206 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.448 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 1.0 OUTLIER -118.39 125.82 50.79 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.444 -0.785 . . . . 0.0 109.67 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.456 ' CG ' HD12 ' A' ' 37' ' ' ILE . 6.7 m-20 -64.01 149.84 46.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.555 -0.716 . . . . 0.0 109.19 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.448 ' CE2' ' HB3' ' A' ' 58' ' ' ASN . 14.5 m-85 -160.57 147.91 15.85 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.463 ' HB2' ' HD1' ' A' ' 34' ' ' TYR . . . -82.82 167.19 18.34 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -62.98 -46.52 87.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.476 -0.765 . . . . 0.0 109.444 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.43 ' CD2' ' HG3' ' A' ' 64' ' ' GLU . 10.2 p-80 -68.7 -20.56 64.42 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.581 -0.7 . . . . 0.0 110.191 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.43 ' HG3' ' CD2' ' A' ' 63' ' ' HIS . 35.7 mt-10 -79.36 -19.7 49.59 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.265 -0.897 . . . . 0.0 110.196 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.418 ' CD1' HG11 ' A' ' 36' ' ' VAL . 14.2 mt -100.92 154.06 18.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.296 -0.877 . . . . 0.0 109.532 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.474 ' O ' HG13 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -124.67 88.75 2.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.547 -0.721 . . . . 0.0 109.393 179.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.0 t -57.75 105.81 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.465 -0.772 . . . . 0.0 109.851 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 66' ' ' GLU . 30.3 m -114.4 30.29 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.709 -0.62 . . . . 0.0 109.557 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.484 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.898 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.533 ' HA ' HG21 ' A' ' 67' ' ' VAL . 2.5 mp -76.12 105.06 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.569 -0.707 . . . . 0.0 109.491 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -89.34 177.65 6.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.689 -0.632 . . . . 0.0 109.439 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 19.2 mtm180 -90.02 125.37 35.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.558 -0.714 . . . . 0.0 109.609 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.92 10.7 80.49 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.0 t -90.42 160.54 16.0 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.169 -1.195 . . . . 0.0 109.48 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.3 mttt -88.59 118.33 28.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.51 -0.744 . . . . 0.0 109.219 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.731 HG12 HG22 ' A' ' 67' ' ' VAL . 33.1 m -118.86 126.16 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.581 -0.699 . . . . 0.0 109.937 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.456 ' CE ' HD21 ' A' ' 11' ' ' LEU . 8.8 ttpt -79.49 116.66 19.85 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.417 HD12 ' CD2' ' A' ' 60' ' ' PHE . 24.3 mm -62.78 131.94 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.651 -0.656 . . . . 0.0 109.539 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.456 HD21 ' CE ' ' A' ' 9' ' ' LYS . 3.6 mm? -114.91 3.36 14.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.498 -0.751 . . . . 0.0 110.598 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.423 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -62.53 120.54 11.32 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.075 -1.016 . . . . 0.0 109.363 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -56.45 -76.48 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.473 -0.767 . . . . 0.0 110.174 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -70.71 89.33 0.74 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.543 -0.723 . . . . 0.0 109.326 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.37 141.88 19.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.573 -0.705 . . . . 0.0 109.801 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.454 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 20.2 t80 -66.75 -13.41 61.36 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.691 -0.631 . . . . 0.0 110.187 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.501 ' CE3' ' CD1' ' A' ' 40' ' ' PHE . 13.8 m0 -126.04 25.73 6.69 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.112 -0.992 . . . . 0.0 110.336 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.406 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 18.9 t80 -67.0 137.11 56.26 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.449 -0.782 . . . . 0.0 109.065 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.36 -9.33 77.64 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -106.24 -169.85 1.64 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.195 -1.179 . . . . 0.0 109.52 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 22' ' ' GLY . 62.2 t -128.06 162.54 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.477 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -145.58 175.1 25.3 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.6 m -106.92 115.14 29.68 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.537 -0.979 . . . . 0.0 109.349 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.0 t -50.3 115.18 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.344 -0.847 . . . . 0.0 110.635 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.554 ' HB2' ' CG ' ' A' ' 39' ' ' ARG . . . -85.35 -47.23 10.22 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.668 -0.645 . . . . 0.0 109.733 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -172.05 160.15 5.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.516 -0.74 . . . . 0.0 109.871 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.817 HD12 HG22 ' A' ' 36' ' ' VAL . 33.1 mm -109.6 154.84 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -109.5 89.75 3.1 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.523 -0.736 . . . . 0.0 109.403 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.6 tptm -63.12 92.4 0.05 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.551 -0.718 . . . . 0.0 109.488 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.6 m -152.98 -45.62 0.1 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.614 -0.679 . . . . 0.0 109.417 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.86 4.39 10.44 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.837 HD11 ' HA ' ' A' ' 35' ' ' PRO . 40.1 pt -61.21 -171.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.158 -1.201 . . . . 0.0 109.717 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.614 ' O ' ' HB2' ' A' ' 61' ' ' ALA . 87.7 mt -88.39 -35.35 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.488 -0.757 . . . . 0.0 110.241 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.452 ' CE2' ' CG2' ' A' ' 33' ' ' ILE . 18.7 m-85 -130.84 70.44 82.55 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.359 -0.838 . . . . 0.0 109.805 -178.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.837 ' HA ' HD11 ' A' ' 32' ' ' ILE . 37.5 Cg_endo -81.64 -14.22 10.33 Favored 'Trans proline' 0 C--N 1.324 -0.76 0 C-N-CA 122.126 1.884 . . . . 0.0 111.991 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.817 HG22 HD12 ' A' ' 27' ' ' ILE . 24.3 t -94.33 110.72 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.004 -1.06 . . . . 0.0 110.558 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.661 HD12 ' HA ' ' A' ' 59' ' ' ASN . 0.8 OUTLIER -96.15 116.63 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.226 -0.922 . . . . 0.0 108.969 179.093 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 39' ' ' ARG . 21.6 t -92.4 164.6 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.481 -0.762 . . . . 0.0 109.131 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.554 ' CG ' ' HB2' ' A' ' 25' ' ' ALA . 3.3 mtt85 -106.87 146.52 30.87 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.518 -0.739 . . . . 0.0 109.382 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.501 ' CD1' ' CE3' ' A' ' 17' ' ' TRP . 69.0 m-85 -140.26 135.22 32.08 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.583 -0.698 . . . . 0.0 109.589 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -62.7 -27.24 69.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.535 -0.728 . . . . 0.0 109.443 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.26 168.27 1.51 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.509 -0.744 . . . . 0.0 109.686 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.406 HG22 ' OD1' ' A' ' 56' ' ' ASN . 33.3 t -150.26 118.52 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.593 -0.692 . . . . 0.0 109.453 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -86.57 87.9 7.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.532 -0.73 . . . . 0.0 109.521 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.407 ' O ' ' CE1' ' A' ' 48' ' ' PHE . 6.8 m-85 -77.35 -27.56 52.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.529 -0.732 . . . . 0.0 109.678 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 39.1 t30 60.71 -90.15 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.616 -0.678 . . . . 0.0 109.669 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.51 40.74 0.04 OUTLIER Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.407 ' CE1' ' O ' ' A' ' 45' ' ' TYR . 39.3 p90 -119.01 35.45 4.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.506 -0.996 . . . . 0.0 109.448 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.38 163.94 0.06 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.58 -0.7 . . . . 0.0 109.679 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -78.17 -94.44 0.26 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.9 -89.09 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.631 -0.923 . . . . 0.0 109.705 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.12 167.1 20.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.064 -1.022 . . . . 0.0 109.443 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.05 140.55 30.1 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -63.16 -167.81 0.9 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.636 HD12 ' N ' ' A' ' 55' ' ' LEU . 6.9 mp -80.4 -75.99 0.24 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.593 -0.945 . . . . 0.0 109.365 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.409 ' C ' HG23 ' A' ' 57' ' ' THR . 33.4 m-80 61.62 15.78 7.14 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.476 -0.765 . . . . 0.0 110.589 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.409 HG23 ' C ' ' A' ' 56' ' ' ASN . 81.2 p -154.56 129.94 9.77 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.281 -0.887 . . . . 0.0 109.424 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.437 ' HB2' ' CE1' ' A' ' 40' ' ' PHE . 1.6 m-20 -123.99 120.55 32.79 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.528 -0.733 . . . . 0.0 109.509 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.661 ' HA ' HD12 ' A' ' 37' ' ' ILE . 0.7 OUTLIER -62.55 152.72 34.02 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.553 -0.717 . . . . 0.0 109.365 179.755 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 58' ' ' ASN . 17.1 m-85 -161.4 141.85 10.9 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.614 ' HB2' ' O ' ' A' ' 33' ' ' ILE . . . -73.13 160.12 32.48 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -60.29 -41.84 94.24 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.478 -0.764 . . . . 0.0 109.682 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.466 ' CE1' ' HB1' ' A' ' 61' ' ' ALA . 7.6 p-80 -70.63 -21.97 62.57 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.545 -0.722 . . . . 0.0 110.088 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -79.7 -12.88 59.78 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.397 -0.814 . . . . 0.0 110.393 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.3 mt -103.31 140.17 37.78 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.147 -0.971 . . . . 0.0 109.53 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.7 86.71 2.49 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.609 -0.682 . . . . 0.0 109.345 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.731 HG22 HG12 ' A' ' 8' ' ' VAL . 44.0 t -58.38 117.19 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.453 -0.779 . . . . 0.0 109.732 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.0 m -111.49 -30.36 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.69 -0.632 . . . . 0.0 109.55 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.43 0 CA-C-O 117.993 -1.449 . . . . 0.0 109.562 -179.996 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.619 HG23 HG11 ' A' ' 8' ' ' VAL . 2.7 mp -86.38 119.14 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.492 -0.755 . . . . 0.0 109.464 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -89.67 178.67 6.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.623 -0.673 . . . . 0.0 109.528 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 27.7 ttm105 -90.17 140.67 29.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.606 -0.684 . . . . 0.0 109.651 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 59.95 20.38 53.21 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.0 t -90.47 -178.07 5.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.325 -1.103 . . . . 0.0 109.465 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.5 mttt -109.26 112.82 25.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.518 -0.739 . . . . 0.0 109.042 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.73 HG12 HG22 ' A' ' 67' ' ' VAL . 29.2 m -117.09 128.39 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.497 -0.752 . . . . 0.0 110.231 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.685 ' CE ' HD21 ' A' ' 11' ' ' LEU . 25.3 ttpt -79.57 127.16 31.81 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.656 ' C ' HD22 ' A' ' 11' ' ' LEU . 26.1 mm -75.02 132.69 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.719 -0.613 . . . . 0.0 109.418 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.685 HD21 ' CE ' ' A' ' 9' ' ' LYS . 4.3 mm? -124.35 27.73 6.92 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.468 -0.77 . . . . 0.0 110.149 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.406 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -86.97 124.64 33.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.464 -0.773 . . . . 0.0 109.092 179.596 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.6 mtpt -57.6 -70.3 0.14 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.437 -0.789 . . . . 0.0 110.015 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -76.93 85.67 3.48 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.545 -0.722 . . . . 0.0 109.438 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.9 t -151.78 138.92 19.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.526 -0.734 . . . . 0.0 109.627 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.433 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 20.8 t80 -63.79 -15.15 58.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.694 -0.628 . . . . 0.0 110.319 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.497 ' CE3' ' CD2' ' A' ' 40' ' ' PHE . 12.8 m0 -126.48 32.33 5.2 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.18 -0.95 . . . . 0.0 110.386 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.403 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 19.5 t80 -71.04 114.46 9.12 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 118.21 -11.4 12.99 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 120.152 -1.023 . . . . 0.0 110.759 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.26 171.2 7.76 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.084 -1.245 . . . . 0.0 109.512 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 22' ' ' GLY . 59.5 t -103.25 162.43 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.481 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -141.27 157.14 25.98 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 51.0 m -90.74 112.24 23.93 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.56 -0.965 . . . . 0.0 109.368 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.2 t -50.56 131.9 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.357 -0.839 . . . . 0.0 110.522 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.05 -48.53 3.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.728 -0.607 . . . . 0.0 109.713 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.43 -178.02 0.9 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.592 -0.693 . . . . 0.0 109.666 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.715 HD12 HG22 ' A' ' 36' ' ' VAL . 34.1 mm -121.56 163.7 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.472 ' N ' HG22 ' A' ' 27' ' ' ILE . 2.3 t0 -96.45 44.99 1.06 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.525 -0.734 . . . . 0.0 109.356 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp 57.25 21.13 6.33 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.723 -0.611 . . . . 0.0 110.424 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 m 57.83 81.89 0.14 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.232 -0.918 . . . . 0.0 109.867 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -141.63 -75.81 0.04 OUTLIER Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.41 HD11 ' O ' ' A' ' 34' ' ' TYR . 25.2 pt -61.92 167.55 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.573 -0.957 . . . . 0.0 109.678 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.551 HG23 ' CD2' ' A' ' 34' ' ' TYR . 6.7 tp -62.41 -27.84 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.648 -0.657 . . . . 0.0 109.554 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.551 ' CD2' HG23 ' A' ' 33' ' ' ILE . 16.4 m-85 -127.16 75.87 76.58 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.478 -0.764 . . . . 0.0 109.026 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -83.26 -20.07 5.2 Favored 'Trans proline' 0 C--N 1.324 -0.722 0 C-N-CA 122.047 1.831 . . . . 0.0 111.735 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.715 HG22 HD12 ' A' ' 27' ' ' ILE . 18.1 t -79.98 110.92 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.248 -0.908 . . . . 0.0 110.497 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.416 HD12 ' HA ' ' A' ' 59' ' ' ASN . 0.6 OUTLIER -96.26 117.23 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.053 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.487 HG12 ' N ' ' A' ' 39' ' ' ARG . 34.5 t -93.35 163.69 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.533 -0.73 . . . . 0.0 109.218 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.487 ' N ' HG12 ' A' ' 38' ' ' VAL . 31.3 ttt180 -105.1 149.36 25.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.637 -0.664 . . . . 0.0 109.368 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.497 ' CD2' ' CE3' ' A' ' 17' ' ' TRP . 82.2 m-85 -145.73 129.27 17.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.584 -0.698 . . . . 0.0 109.582 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -62.56 -28.77 70.1 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.517 -0.74 . . . . 0.0 109.3 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.41 ' HB3' ' NE1' ' A' ' 17' ' ' TRP . 4.9 tptm -60.71 161.52 7.77 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.638 -0.664 . . . . 0.0 109.469 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.1 t -130.42 122.97 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.56 -0.713 . . . . 0.0 109.446 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.401 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 33.5 t30 -97.05 174.33 6.81 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.562 -0.711 . . . . 0.0 109.432 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.401 ' CG ' ' O ' ' A' ' 44' ' ' ASN . 54.9 m-85 -155.54 112.75 3.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.61 -0.681 . . . . 0.0 109.493 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -101.56 33.34 2.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.626 -0.672 . . . . 0.0 109.475 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.17 69.42 0.83 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -77.6 149.32 34.81 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.656 -0.908 . . . . 0.0 109.449 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.9 t -131.27 31.33 4.39 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.6 -0.687 . . . . 0.0 109.493 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.95 -168.18 13.3 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.1 m 59.91 175.3 0.09 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.513 -0.992 . . . . 0.0 109.742 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -106.96 97.81 7.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.555 -0.715 . . . . 0.0 109.424 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -121.3 -91.38 1.16 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.659 ' C ' HD12 ' A' ' 55' ' ' LEU . . . 67.4 -175.61 25.08 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.659 HD12 ' C ' ' A' ' 54' ' ' GLY . 9.7 mp -116.31 -76.4 0.57 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.552 -0.97 . . . . 0.0 109.409 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.4 m120 64.76 12.0 7.31 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.487 -0.758 . . . . 0.0 110.761 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.8 p -155.32 129.76 9.04 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.187 -0.946 . . . . 0.0 109.134 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.449 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 11.3 t-20 -119.39 124.89 47.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.545 -0.722 . . . . 0.0 109.782 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.425 ' O ' ' CD1' ' A' ' 60' ' ' PHE . 8.2 m120 -63.86 148.86 48.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.581 -0.7 . . . . 0.0 109.31 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.449 ' CE2' ' HB3' ' A' ' 58' ' ' ASN . 14.7 m-85 -159.79 146.01 15.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.6 -0.688 . . . . 0.0 109.41 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.46 ' HB2' ' HD1' ' A' ' 34' ' ' TYR . . . -80.09 168.42 19.17 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.591 ' HA ' HD11 ' A' ' 2' ' ' ILE . 2.5 mp0 -62.66 -46.8 86.53 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.46 -0.775 . . . . 0.0 109.58 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -70.81 -17.22 62.76 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.52 -0.737 . . . . 0.0 110.279 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -79.72 -15.04 58.27 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.251 -0.906 . . . . 0.0 110.37 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.528 ' CD1' HG11 ' A' ' 36' ' ' VAL . 11.0 mt -105.07 154.37 20.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.32 -0.863 . . . . 0.0 109.421 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.505 ' O ' HG13 ' A' ' 68' ' ' VAL . 6.1 tp10 -127.87 84.28 2.23 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.73 HG22 HG12 ' A' ' 8' ' ' VAL . 45.1 t -56.04 113.05 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.432 -0.792 . . . . 0.0 109.897 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 66' ' ' GLU . 30.0 m -120.95 30.17 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.605 -0.684 . . . . 0.0 109.562 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.408 0 CA-C-O 117.968 -1.462 . . . . 0.0 109.589 -179.985 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.6 mm -114.23 129.59 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.592 -0.692 . . . . 0.0 109.478 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.421 ' O ' HG11 ' A' ' 24' ' ' VAL . 3.6 mm-40 -87.87 163.84 16.19 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.648 -0.658 . . . . 0.0 109.375 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.0 ttt-85 -90.03 133.27 34.92 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.556 -0.715 . . . . 0.0 109.469 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.69 21.29 57.89 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.442 ' OG ' HG13 ' A' ' 67' ' ' VAL . 28.4 t -90.5 159.98 16.23 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.319 -1.107 . . . . 0.0 109.566 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.0 mttp -84.6 98.74 10.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.561 -0.712 . . . . 0.0 109.177 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.781 HG12 HG22 ' A' ' 67' ' ' VAL . 26.6 m -99.59 125.41 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.569 -0.707 . . . . 0.0 110.211 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.42 ' CE ' HD21 ' A' ' 11' ' ' LEU . 5.5 tttp -79.23 113.2 17.17 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.484 HG22 ' H ' ' A' ' 12' ' ' ARG . 37.1 mm -61.67 130.48 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.627 -0.671 . . . . 0.0 109.747 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.497 HD13 ' HA ' ' A' ' 11' ' ' LEU . 2.7 mm? -119.01 27.88 8.61 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.81 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.484 ' H ' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -87.04 120.44 28.31 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.452 -0.78 . . . . 0.0 109.261 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.18 -67.2 0.34 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.409 -0.807 . . . . 0.0 109.947 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -80.37 82.68 6.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.479 -0.763 . . . . 0.0 109.416 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -147.99 139.51 23.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.587 -0.696 . . . . 0.0 109.541 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.457 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 20.0 t80 -64.4 -17.41 63.74 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.678 -0.638 . . . . 0.0 110.181 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.5 ' CE3' ' CD1' ' A' ' 40' ' ' PHE . 11.2 m0 -124.25 32.8 5.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.211 -0.931 . . . . 0.0 109.956 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.409 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 13.8 t80 -68.6 134.63 50.25 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.542 -0.724 . . . . 0.0 109.124 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.65 -17.2 58.29 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -100.17 160.12 14.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.238 -1.154 . . . . 0.0 109.647 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 22' ' ' GLY . 60.0 t -95.79 162.73 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.484 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -144.61 154.4 25.78 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 51.6 m -86.92 112.29 21.64 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.553 -0.969 . . . . 0.0 109.223 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 6' ' ' SER . 25.3 t -50.59 128.29 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.383 -0.823 . . . . 0.0 110.652 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.24 -49.93 4.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.557 -0.715 . . . . 0.0 109.226 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.676 ' C ' HD12 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -176.73 171.21 2.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.588 -0.695 . . . . 0.0 109.624 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.676 HD12 ' C ' ' A' ' 26' ' ' SER . 1.8 mp -112.12 163.48 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.408 ' N ' HG22 ' A' ' 27' ' ' ILE . 6.7 t0 -136.95 78.52 1.7 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.558 -0.714 . . . . 0.0 109.517 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.3 mmmt -63.09 92.38 0.05 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.529 -0.732 . . . . 0.0 109.4 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.1 m -124.5 -53.31 1.69 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.589 -0.695 . . . . 0.0 109.638 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 152.81 -23.01 0.81 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.487 HD11 ' HA ' ' A' ' 35' ' ' PRO . 36.8 pt -57.47 173.36 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.31 -1.112 . . . . 0.0 110.008 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.473 HG23 ' CD2' ' A' ' 34' ' ' TYR . 1.3 tp -76.32 -34.01 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.585 -0.697 . . . . 0.0 109.676 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.473 ' CD2' HG23 ' A' ' 33' ' ' ILE . 17.4 m-85 -120.03 81.18 27.45 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.49 -0.756 . . . . 0.0 109.454 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.487 ' HA ' HD11 ' A' ' 32' ' ' ILE . 37.3 Cg_endo -81.76 -13.49 10.56 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.008 1.806 . . . . 0.0 111.925 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 37' ' ' ILE . 14.1 t -90.04 163.65 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.137 -0.977 . . . . 0.0 109.988 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.653 HD12 ' HA ' ' A' ' 59' ' ' ASN . 1.3 tp -139.22 116.37 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 39' ' ' ARG . 30.9 t -93.22 163.68 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.506 -0.746 . . . . 0.0 109.477 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.486 ' N ' HG12 ' A' ' 38' ' ' VAL . 28.5 ttt180 -106.42 149.37 27.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.58 -0.7 . . . . 0.0 109.233 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.5 ' CD1' ' CE3' ' A' ' 17' ' ' TRP . 85.1 m-85 -143.88 158.63 43.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.604 -0.685 . . . . 0.0 109.757 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -100.47 31.75 3.33 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -118.71 158.75 24.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.689 -0.632 . . . . 0.0 109.353 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.429 ' CG1' ' CZ ' ' A' ' 45' ' ' TYR . 38.3 t -142.03 116.68 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.588 -0.695 . . . . 0.0 109.272 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -79.79 106.29 11.71 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.489 -0.757 . . . . 0.0 109.701 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.429 ' CZ ' ' CG1' ' A' ' 43' ' ' VAL . 82.1 m-85 -95.23 43.55 1.09 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.693 -0.629 . . . . 0.0 109.503 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -137.58 -54.85 0.68 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.435 -0.791 . . . . 0.0 109.481 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.25 81.54 1.73 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -131.68 133.7 45.15 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.678 -0.895 . . . . 0.0 109.469 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.6 p -130.68 112.72 13.36 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.552 -0.718 . . . . 0.0 109.533 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 129.8 -126.44 5.08 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -112.78 -33.1 6.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.564 -0.962 . . . . 0.0 109.499 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -114.59 159.97 19.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.569 -0.707 . . . . 0.0 109.542 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -145.72 -154.69 6.23 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.89 117.7 0.03 OUTLIER Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.698 ' N ' HD22 ' A' ' 55' ' ' LEU . 2.6 mm? -106.77 130.8 54.42 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.486 -1.008 . . . . 0.0 109.125 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.402 ' C ' HG23 ' A' ' 57' ' ' THR . 3.8 m120 -117.48 20.5 13.53 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.613 -0.679 . . . . 0.0 109.612 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.402 HG23 ' C ' ' A' ' 56' ' ' ASN . 66.3 p -154.3 130.42 10.33 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.361 -0.837 . . . . 0.0 108.887 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.467 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 4.6 m-20 -115.63 136.94 52.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.543 -0.723 . . . . 0.0 109.685 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.653 ' HA ' HD12 ' A' ' 37' ' ' ILE . 6.6 m120 -74.89 133.79 41.75 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.571 -0.706 . . . . 0.0 109.475 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.467 ' CE2' ' HB3' ' A' ' 58' ' ' ASN . 28.7 m-85 -145.71 152.13 39.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.58 -0.7 . . . . 0.0 109.555 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.77 167.75 17.85 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -64.06 -46.82 82.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.468 -0.77 . . . . 0.0 109.241 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -71.75 -18.15 62.15 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.611 -0.681 . . . . 0.0 110.399 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -79.4 -11.49 59.92 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.278 -0.889 . . . . 0.0 110.274 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.9 mt -107.43 144.34 34.5 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.231 -0.918 . . . . 0.0 109.243 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.604 ' O ' HG13 ' A' ' 68' ' ' VAL . 5.5 tp10 -119.49 83.95 2.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.617 -0.677 . . . . 0.0 109.337 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.781 HG22 HG12 ' A' ' 8' ' ' VAL . 47.0 t -51.65 97.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.323 -0.861 . . . . 0.0 110.064 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.604 HG13 ' O ' ' A' ' 66' ' ' GLU . 30.8 m -97.45 36.14 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.595 -0.69 . . . . 0.0 109.588 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.488 0 CA-C-O 118.024 -1.431 . . . . 0.0 109.59 179.962 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.575 HD11 ' HA ' ' A' ' 62' ' ' GLU . 37.5 mt -70.4 89.64 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.572 -0.705 . . . . 0.0 109.372 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -81.16 -179.16 7.23 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.628 -0.67 . . . . 0.0 109.369 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -89.97 141.88 28.24 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.599 -0.688 . . . . 0.0 109.505 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.69 21.29 57.89 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.8 t -90.53 -177.48 5.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.317 -1.108 . . . . 0.0 109.414 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.9 mttp -109.8 118.8 37.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.526 -0.734 . . . . 0.0 109.24 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 8' ' ' VAL . 34.4 m -122.96 123.66 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.557 -0.714 . . . . 0.0 109.959 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.415 ' HE2' HD21 ' A' ' 11' ' ' LEU . 9.4 ttpt -79.62 115.15 19.07 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.2 mm -61.49 132.26 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.611 -0.68 . . . . 0.0 109.629 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.464 ' HA ' HD13 ' A' ' 11' ' ' LEU . 3.6 mm? -113.6 1.52 14.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.552 -0.718 . . . . 0.0 110.602 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.411 ' O ' ' CD1' ' A' ' 18' ' ' TYR . 1.8 tmt_? -62.23 119.67 9.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.088 -1.007 . . . . 0.0 109.398 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -56.02 -75.33 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.46 -0.775 . . . . 0.0 110.185 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -69.89 89.78 0.6 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.523 -0.735 . . . . 0.0 109.276 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.3 141.13 14.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.602 -0.686 . . . . 0.0 109.833 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.458 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 20.2 t80 -66.72 -13.06 60.89 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.73 -0.606 . . . . 0.0 110.247 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.458 ' NE1' ' CD2' ' A' ' 16' ' ' TYR . 11.5 m0 -125.04 26.77 6.89 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.066 -1.021 . . . . 0.0 110.334 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.411 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 19.4 t80 -68.07 137.56 55.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.4 -0.812 . . . . 0.0 109.163 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.55 -10.47 69.48 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.786 -0.925 . . . . 0.0 110.786 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.16 -169.58 1.72 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.108 -1.231 . . . . 0.0 109.483 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 22' ' ' GLY . 60.1 t -127.85 162.68 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.476 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -145.75 156.48 26.99 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 49.3 m -89.73 112.78 24.17 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.558 -0.966 . . . . 0.0 109.225 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.0 t -47.77 125.21 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.527 -0.733 . . . . 0.0 110.927 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.1 -46.49 5.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.669 -0.644 . . . . 0.0 109.615 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.664 ' C ' HD12 ' A' ' 27' ' ' ILE . 0.3 OUTLIER -176.64 170.66 2.4 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.529 -0.732 . . . . 0.0 109.631 -179.865 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.664 HD12 ' C ' ' A' ' 26' ' ' SER . 1.8 mp -111.95 162.58 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -125.98 74.47 1.43 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.507 -0.746 . . . . 0.0 109.512 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.1 tptt -63.46 92.36 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.484 -0.76 . . . . 0.0 109.449 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.6 t -137.0 -45.24 0.57 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.564 -0.71 . . . . 0.0 109.658 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.24 -20.36 1.91 Allowed Glycine 0 N--CA 1.495 2.571 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.629 HD11 ' HA ' ' A' ' 35' ' ' PRO . 33.8 pt -56.75 174.63 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.296 -1.12 . . . . 0.0 110.112 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.606 ' O ' ' HB2' ' A' ' 61' ' ' ALA . 7.7 tp -90.12 -17.57 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.556 -0.715 . . . . 0.0 110.318 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.478 ' CD2' HG23 ' A' ' 33' ' ' ILE . 15.0 m-85 -130.46 69.31 82.11 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.148 -0.97 . . . . 0.0 109.692 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.629 ' HA ' HD11 ' A' ' 32' ' ' ILE . 37.8 Cg_endo -82.65 -17.05 7.52 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.048 1.832 . . . . 0.0 111.916 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.8 t -86.56 113.03 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.139 -0.976 . . . . 0.0 110.659 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.465 HD12 ' HA ' ' A' ' 59' ' ' ASN . 1.2 tp -96.39 116.81 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.357 -0.839 . . . . 0.0 108.955 179.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 39' ' ' ARG . 39.2 t -91.3 164.33 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.454 -0.779 . . . . 0.0 109.115 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.486 ' N ' HG12 ' A' ' 38' ' ' VAL . 32.9 ttt180 -102.01 140.76 35.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.561 -0.712 . . . . 0.0 109.386 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.445 ' CE2' ' HB2' ' A' ' 58' ' ' ASN . 91.0 m-85 -137.92 126.88 24.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.559 -0.713 . . . . 0.0 109.647 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -62.47 -27.37 69.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.595 -0.69 . . . . 0.0 109.269 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.73 173.9 0.52 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.584 -0.697 . . . . 0.0 109.573 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 36.8 t -150.77 114.37 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.553 -0.717 . . . . 0.0 109.244 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -94.15 144.13 25.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.52 -0.737 . . . . 0.0 109.405 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.431 ' CE1' ' HA3' ' A' ' 54' ' ' GLY . 14.5 m-85 -139.72 165.05 28.3 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.574 -0.704 . . . . 0.0 109.572 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -149.1 82.83 1.44 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.619 -0.676 . . . . 0.0 109.318 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.86 29.27 74.7 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.96 -172.09 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.565 -0.961 . . . . 0.0 110.247 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.1 t -164.53 31.54 0.07 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.591 -0.693 . . . . 0.0 109.407 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 153.86 -161.09 29.75 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 61.0 107.67 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.535 -0.979 . . . . 0.0 109.712 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.22 -60.46 3.54 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.538 -0.726 . . . . 0.0 109.59 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.9 143.64 32.56 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.431 ' HA3' ' CE1' ' A' ' 45' ' ' TYR . . . -141.05 116.86 1.17 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 60.41 -89.98 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.698 -0.884 . . . . 0.0 109.898 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.411 ' C ' HG23 ' A' ' 57' ' ' THR . 30.9 m-20 61.98 15.56 7.36 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.935 -1.103 . . . . 0.0 110.389 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.411 HG23 ' C ' ' A' ' 56' ' ' ASN . 72.1 p -155.06 130.08 9.47 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.181 -0.949 . . . . 0.0 108.984 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.445 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . 0.8 OUTLIER -120.02 148.63 43.33 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.561 -0.712 . . . . 0.0 109.439 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.465 ' HA ' HD12 ' A' ' 37' ' ' ILE . 11.2 m120 -82.9 143.13 30.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.52 -0.737 . . . . 0.0 109.315 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.434 ' CE2' ' HB3' ' A' ' 58' ' ' ASN . 21.4 m-85 -156.63 141.95 17.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.537 -0.727 . . . . 0.0 109.537 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.606 ' HB2' ' O ' ' A' ' 33' ' ' ILE . . . -77.62 169.06 18.95 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.575 ' HA ' HD11 ' A' ' 2' ' ' ILE . 18.6 mt-10 -63.38 -46.23 87.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.513 -0.742 . . . . 0.0 109.454 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 12.7 p-80 -68.93 -18.94 64.17 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.597 -0.689 . . . . 0.0 110.213 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -79.6 -19.65 48.79 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.366 -0.834 . . . . 0.0 110.2 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 19.5 mt -99.37 143.13 29.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.242 -0.911 . . . . 0.0 109.666 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.444 ' HB2' HD23 ' A' ' 11' ' ' LEU . 0.3 OUTLIER -113.02 89.21 3.02 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.759 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.3 t -58.24 115.29 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.495 -0.753 . . . . 0.0 110.018 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.428 HG13 ' O ' ' A' ' 66' ' ' GLU . 28.0 m -119.6 29.22 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.617 -0.677 . . . . 0.0 109.51 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.402 0 CA-C-O 118.013 -1.437 . . . . 0.0 109.525 -179.936 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.605 HD12 ' HG2' ' A' ' 62' ' ' GLU . 54.3 mt 60.42 50.38 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.5 -0.75 . . . . 0.0 109.547 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -79.95 170.94 15.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.498 -0.751 . . . . 0.0 109.282 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.14 151.82 21.41 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.552 -0.718 . . . . 0.0 109.692 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.65 -16.81 59.24 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.189 -1.165 . . . . 0.0 110.189 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.4 t -90.87 -177.36 4.93 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.228 -1.16 . . . . 0.0 109.755 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.7 mtmt -108.59 124.53 50.63 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.504 HG13 ' CG2' ' A' ' 24' ' ' VAL . 34.0 m -118.68 127.16 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.532 -0.73 . . . . 0.0 110.165 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.427 ' HA ' HG22 ' A' ' 21' ' ' VAL . 4.8 tttp -79.48 114.02 18.08 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.475 HG22 ' H ' ' A' ' 12' ' ' ARG . 29.3 mm -59.99 129.62 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.646 -0.659 . . . . 0.0 110.008 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.418 ' HA ' HD13 ' A' ' 11' ' ' LEU . 2.6 mm? -119.62 26.05 9.63 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.659 -0.651 . . . . 0.0 109.567 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.475 ' H ' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -84.88 120.95 27.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.404 -0.81 . . . . 0.0 109.466 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.6 mtpt -59.24 -56.18 25.37 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.497 -0.752 . . . . 0.0 110.004 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -90.31 78.72 6.44 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.483 -0.761 . . . . 0.0 109.921 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.1 p -147.81 141.76 25.88 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.42 -0.8 . . . . 0.0 109.598 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.458 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 21.8 t80 -61.59 -15.6 40.52 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.7 -0.625 . . . . 0.0 110.869 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.495 ' CZ3' ' CD1' ' A' ' 40' ' ' PHE . 11.9 m0 -125.35 35.14 4.8 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.09 -1.006 . . . . 0.0 110.738 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.41 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 20.9 t80 -68.36 130.72 43.72 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.448 -0.783 . . . . 0.0 109.067 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.64 -11.68 62.91 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 120.249 -0.977 . . . . 0.0 110.823 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -109.07 173.94 6.09 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.159 -1.2 . . . . 0.0 109.655 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 22' ' ' GLY . 87.4 t -111.2 162.53 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.483 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -143.07 155.17 25.84 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.7 m -86.13 111.43 20.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.514 -0.992 . . . . 0.0 109.219 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.504 ' CG2' HG13 ' A' ' 8' ' ' VAL . 3.8 t -53.16 140.29 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 121.306 -0.871 . . . . 0.0 109.987 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -109.37 -49.94 3.05 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.544 -0.722 . . . . 0.0 109.706 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -170.96 164.82 7.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.622 -0.674 . . . . 0.0 109.584 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.761 HD12 HG22 ' A' ' 36' ' ' VAL . 38.1 mm -112.14 163.29 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.469 ' N ' HG22 ' A' ' 27' ' ' ILE . 2.1 t0 -101.47 -171.93 2.07 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.637 -0.665 . . . . 0.0 109.323 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -99.64 37.41 1.6 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.448 -0.782 . . . . 0.0 109.536 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.1 t 60.15 32.11 20.79 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.478 -0.764 . . . . 0.0 109.676 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.38 -30.76 48.69 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.557 HD11 ' O ' ' A' ' 34' ' ' TYR . 16.3 pt -124.21 -174.82 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.563 -0.963 . . . . 0.0 109.511 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.497 HG23 ' CD2' ' A' ' 34' ' ' TYR . 16.1 tt -78.37 -27.78 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.537 -0.727 . . . . 0.0 109.488 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.557 ' O ' HD11 ' A' ' 32' ' ' ILE . 17.6 m-85 -121.65 80.1 39.53 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.473 -0.767 . . . . 0.0 109.373 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -82.52 -9.53 11.21 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.08 1.854 . . . . 0.0 111.95 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.761 HG22 HD12 ' A' ' 27' ' ' ILE . 21.3 t -93.79 113.46 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 120.962 -1.086 . . . . 0.0 110.261 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.658 HD12 ' HA ' ' A' ' 59' ' ' ASN . 1.6 tp -98.05 116.0 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.17 -0.956 . . . . 0.0 108.78 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 39' ' ' ARG . 40.7 t -92.08 164.58 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.573 -0.704 . . . . 0.0 109.365 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.5 ' N ' HG12 ' A' ' 38' ' ' VAL . 16.5 ttt180 -109.22 149.52 29.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.565 -0.71 . . . . 0.0 109.467 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.495 ' CD1' ' CZ3' ' A' ' 17' ' ' TRP . 61.7 m-85 -146.55 154.71 41.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.581 -0.7 . . . . 0.0 109.486 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -100.82 34.0 2.61 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.409 ' HB3' ' NE1' ' A' ' 17' ' ' TRP . 1.9 tppt? -125.18 55.81 1.37 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.498 HG22 ' OD1' ' A' ' 56' ' ' ASN . 36.8 t -59.12 114.1 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.299 -0.876 . . . . 0.0 109.761 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -80.3 153.11 28.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.62 -0.675 . . . . 0.0 109.513 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -138.77 78.38 1.67 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.542 -0.724 . . . . 0.0 109.451 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -96.74 -63.68 1.12 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.509 -0.744 . . . . 0.0 109.526 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.421 ' O ' ' CG ' ' A' ' 48' ' ' PHE . . . -163.82 -82.24 0.04 OUTLIER Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.421 ' CG ' ' O ' ' A' ' 47' ' ' GLY . 42.8 p90 40.82 31.09 0.11 Allowed 'General case' 0 N--CA 1.509 2.524 0 O-C-N 122.136 -0.626 . . . . 0.0 111.568 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.6 t -63.03 125.19 23.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.487 -0.758 . . . . 0.0 109.51 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.95 30.68 3.87 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 t -176.11 97.99 0.06 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.552 -0.97 . . . . 0.0 109.532 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 60.14 179.26 0.09 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.456 -0.777 . . . . 0.0 109.612 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.56 -30.26 3.86 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -159.6 166.22 34.79 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.654 HD12 ' N ' ' A' ' 55' ' ' LEU . 6.4 mp -87.9 -74.24 0.46 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.614 -0.933 . . . . 0.0 109.441 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.73 ' O ' HG23 ' A' ' 57' ' ' THR . 3.4 m-20 64.53 13.38 8.16 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.543 -0.723 . . . . 0.0 110.547 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.73 HG23 ' O ' ' A' ' 56' ' ' ASN . 0.8 OUTLIER -167.78 132.22 1.8 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.24 -0.913 . . . . 0.0 108.825 179.493 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.45 ' ND2' ' CZ3' ' A' ' 17' ' ' TRP . 0.3 OUTLIER -108.39 167.9 9.7 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.522 -0.736 . . . . 0.0 109.357 -179.755 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.658 ' HA ' HD12 ' A' ' 37' ' ' ILE . 5.6 m120 -104.85 141.44 36.51 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.575 -0.703 . . . . 0.0 109.173 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.495 ' HB2' HD21 ' A' ' 65' ' ' LEU . 42.2 m-85 -155.36 146.61 22.75 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.491 -0.756 . . . . 0.0 109.447 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.461 ' HB2' ' HD1' ' A' ' 34' ' ' TYR . . . -83.0 171.0 14.29 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.605 ' HG2' HD12 ' A' ' 2' ' ' ILE . 5.7 mt-10 -62.81 -48.73 77.83 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.543 -0.723 . . . . 0.0 109.571 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 16.2 p-80 -68.0 -20.93 65.06 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.557 -0.714 . . . . 0.0 110.225 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -79.57 -20.49 46.87 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.315 -0.866 . . . . 0.0 110.175 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.552 HD13 HG11 ' A' ' 36' ' ' VAL . 7.9 mt -98.98 146.23 26.24 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.264 -0.897 . . . . 0.0 109.669 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.473 ' O ' HG13 ' A' ' 68' ' ' VAL . 31.5 tt0 -120.63 86.79 2.63 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.8 t -50.97 114.35 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.372 -0.83 . . . . 0.0 110.363 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 66' ' ' GLU . 31.4 m -106.9 -29.58 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.556 -0.715 . . . . 0.0 109.562 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.461 0 CA-C-O 117.958 -1.468 . . . . 0.0 109.531 -179.992 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.0 mm -106.06 133.51 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.575 -0.703 . . . . 0.0 109.538 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.431 ' O ' HG11 ' A' ' 24' ' ' VAL . 5.8 mt-10 -80.05 161.54 25.32 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.488 -0.758 . . . . 0.0 109.421 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -90.05 128.94 36.4 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.581 -0.699 . . . . 0.0 109.569 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.57 20.91 56.91 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.423 ' O ' HG23 ' A' ' 24' ' ' VAL . 13.2 t -90.4 162.06 15.28 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.375 -1.073 . . . . 0.0 109.377 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.457 ' HE3' HG11 ' A' ' 21' ' ' VAL . 5.6 mtpp -79.77 116.93 20.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.552 -0.718 . . . . 0.0 109.286 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 8' ' ' VAL . 33.2 m -120.04 122.49 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.533 -0.729 . . . . 0.0 109.776 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.472 ' CE ' HD21 ' A' ' 11' ' ' LEU . 10.1 ttpt -79.38 113.72 17.74 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.416 HD12 ' CD2' ' A' ' 60' ' ' PHE . 27.1 mm -61.78 132.23 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.66 -0.65 . . . . 0.0 109.516 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.472 HD21 ' CE ' ' A' ' 9' ' ' LYS . 3.5 mm? -114.9 5.0 14.98 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.504 -0.747 . . . . 0.0 110.694 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.434 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . 0.2 OUTLIER -62.43 124.44 20.95 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.948 -1.095 . . . . 0.0 109.422 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -59.55 -73.95 0.08 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.483 -0.76 . . . . 0.0 109.818 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -76.32 86.19 3.1 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.575 -0.703 . . . . 0.0 109.359 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.98 143.15 28.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.553 -0.717 . . . . 0.0 109.613 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.45 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 20.0 t80 -66.2 -13.62 60.58 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.682 -0.636 . . . . 0.0 110.191 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.505 ' CE3' ' CD2' ' A' ' 40' ' ' PHE . 13.2 m0 -127.34 25.76 6.09 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.084 -1.01 . . . . 0.0 110.333 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -67.82 127.93 34.62 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.381 -0.824 . . . . 0.0 108.834 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.17 -5.4 49.47 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.639 -0.985 . . . . 0.0 110.639 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -117.72 175.05 5.83 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.111 -1.229 . . . . 0.0 109.359 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 22' ' ' GLY . 54.6 t -108.63 162.5 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.484 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -143.44 154.94 25.82 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.403 ' HB ' ' HB3' ' A' ' 39' ' ' ARG . 48.5 m -87.92 111.95 22.0 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.444 -1.033 . . . . 0.0 109.241 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.431 HG11 ' O ' ' A' ' 3' ' ' GLU . 47.9 t -51.32 125.41 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.446 -0.784 . . . . 0.0 110.379 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -95.11 -49.98 5.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.716 -0.615 . . . . 0.0 109.441 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.7 ' C ' HD12 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -176.48 175.55 1.74 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.5 -0.75 . . . . 0.0 109.661 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.7 HD12 ' C ' ' A' ' 26' ' ' SER . 1.8 mp -113.65 164.36 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.417 ' N ' HG22 ' A' ' 27' ' ' ILE . 9.5 t0 -135.62 96.17 3.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.477 -0.764 . . . . 0.0 109.546 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.5 mmtm -71.64 89.2 0.99 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.642 -0.661 . . . . 0.0 109.282 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.5 m -123.25 -58.37 1.63 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.593 -0.692 . . . . 0.0 109.603 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.67 -21.67 1.03 Allowed Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.099 -1.201 . . . . 0.0 110.099 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 29.8 pt -57.65 163.66 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.212 -1.17 . . . . 0.0 110.019 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.472 HG23 ' CD2' ' A' ' 34' ' ' TYR . 5.0 tt -69.22 -26.27 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.595 -0.691 . . . . 0.0 109.759 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.472 ' CD2' HG23 ' A' ' 33' ' ' ILE . 17.5 m-85 -121.65 78.82 38.74 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.402 -0.811 . . . . 0.0 109.312 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -81.91 -15.97 9.07 Favored 'Trans proline' 0 C--N 1.324 -0.714 0 C-N-CA 122.048 1.832 . . . . 0.0 111.969 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 37' ' ' ILE . 11.7 t -87.22 164.47 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.066 -1.021 . . . . 0.0 109.898 -178.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.603 HD12 ' HA ' ' A' ' 59' ' ' ASN . 1.2 tp -140.62 114.85 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.493 HG12 ' N ' ' A' ' 39' ' ' ARG . 39.5 t -91.45 164.49 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.429 -0.795 . . . . 0.0 109.283 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.493 ' N ' HG12 ' A' ' 38' ' ' VAL . 12.5 ttt85 -105.48 145.14 31.27 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.637 -0.664 . . . . 0.0 109.349 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.505 ' CD2' ' CE3' ' A' ' 17' ' ' TRP . 80.7 m-85 -141.77 136.87 31.14 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.656 -0.653 . . . . 0.0 109.759 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 30.8 m-20 -67.66 -28.19 67.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.551 -0.718 . . . . 0.0 109.094 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.26 165.87 2.46 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.537 -0.727 . . . . 0.0 109.62 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.717 HG11 ' CZ ' ' A' ' 45' ' ' TYR . 31.5 t -149.16 120.32 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.507 -0.746 . . . . 0.0 109.453 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -93.1 92.8 7.96 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.599 -0.688 . . . . 0.0 109.482 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.717 ' CZ ' HG11 ' A' ' 43' ' ' VAL . 66.9 m-85 -80.95 -58.73 2.95 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.58 -0.7 . . . . 0.0 109.446 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 60.03 32.6 21.13 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.545 -0.722 . . . . 0.0 109.674 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.434 ' O ' ' CG ' ' A' ' 48' ' ' PHE . . . 122.65 176.29 14.91 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.434 ' CG ' ' O ' ' A' ' 47' ' ' GLY . 42.6 p90 40.82 31.12 0.11 Allowed 'General case' 0 N--CA 1.509 2.513 0 O-C-N 122.052 -0.675 . . . . 0.0 111.6 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.8 t -63.49 96.98 0.13 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.562 -0.711 . . . . 0.0 109.425 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -151.34 36.42 0.87 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 59.97 -167.5 0.17 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.505 -0.997 . . . . 0.0 109.745 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 63.23 -89.0 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.597 -0.689 . . . . 0.0 109.727 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.93 142.03 44.43 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 173.69 165.5 30.52 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.643 HD12 ' N ' ' A' ' 55' ' ' LEU . 6.8 mp -97.9 -76.96 0.51 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.615 -0.932 . . . . 0.0 109.381 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.406 ' C ' HG23 ' A' ' 57' ' ' THR . 3.0 m120 61.6 15.98 7.3 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.505 -0.747 . . . . 0.0 110.497 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.406 HG23 ' C ' ' A' ' 56' ' ' ASN . 72.6 p -154.76 129.75 9.48 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.155 -0.966 . . . . 0.0 109.202 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.448 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -117.24 151.22 37.38 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.55 -0.719 . . . . 0.0 109.287 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.603 ' HA ' HD12 ' A' ' 37' ' ' ILE . 5.7 m120 -87.46 134.54 33.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.487 -0.758 . . . . 0.0 109.376 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.448 ' CE2' ' HB3' ' A' ' 58' ' ' ASN . 22.3 m-85 -148.61 150.78 33.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.632 -0.668 . . . . 0.0 109.35 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.9 168.33 17.16 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -64.17 -45.95 86.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.497 -0.752 . . . . 0.0 109.28 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -70.87 -19.75 62.59 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.615 -0.678 . . . . 0.0 110.288 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -79.29 -14.24 59.14 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.292 -0.88 . . . . 0.0 110.215 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.1 mt -103.73 144.38 31.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 109.31 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.439 ' O ' HG13 ' A' ' 68' ' ' VAL . 5.1 tt0 -111.25 87.23 2.49 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.599 -0.688 . . . . 0.0 109.588 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.1 t -58.95 100.88 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.505 -0.747 . . . . 0.0 109.784 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.439 HG13 ' O ' ' A' ' 66' ' ' GLU . 30.7 m -103.6 -29.06 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.625 -0.672 . . . . 0.0 109.598 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.377 0 CA-C-O 117.986 -1.452 . . . . 0.0 109.564 -179.994 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 39.2 mm -101.43 136.11 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.571 -0.706 . . . . 0.0 109.404 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -79.93 162.22 25.08 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.577 -0.702 . . . . 0.0 109.529 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -90.07 129.27 36.39 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.644 -0.66 . . . . 0.0 109.523 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.71 18.97 54.22 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.3 t -90.44 160.88 15.81 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.358 -1.084 . . . . 0.0 109.364 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.4 mtpp -79.88 118.32 21.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.503 -0.748 . . . . 0.0 109.289 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 8' ' ' VAL . 33.0 m -120.3 123.48 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.601 -0.687 . . . . 0.0 109.773 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.461 ' CE ' HD21 ' A' ' 11' ' ' LEU . 4.2 ttpt -79.36 115.13 18.82 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.424 ' CG2' ' CZ ' ' A' ' 60' ' ' PHE . 27.3 mm -62.56 132.14 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.657 -0.652 . . . . 0.0 109.462 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.461 HD21 ' CE ' ' A' ' 9' ' ' LYS . 3.3 mm? -116.5 5.28 13.36 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.489 -0.757 . . . . 0.0 110.786 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.434 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -63.35 124.31 20.94 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.984 -1.072 . . . . 0.0 109.36 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -59.06 -69.31 0.2 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.479 -0.763 . . . . 0.0 109.968 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -81.14 81.87 7.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.602 -0.686 . . . . 0.0 109.337 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.64 143.35 37.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.495 -0.753 . . . . 0.0 109.579 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.449 ' CD2' ' NE1' ' A' ' 17' ' ' TRP . 25.4 t80 -64.28 -15.64 60.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.667 -0.646 . . . . 0.0 110.101 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.497 ' CE3' ' CD1' ' A' ' 40' ' ' PHE . 16.2 m0 -129.58 30.71 4.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.254 -0.904 . . . . 0.0 110.242 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.403 ' CD1' ' O ' ' A' ' 12' ' ' ARG . 16.3 t80 -69.17 121.3 16.49 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.45 -8.67 26.41 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 120.205 -0.998 . . . . 0.0 110.63 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -116.36 171.6 7.73 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.065 -1.256 . . . . 0.0 109.512 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 22' ' ' GLY . 60.7 t -104.58 162.63 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.484 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -143.56 153.69 25.04 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 51.8 m -87.91 112.35 22.43 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.566 -0.961 . . . . 0.0 109.239 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.1 t -52.35 127.03 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.458 -0.776 . . . . 0.0 110.186 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -96.48 -49.61 5.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.633 -0.667 . . . . 0.0 109.682 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -173.89 167.8 4.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.638 -0.664 . . . . 0.0 109.748 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.82 HD12 HG22 ' A' ' 36' ' ' VAL . 27.4 mm -113.73 164.3 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.609 -0.682 . . . . 0.0 109.255 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.459 ' N ' HG22 ' A' ' 27' ' ' ILE . 0.6 OUTLIER -101.15 44.65 1.0 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.58 -0.7 . . . . 0.0 109.283 179.831 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? 57.17 21.36 6.45 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.665 -0.647 . . . . 0.0 110.399 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 31.1 t 57.02 81.74 0.13 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.213 -0.929 . . . . 0.0 109.872 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -135.09 -70.88 0.07 OUTLIER Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.495 HD11 ' HA ' ' A' ' 35' ' ' PRO . 17.8 pt -69.64 178.04 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.547 -0.972 . . . . 0.0 109.907 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.582 ' O ' ' HB2' ' A' ' 61' ' ' ALA . 61.6 mt -68.65 -32.78 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.65 -0.656 . . . . 0.0 109.474 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.465 ' CE1' ' CG2' ' A' ' 33' ' ' ILE . 4.7 m-85 -131.97 70.4 80.68 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.547 -0.721 . . . . 0.0 109.101 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.495 ' HA ' HD11 ' A' ' 32' ' ' ILE . 37.6 Cg_endo -82.54 -17.12 7.62 Favored 'Trans proline' 0 C--N 1.325 -0.663 0 C-N-CA 122.131 1.887 . . . . 0.0 111.653 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.82 HG22 HD12 ' A' ' 27' ' ' ILE . 22.0 t -79.6 113.05 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.203 -0.936 . . . . 0.0 110.169 -178.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.696 HD12 ' HA ' ' A' ' 59' ' ' ASN . 1.4 tp -95.45 115.24 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 39' ' ' ARG . 35.3 t -90.8 163.67 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.518 -0.739 . . . . 0.0 109.258 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.49 ' N ' HG12 ' A' ' 38' ' ' VAL . 13.3 ttt180 -106.47 147.95 28.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.595 -0.69 . . . . 0.0 109.221 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.497 ' CD1' ' CE3' ' A' ' 17' ' ' TRP . 79.6 m-85 -144.05 157.62 44.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.553 -0.717 . . . . 0.0 109.502 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -100.07 32.19 3.04 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.413 ' HB3' ' NE1' ' A' ' 17' ' ' TRP . 0.0 OUTLIER -127.33 136.64 52.2 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.519 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.696 HG11 ' CZ ' ' A' ' 45' ' ' TYR . 36.2 t -108.91 141.88 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.481 -0.762 . . . . 0.0 109.479 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -119.68 96.54 5.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.528 -0.732 . . . . 0.0 109.458 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.696 ' CZ ' HG11 ' A' ' 43' ' ' VAL . 82.1 m-85 -83.72 88.19 7.07 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.569 -0.707 . . . . 0.0 109.495 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -97.92 122.02 40.53 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.619 -0.676 . . . . 0.0 109.489 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.25 73.98 0.57 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -121.62 134.87 55.0 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.541 -0.976 . . . . 0.0 109.507 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.5 m -161.13 31.09 0.14 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.607 -0.683 . . . . 0.0 109.517 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 124.19 49.09 0.21 Allowed Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.8 m -154.26 151.77 29.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.555 -0.968 . . . . 0.0 109.482 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -111.28 177.21 4.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.606 -0.684 . . . . 0.0 109.565 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.82 91.46 2.17 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.598 ' C ' HD12 ' A' ' 55' ' ' LEU . . . -88.49 -162.83 38.69 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.622 HD12 ' N ' ' A' ' 55' ' ' LEU . 7.5 mp -115.73 -76.3 0.58 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.605 -0.938 . . . . 0.0 109.513 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.442 ' OD1' HG22 ' A' ' 43' ' ' VAL . 20.8 m-20 61.58 16.81 8.0 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.489 -0.757 . . . . 0.0 110.32 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.413 HG23 ' C ' ' A' ' 56' ' ' ASN . 65.1 p -154.61 132.35 11.45 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.247 -0.908 . . . . 0.0 108.894 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.459 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 3.7 t-20 -124.36 133.24 53.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.538 -0.726 . . . . 0.0 109.872 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.696 ' HA ' HD12 ' A' ' 37' ' ' ILE . 28.6 m-80 -68.74 145.68 53.6 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.597 -0.689 . . . . 0.0 109.453 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.459 ' CE2' ' HB3' ' A' ' 58' ' ' ASN . 14.9 m-85 -158.04 145.91 18.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.634 -0.666 . . . . 0.0 109.343 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.582 ' HB2' ' O ' ' A' ' 33' ' ' ILE . . . -82.73 169.1 16.56 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -62.71 -48.29 79.9 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.442 -0.786 . . . . 0.0 109.601 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -69.32 -18.1 63.78 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.534 -0.729 . . . . 0.0 110.452 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -79.6 -19.14 50.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.178 -0.951 . . . . 0.0 110.256 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.4 mt -102.34 146.38 28.13 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.272 -0.892 . . . . 0.0 109.496 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.429 ' O ' HG13 ' A' ' 68' ' ' VAL . 3.9 tt0 -116.49 88.11 2.83 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.652 -0.655 . . . . 0.0 109.265 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.3 t -57.92 110.9 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.498 -0.751 . . . . 0.0 109.861 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 66' ' ' GLU . 28.4 m -109.67 -29.87 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.645 -0.659 . . . . 0.0 109.485 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.434 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.98 . . . . . . . . 0 0 . 1 stop_ save_